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Abstract
Health Equity Indicators for the English NHS: a longitudinal
whole-population study at the small-area level
Richard Cookson,1* Miqdad Asaria,1 Shehzad Ali,1,2 Brian Ferguson,3
Robert Fleetcroft,4 Maria Goddard,1 Peter Goldblatt,5
Mauro Laudicella6 and Rosalind Raine7
1Centre for Health Economics, University of York, York, UK
2Department of Health Sciences, University of York, York, UK
3Knowledge and Intelligence, Public Health England, York, UK
4Norwich Medical School, University of East Anglia, Norwich, UK
5Institute of Health Equity, University College London, London, UK
6School of Health Sciences, City University, London, UK
7Department of Applied Health Research, University College London, London, UK
*Corresponding author richard.cookson@york.ac.uk
Background: Inequalities in health-care access and outcomes raise concerns about quality of care and
justice, and the NHS has a statutory duty to consider reducing them.
Objectives: The objectives were to (1) develop indicators of socioeconomic inequality in health-care access
and outcomes at different stages of the patient pathway; (2) develop methods for monitoring local NHS equity
performance in tackling socioeconomic health-care inequalities; (3) track the evolution of socioeconomic
health-care inequalities in the 2000s; and (4) develop ‘equity dashboards’ for communicating equity findings
to decision-makers in a clear and concise format.
Design: Longitudinal whole-population study at the small-area level.
Setting: England from 2001/2 to 2011/12.
Participants: A total of 32,482 small-area neighbourhoods (lower-layer super output areas) of
approximately 1500 people.
Main outcome measures: Slope index of inequality gaps between the most and least deprived
neighbourhoods in England, adjusted for need or risk, for (1) patients per family doctor, (2) primary care
quality, (3) inpatient hospital waiting time, (4) emergency hospitalisation for chronic ambulatory
care-sensitive conditions, (5) repeat emergency hospitalisation in the same year, (6) dying in hospital,
(7) mortality amenable to health care and (8) overall mortality.
Data sources: Practice-level workforce data from the general practice census (indicator 1), practice-level
Quality and Outcomes Framework data (indicator 2), inpatient hospital data from Hospital Episode
Statistics (indicators 3–6) and mortality data from the Office for National Statistics (indicators 6–8).
Results: Between 2004/5 and 2011/12, more deprived neighbourhoods gained larger absolute
improvements on all indicators except waiting time, repeat hospitalisation and dying in hospital.
In 2011/12, there was little measurable inequality in primary care supply and quality, but inequality
was associated with 171,119 preventable hospitalisations and 41,123 deaths amenable to health care.
In 2011/12, > 20% of Clinical Commissioning Groups performed statistically significantly better or worse
than the England equity benchmark.
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Limitations: General practitioner supply is a limited measure of primary care access, need in deprived
neighbourhoods may be underestimated because of a lack of data on multimorbidity, and the quality and
outcomes indicators capture only one aspect of primary care quality. Health-care outcomes are adjusted for
age and sex but not for other risk factors that contribute to unequal health-care outcomes and may be
outside the control of the NHS, so they overestimate the extent of inequality for which the NHS can
reasonably be held responsible.
Conclusions: NHS actions can have a measurable impact on socioeconomic inequality in both health-care
access and outcomes. Reducing inequality in health-care outcomes is more challenging than reducing
inequality of access to health care. Local health-care equity monitoring against a national benchmark can
be performed using any administrative geography comprising ≥ 100,000 people.
Future work: Exploration of quality improvement lessons from local areas performing well and badly
on health-care equity, improved methods including better measures of need and risk and measures of
health-care inequality over the life-course, and monitoring of other dimensions of equity. These indicators
can also be used to evaluate the health-care equity impacts of interventions and make international
health-care equity comparisons.
Funding: The National Institute for Health Research Health Services and Delivery Research programme.
ABSTRACT
NIHR Journals Library www.journalslibrary.nihr.ac.uk
vi
Contents
List of tables xi
List of figures xiii
List of abbreviations xix
Plain English summary xxi
Scientific summary xxiii
Chapter 1 Introduction 1
Overview 1
Background on equity in health care 6
Why monitoring health-care equity is important 6
Concepts of equity in health care 7
Monitoring of equity in health and health care in England 10
Conceptual framework 12
Chapter 2 Public involvement 15
Introduction 15
Methods of public consultation 16
Sampling 16
Questionnaire 16
Data collection 17
Results of public consultation 17
Survey sample 17
Ranking of unfair inequalities 18
Rating of unfair inequalities 20
Role of the lay members of the advisory group 21
Conclusion 21
Chapter 3 Indicator selection 23
Introduction 23
Indicator selection criteria 24
General criteria for each individual indicator 24
Technical criteria for each individual indicator 25
Criteria for selecting an appropriate mix of indicators within each domain 25
Criteria for selecting the two disease-specific indicator domains 26
Indicator review process 27
Indicator consultation process 28
Potential quasi-experiments and additional indicators 29
Potential quasi-experiments 29
Additional indicators 29
DOI: 10.3310/hsdr04260 HEALTH SERVICES AND DELIVERY RESEARCH 2016 VOL. 4 NO. 26
© Queen’s Printer and Controller of HMSO 2016. This work was produced by Cookson et al. under the terms of a commissioning contract issued by the Secretary of State for
Health. This issue may be freely reproduced for the purposes of private research and study and extracts (or indeed, the full report) may be included in professional journals
provided that suitable acknowledgement is made and the reproduction is not associated with any form of advertising. Applications for commercial reproduction should be
addressed to: NIHR Journals Library, National Institute for Health Research, Evaluation, Trials and Studies Coordinating Centre, Alpha House, University of Southampton Science
Park, Southampton SO16 7NS, UK.
vii
Chapter 4 Methods 33
Introduction 33
Data sources 33
Small-area geography 33
Small-area deprivation 33
Small-area population 34
Attribution Data Set 34
General and Personal Medical Services 34
Quality and Outcomes Framework 34
Hospital Episode Statistics 34
Office for National Statistics mortality 35
Linkage and aggregation of data 35
Data cleaning 36
Adjustment for need and risk factors 36
National inequality indicators 38
Local inequality indicators 41
Chapter 5 Results 45
Introduction 45
Population 45
Primary care supply 48
Primary care quality 49
Hospital waiting time 54
Preventable hospitalisation 58
Repeat hospitalisation 76
Dying in hospital 83
Amenable mortality 85
Overall mortality 92
Summary of findings on local health-care equity monitoring 101
Chapter 6 Development of equity visualisation tools 111
Introduction 111
Development of equity dashboards 112
Development of equity chart packs 114
Development of equity custom graphs 115
Chapter 7 Prototype equity dashboards 117
Notes on how to read the national dashboard 117
Notes on how to read the local equity dashboard 119
Chapter 8 Discussion 123
Summary of findings 123
National equity findings in 2011/12 123
National trends during the 2000s 124
Local equity findings in 2011/12 126
Strengths and weaknesses of the study 126
Strengths 126
Weaknesses 127
Comparison with other studies 127
Primary care supply 127
Primary care quality 128
Waiting time 128
Preventable hospitalisation 128
CONTENTS
NIHR Journals Library www.journalslibrary.nihr.ac.uk
viii
Repeat hospitalisation 128
Dying in hospital 129
Amenable mortality 129
Overall mortality 129
Implications for clinicians, policy-makers and managers 129
Chapter 9 Conclusion and research recommendations 133
Main conclusions 133
NHS actions can have measurable impacts on socioeconomic inequality in both
health-care access and health-care outcomes 133
Increasing the number of primary care physicians and paying them for the quality of
care they provide has been associated with small impacts on reducing inequality in
health-care outcomes, although the causal link between primary care inputs and
health-care outcomes has not been established in this study 133
Local NHS equity monitoring against a national NHS equity benchmark can produce
useful findings both to help managers improve quality and to enhance
democratic accountability 134
Currently, the most useful indicators for local NHS equity monitoring are primary care
supply, primary care quality and preventable hospitalisation 134
National NHS monitoring of change over time in NHS equity can usefully be done
using a much wider range of indicators of health-care access and outcomes, including
disease-specific indicators 134
Indicators of equity are more useful to decision-makers if they are presented together
on the same page, alongside information about average NHS performance, and
accompanied by graphs showing the underlying inequality patterns 135
Variants on our equity indicators could be used for international comparisons of
equity in health care and for evaluating the impacts of interventions on equity in
health care 135
Technical conclusions about equity indicator production and communication 136
Visualisation: as well as producing a headline equity statistic (e.g. the slope index of
inequality), we recommend visualising inequality levels and trends by producing
‘equity chart packs’ that include cross-sectional scatterplots showing the shape of the
social gradient, time trend line plots showing recent change in the social gradient,
matrix plots showing the breakdown of equity patterns by age and sex group, and
caterpillar plots showing how equity in your area compares with equity in other areas
and against the national benchmark 136
Periodicity and indicator year: we recommend updating both national and local equity
indicators on an annual basis, based on the financial year 136
Data lags: it should be possible to release updated indicators for the previous financial
year in autumn or spring each year 136
Inequality measures: we recommend using the slope index of inequality as the
primary headline measure, supplemented by a battery of further measures including
at least one relative measure such as the relative index of inequality and ideally both
a relative shortfall measure and a relative attainment measure 137
Recommendations for further research 137
To investigate potential explanations for variation in health-care equity performance
between local NHS areas, so that health-care managers can learn quality
improvement lessons 138
To perform experimental and quasi-experimental evaluations of the impacts of
complex interventions on socioeconomic inequalities in health-care access and
outcomes, including interventions to improve system-wide co-ordination between
different specialties, health-care settings and public services 138
DOI: 10.3310/hsdr04260 HEALTH SERVICES AND DELIVERY RESEARCH 2016 VOL. 4 NO. 26
© Queen’s Printer and Controller of HMSO 2016. This work was produced by Cookson et al. under the terms of a commissioning contract issued by the Secretary of State for
Health. This issue may be freely reproduced for the purposes of private research and study and extracts (or indeed, the full report) may be included in professional journals
provided that suitable acknowledgement is made and the reproduction is not associated with any form of advertising. Applications for commercial reproduction should be
addressed to: NIHR Journals Library, National Institute for Health Research, Evaluation, Trials and Studies Coordinating Centre, Alpha House, University of Southampton Science
Park, Southampton SO16 7NS, UK.
ix
To make international health-care equity comparisons using these indicators of
health-care access and outcomes 138
To develop better measures of small-area-level need for primary care, by investigating
how multiple morbidity and disadvantage combine to generate additional
health-care needs 138
To develop convincing methods for risk-adjusting small-area-level health-care
outcomes for exogenous morbidity factors beyond the control of health-care services 139
To develop methods for monitoring other social dimensions of health-care inequality 139
To improve these indicator methods by refining and adding indicators, decomposing
national inequality into between-area and within-area components, and exploring the
use of statistical process control methods, direct standardisation methods and
non-linear functional forms 139
To develop sources of small-area-level data on the supply, utilisation, quality and
outcomes of public and private social care and other goods and services that may
influence health-care outcomes 140
Acknowledgements 141
References 145
Appendix 1 Prototype coronary heart disease indicators 159
Appendix 2 Prototype diabetes indicators 175
Appendix 3 Advisory group members 191
Appendix 4 Indicator definitions 193
Appendix 5 Trimming analysis 205
Appendix 6 Public consultation materials 217
Appendix 7 Letters of support 221
CONTENTS
NIHR Journals Library www.journalslibrary.nihr.ac.uk
x
List of tables
TABLE 1 Respondent characteristics of citizens’ panel and online groups 18
TABLE 2 Rating of unfairness of different types of inequalities in health and
health care 20
TABLE 3 The number and percentage of CCGs detected as performing
significantly better or worse than the national benchmark for health-care equity
in 2011/12 110
TABLE 4 The QOF target for HbA1c level 175
TABLE 5 The ONS classification of emergency diabetes admissions 177
TABLE 6 Component weights for the calculation of patient-level overall
workload weights 194
TABLE 7 List of conditions in the QOF 195
TABLE 8 The ICD-10 codes for chronic ambulatory care-sensitive conditions.
This is based on the list produced by the ONS and adopted by the NHS
Outcomes Framework 197
TABLE 9 The ONS list of causes of death considered amenable to health care.
Note that the ONS produce separate lists for ‘amenable’ and ‘preventable’
deaths, where the latter are considered preventable by wider public health
activities outside the health-care system. In line with the NHS Outcomes
Framework, we use the former list (i.e. ‘amenable’) 201
DOI: 10.3310/hsdr04260 HEALTH SERVICES AND DELIVERY RESEARCH 2016 VOL. 4 NO. 26
© Queen’s Printer and Controller of HMSO 2016. This work was produced by Cookson et al. under the terms of a commissioning contract issued by the Secretary of State for
Health. This issue may be freely reproduced for the purposes of private research and study and extracts (or indeed, the full report) may be included in professional journals
provided that suitable acknowledgement is made and the reproduction is not associated with any form of advertising. Applications for commercial reproduction should be
addressed to: NIHR Journals Library, National Institute for Health Research, Evaluation, Trials and Studies Coordinating Centre, Alpha House, University of Southampton Science
Park, Southampton SO16 7NS, UK.
xi

List of figures
FIGURE 1 Conceptual framework for monitoring inequality in health-care access
and outcomes at key stages of the patient pathway 12
FIGURE 2 National monitoring of change in equity over time 13
FIGURE 3 Local equity monitoring against a national benchmark: preventable
hospitalisation in neighbourhoods in a fictional NHS area (Any Town) 14
FIGURE 4 Choice of the most unfair type of inequality in the citizens’ panel and
online samples 19
FIGURE 5 Generic national absolute inequality graph showing the SII slope,
inequality gap, national and decile averages for the indicator 40
FIGURE 6 Absolute inequality graph for a hypothetical CCG showing the AGI
slope, inequality gap, within-CCG LSOA-level results, national and CCG average
for an example indicator (e.g. preventable hospitalisation per 1000 general
population) 42
FIGURE 7 The CCG-level caterpillar plot comparing absolute inequality at the
CCG level in terms of AGI to absolute inequality at the national level in terms of SII 43
FIGURE 8 Correlations between deprivation and average and inequality
performance at the CCG level 44
FIGURE 9 Population matrix showing breakdown by deprivation group,
age group and sex (y-axes fixed for comparison across age groups) 46
FIGURE 10 Population matrix showing breakdown by deprivation group,
age group and sex (y-axes free for comparison across deprivation groups) 47
FIGURE 11 Unadjusted equity time trends in patients per GP 50
FIGURE 12 Adjusted equity time trends in patients per GP 51
FIGURE 13 National social gradient in patients per GP in 2011/12: adjusted 52
FIGURE 14 Caterpillar plot of the AGI of inequality in patients per GP in 2011/12
at the CCG level 52
FIGURE 15 Scatterplots of CCG performance on patients per GP in 2011/12 against
deprivation, showing both mean performance and equity performance (AGI) 53
FIGURE 16 National equity trends in primary care quality: adjustment not necessary 55
FIGURE 17 National social gradient in primary care quality in 2011/12:
adjustment not necessary 56
DOI: 10.3310/hsdr04260 HEALTH SERVICES AND DELIVERY RESEARCH 2016 VOL. 4 NO. 26
© Queen’s Printer and Controller of HMSO 2016. This work was produced by Cookson et al. under the terms of a commissioning contract issued by the Secretary of State for
Health. This issue may be freely reproduced for the purposes of private research and study and extracts (or indeed, the full report) may be included in professional journals
provided that suitable acknowledgement is made and the reproduction is not associated with any form of advertising. Applications for commercial reproduction should be
addressed to: NIHR Journals Library, National Institute for Health Research, Evaluation, Trials and Studies Coordinating Centre, Alpha House, University of Southampton Science
Park, Southampton SO16 7NS, UK.
xiii
FIGURE 18 Caterpillar plot of the AGI of inequality in primary care quality in
2011/12 at the CCG level 56
FIGURE 19 Scatterplots of CCG performance on primary care quality in 2011/12
against deprivation, showing both mean performance and equity performance
(AGI) 57
FIGURE 20 Matrix plot showing unadjusted trends in inpatient hospital waiting
time by age, sex and deprivation (fixed axes for comparisons across age groups) 59
FIGURE 21 Matrix plot showing unadjusted trends in inpatient hospital waiting
time by age, sex and deprivation (free axes for comparisons across deprivation
groups) 60
FIGURE 22 Unadjusted national equity trends in inpatient hospital waiting time 61
FIGURE 23 Adjusted national equity trends in inpatient hospital waiting time 63
FIGURE 24 National social gradient in inpatient hospital waiting time in 2011/12 65
FIGURE 25 Caterpillar plot of AGI of inequality in inpatient hospital waiting time
in 2011/12 at the CCG level 65
FIGURE 26 Scatterplots of CCG performance on inpatient hospital waiting time
in 2011/12 against deprivation, showing both mean performance and equity
performance (AGI) 66
FIGURE 27 Matrix plot showing unadjusted trends in preventable hospitalisation
by age, sex and deprivation (fixed axes for comparisons across age groups) 68
FIGURE 28 Matrix plot showing unadjusted trends in preventable hospitalisation
by age, sex and deprivation (free axes for comparisons across deprivation groups) 69
FIGURE 29 Unadjusted national equity trends in preventable hospitalisation 70
FIGURE 30 Adjusted national equity trends in preventable hospitalisation 72
FIGURE 31 Scatterplots of CCG performance on preventable hospitalisation in
2011/12 against deprivation, showing both mean performance and equity
performance (AGI) 74
FIGURE 32 National social gradient in preventable hospitalisation in 2011/12 75
FIGURE 33 Caterpillar plot of the AGI of inequality in preventable hospitalisation
in 2011/12 at the CCG level 75
FIGURE 34 Matrix plot showing unadjusted trends in repeat hospitalisation by
age, sex and deprivation (fixed axes for comparisons across age groups) 77
FIGURE 35 Matrix plot showing unadjusted trends in repeat hospitalisation by
age, sex and deprivation (free axes for comparisons across deprivation groups) 78
FIGURE 36 Unadjusted national equity time trends in repeat hospitalisation 79
LIST OF FIGURES
NIHR Journals Library www.journalslibrary.nihr.ac.uk
xiv
FIGURE 37 Adjusted national equity time trends in repeat hospitalisation 81
FIGURE 38 National social gradient in repeat hospitalisation in 2011/12 83
FIGURE 39 Scatterplots of CCG performance on repeat hospitalisation in 2011/12
against deprivation, showing both mean performance and equity performance
(AGI) 84
FIGURE 40 Caterpillar plot of AGI of inequality in repeat hospitalisation in
2011/12 at the CCG level 85
FIGURE 41 Matrix plot showing unadjusted trends in dying in hospital by age,
sex and deprivation (fixed axes for comparisons across age groups) 86
FIGURE 42 Matrix plot showing unadjusted trends in dying in hospital by age,
sex and deprivation (free axes for comparisons across deprivation groups) 87
FIGURE 43 National equity trends in dying in hospital – adjustment not necessary 88
FIGURE 44 National social gradient in dying in hospital in 2011/12 90
FIGURE 45 Scatterplots of CCG performance on dying in hospital in 2011/12
against deprivation, showing both mean performance and equity performance
(AGI) 90
FIGURE 46 Caterpillar plot of the AGI of inequality in dying in hospital in 2011/12
at the CCG level 91
FIGURE 47 Matrix plot showing unadjusted trends in amenable mortality by age,
sex and deprivation (fixed axes for comparisons across age groups) 93
FIGURE 48 Matrix plot showing unadjusted trends in amenable mortality by age,
sex and deprivation (free axes for comparisons across deprivation groups) 94
FIGURE 49 Unadjusted national equity trends in amenable mortality 95
FIGURE 50 Adjusted national equity trends for amenable mortality 97
FIGURE 51 National social gradient in amenable mortality in 2011/12 99
FIGURE 52 Scatterplots of CCG performance on amenable mortality 2011/12
against deprivation, showing both mean performance and equity performance
(AGI) 99
FIGURE 53 Caterpillar plot of AGI of inequality in amenable mortality in 2011/12
at the CCG level 100
FIGURE 54 Matrix plot showing unadjusted trends in overall mortality by age,
sex and deprivation (fixed axes for comparisons across age groups) 102
FIGURE 55 Matrix plot showing unadjusted trends in overall mortality by age,
sex and deprivation (free axes for comparisons across deprivation groups) 103
DOI: 10.3310/hsdr04260 HEALTH SERVICES AND DELIVERY RESEARCH 2016 VOL. 4 NO. 26
© Queen’s Printer and Controller of HMSO 2016. This work was produced by Cookson et al. under the terms of a commissioning contract issued by the Secretary of State for
Health. This issue may be freely reproduced for the purposes of private research and study and extracts (or indeed, the full report) may be included in professional journals
provided that suitable acknowledgement is made and the reproduction is not associated with any form of advertising. Applications for commercial reproduction should be
addressed to: NIHR Journals Library, National Institute for Health Research, Evaluation, Trials and Studies Coordinating Centre, Alpha House, University of Southampton Science
Park, Southampton SO16 7NS, UK.
xv
FIGURE 56 Unadjusted national equity trends in mortality 104
FIGURE 57 Adjusted national equity trends in mortality 106
FIGURE 58 National social gradient in mortality in 2011/12 108
FIGURE 59 Caterpillar plot of AGI of inequality in mortality in 2011/12 at the
CCG level 108
FIGURE 60 Scatterplots of CCG performance on all-cause mortality in 2011/12
against deprivation, showing both mean performance and equity performance
(AGI) 109
FIGURE 61 National NHS equity dashboard 2011/12 118
FIGURE 62 National equity dashboard notes 119
FIGURE 63 The CCG equity dashboard 2011/12; ‘Any Town’ CCG 120
FIGURE 64 The CCG equity dashboard 2011/12 local indicator notes 121
FIGURE 65 Equity time trend in CHD primary care quality 161
FIGURE 66 National social gradient in CHD primary care quality in 2011/12 163
FIGURE 67 Unadjusted equity time trend in emergency hospitalisation for CHD 164
FIGURE 68 Adjusted equity time trend in emergency hospitalisation for CHD 166
FIGURE 69 National social gradient in emergency hospitalisation for CHD in
2011/12 168
FIGURE 70 Unadjusted equity time trend in mortality from CHD 169
FIGURE 71 Adjusted equity time trend in mortality from CHD 171
FIGURE 72 National social gradient in mortality from CHD in 2011/12 173
FIGURE 73 Equity time trend in diabetes primary care quality 178
FIGURE 74 National social gradient in diabetes primary care quality in 2011/12 180
FIGURE 75 Unadjusted equity time trend in emergency hospitalisation for diabetes 181
FIGURE 76 Adjusted equity time trend in emergency hospitalisation for diabetes 183
FIGURE 77 National social gradient in emergency hospitalisation for diabetes in
2011/12 185
FIGURE 78 Unadjusted equity time trend in mortality from diabetes 186
FIGURE 79 Adjusted equity time trend in mortality from diabetes 188
LIST OF FIGURES
NIHR Journals Library www.journalslibrary.nihr.ac.uk
xvi
FIGURE 80 National social gradient in mortality from diabetes in 2011/12 190
FIGURE 81 Kernel density plots by indicator, showing six standard deviation trim
points in 2011/12 205
FIGURE 82 Bar charts by indicator, showing percentage trimmed by deprivation
vingtile in 2011/12 using six standard deviation trim points 206
FIGURE 83 Percentage of LSOAs trimmed by year for each indicator,
using six standard deviation trim points 207
FIGURE 84 Kernel density plots by indicator, showing three standard deviation
trim points in 2011/12 211
FIGURE 85 Bar charts by indicator, showing percentage trimmed by deprivation
vingtile in 2011/12 using three standard deviation trim points 212
FIGURE 86 Percentage of LSOAs trimmed by year for each indicator, using
three standard deviation trim points 213
DOI: 10.3310/hsdr04260 HEALTH SERVICES AND DELIVERY RESEARCH 2016 VOL. 4 NO. 26
© Queen’s Printer and Controller of HMSO 2016. This work was produced by Cookson et al. under the terms of a commissioning contract issued by the Secretary of State for
Health. This issue may be freely reproduced for the purposes of private research and study and extracts (or indeed, the full report) may be included in professional journals
provided that suitable acknowledgement is made and the reproduction is not associated with any form of advertising. Applications for commercial reproduction should be
addressed to: NIHR Journals Library, National Institute for Health Research, Evaluation, Trials and Studies Coordinating Centre, Alpha House, University of Southampton Science
Park, Southampton SO16 7NS, UK.
xvii

List of abbreviations
ADS Attribution Data Set
AGI absolute gradient index
AHRQ Agency for Healthcare Research
and Quality
APC admitted patient care
BMA British Medical Association
CCG Clinical Commissioning Group
CHD coronary heart disease
CIPS continuous inpatient spell
COPD chronic obstructive pulmonary
disease
FCE finished consultant episode
FTE full-time equivalent
GMS General and Personal Medical
Services
GP general practitioner
HbA1c glycated haemoglobin
HES Hospital Episode Statistics
HRG Healthcare Resource Group
HSCIC Health and Social Care Information
Centre
ICD-10 International Classification of
Diseases, Tenth Edition
IMD Index of Multiple Deprivation
LSOA lower-layer super output area
NIHR National Institute for Health
Research
OECD Organisation for Economic
Co-operation and Development
ONS Office for National Statistics
PHOF Public Health Outcomes Framework
QOF Quality and Outcomes Framework
RGI relative gradient index
RII relative index of inequality
SII slope index of inequality
WHO World Health Organization
DOI: 10.3310/hsdr04260 HEALTH SERVICES AND DELIVERY RESEARCH 2016 VOL. 4 NO. 26
© Queen’s Printer and Controller of HMSO 2016. This work was produced by Cookson et al. under the terms of a commissioning contract issued by the Secretary of State for
Health. This issue may be freely reproduced for the purposes of private research and study and extracts (or indeed, the full report) may be included in professional journals
provided that suitable acknowledgement is made and the reproduction is not associated with any form of advertising. Applications for commercial reproduction should be
addressed to: NIHR Journals Library, National Institute for Health Research, Evaluation, Trials and Studies Coordinating Centre, Alpha House, University of Southampton Science
Park, Southampton SO16 7NS, UK.
xix

Plain English summary
Inequalities of access to health care, and in the outcomes from health care, raise important concernsabout both quality of care and justice. People living in more deprived neighbourhoods are diagnosed
later, less likely to see a specialist and more likely to die from treatable conditions such as heart disease.
The NHS has a legal duty to consider reducing such inequalities. However, reliable information on
inequalities is scarce because monitoring currently focuses on the average patient rather than on
systematic differences between patients. Local information is especially scarce because it is hard to
establish reliable facts about health-care access and outcomes in every single neighbourhood within
a local area.
In consultation with members of the public and NHS and public health officials, we developed eight
indicators of social inequality in health-care access and health outcomes and a visual way of communicating
these indicators on a single page, called ‘equity dashboards’. The public were concerned about inequalities
in health-care access, such as the number of patients per general practitioner and hospital waiting times, as
well as inequalities in health-care outcomes. The officials told us that equity indicators are more useful if they
are presented together on the same page, alongside average performance indicators, and accompanied by
graphs showing the underlying inequality patterns. Our indicators look at inequality in health care between
more and less deprived neighbourhoods in England of about 1500 people. Five of our indicators are suitable
for local monitoring using any administrative geography comprising 100,000 people or more: number of
patients per general practitioner, primary care quality, hospital waiting time, preventable emergency
hospitalisation and repeat emergency hospitalisation. National equity monitoring can be done using a wider
range of indicators, including disease-specific indicators.
We found that NHS health-care inequalities reduced between 2004 and 2011, during a period of
substantial investment in primary care services, but that inequality reduction was larger in primary care
access and quality than health-care outcomes. NHS actions can therefore have measurable impacts on
socioeconomic inequality in both health-care access and health-care outcomes. However, reducing
inequality in health-care outcomes is more challenging than reducing inequality in health-care access.
Increasing the number of primary care doctors and paying for the quality of care they provide may have
small impacts on reducing inequality in health-care outcomes, but further reductions will require new
wider approaches to primary care and improved co-ordination between different service providers. Further
research is needed to help managers learn quality improvement lessons from areas performing well and
badly on health-care equity, to refine the methods, and to monitor other dimensions of equity such as
ethnic and regional differences. These indicators can also be used to evaluate the health-care equity
impacts of interventions and make international health-care equity comparisons.
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Scientific summary
Background
There are inequalities in health-care access and outcomes in the English NHS, which raise concerns about
both quality of care and justice. Between 2004 and 2011, the NHS made substantial investments to
strengthen primary care and reduce health inequalities. This included the introduction of a substantial
primary care pay-for-performance programme, investment in opening new family medical practices in
deprived communities, and a programme of guidance and support for local health-care managers to help
them meet national targets for reducing health inequality. In 2012, the NHS was given a statutory duty to
consider reducing inequalities of health-care access and outcomes, which applies both nationally and at
the local level of Clinical Commissioning Groups (CCGs). This report developed methods for systematic
monitoring of these inequalities and, in particular, for detailed local monitoring of health-care inequalities
within CCG areas.
Objectives
l To develop indicators of socioeconomic inequality in health-care access and outcomes at different
stages of the patient pathway.
l To develop methods for monitoring local NHS equity performance in tackling socioeconomic
health-care inequalities.
l To track the evolution of socioeconomic health-care inequalities in the 2000s.
l To develop ‘equity dashboards’ for communicating equity indicator findings to decision-makers in a
clear and concise format.
Methods
Indicator selection
The indicator selection process included (1) reviewing existing indicators used by the NHS to monitor
health-care quality, (2) consulting health indicator experts about technical feasibility, (3) consulting a
diverse range of NHS and public health experts about policy relevance through one-to-one conversations
and an online expert survey and (4) consulting members of the public through a full-day citizens’ panel
meeting and an online public survey.
Our main indicator selection criteria were (1) face validity to NHS and public health stakeholders, as well
as the general public; (2) sensitivity to health-care intervention; (3) likely impact on population health;
(4) data availability at the small-area level from the early 2000s; and (5) statistical confidence for monitoring
within local areas, as well as nationally. Our criteria for selecting an appropriate mix of indicators were
(1) coverage of inequality in both access and outcomes; (2) coverage of inequality at all main stages of the
patient pathway; (3) coverage of inequality in multiple domains of the NHS Outcomes Framework;
(4) synergy between indicators; and (5) relevance to potential future quasi-experimental evaluations of
the impacts of interventions on health-care inequalities. Our criteria for selecting the two disease domains
were (1) substantial disease burden and cost to the NHS, (2) data availability for national monitoring and
(3) synergy between the two domains.
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Indicator definitions
We selected eight general indicators for production at both the national and local level:
1. primary care supply: patients per full-time-equivalent general practitioner (GP), need-adjusted for age,
sex and ill health
2. primary care quality: composite score based on Quality and Outcomes Framework (QOF) population
achievement on clinical indicators weighted by importance in terms of estimated lives saved
3. hospital waiting time: waiting time from outpatient decision to admit to inpatient admission, risk
adjusted for specialty
4. preventable hospitalisation: proportion of people with emergency hospitalisation for chronic ambulatory
care-sensitive conditions (NHS Outcomes Framework list), risk adjusted for age and sex
5. repeat hospitalisation: proportion of people discharged from hospital who have a repeat emergency
hospitalisation within the same year, risk adjusted for age and sex
6. dying in hospital: proportion of deaths that occur in hospital
7. amenable mortality: mortality from causes considered sensitive to health care (NHS Outcomes
Framework list), risk adjusted for age and sex
8. overall mortality: all-age all-cause mortality, risk adjusted for age and sex.
To illustrate the scope for additional disease-specific monitoring at the national level, we also produced
versions of indicators 2, 4 and 7 for coronary heart disease and diabetes.
Data sources
We used four main health data sets: practice-level data on GP supply from the annual NHS General and
Personal Medical Services workforce census (indicator 1), practice-level data on primary care quality from
the QOF (indicator 2), inpatient hospital data from Hospital Episode Statistics (indicators 3–6) and mortality
data from the Office for National Statistics (ONS) (indicators 6–8). We produced indicators from 2001/2 to
2011/12 except for indicators 1 and 2, which only started in 2004/5. The basic small-area geographical
unit provided in these data sets was the 2001 ‘lower-layer super output area’ (LSOA). The 2001 census
defined 32,482 of these small-area neighbourhoods to cover approximately 1500 people each (minimum
1000 and maximum 3000). Indicators were produced using 2001 LSOAs then mapped to the updated
LSOA geography from the 2011 census, resulting in 32,844 neighbourhoods that could be aggregated to
the CCG level. We measured deprivation using a time-fixed deprivation score to ensure that time trends
reflect real changes in health care rather than changes in deprivation measurement methodology or the
composition of neighbourhoods, in particular quantile groups. We used the 2010 Index of Multiple
Deprivation overall deprivation rank, which combines data on multiple domains of deprivation mostly
relating to the year 2007 in the middle of our analysis period. For indicators 1 and 2, we used the NHS
Attribution Data Set of GP-registered populations to map the number of GPs and quality scores provided
at the practice to small-area level. For all indicators requiring a general population denominator, including
indicator 1, we used time-varying mid-year population estimates from the ONS at the 2001 LSOA level
rather than GP-registered populations. The ONS figures estimate the total resident population including
homeless people and people living in institutions such as prisons, barracks and nursing homes. For age
breakdowns and risk adjustment, we used seven age groups (0–4 years, 5–15 years, 16–24 years,
25–39 years, 40–59 years, 60–74 years and ≥ 75 years) to minimise the number of subgroups while
distinguishing key life stages of policy interest. We cleaned the assembled LSOA-level data using national
year-specific trimming of outliers six standard deviations from the mean. This excluded < 0.15% of LSOAs
in any year for any indicator and did not disproportionately exclude deprived neighbourhoods.
Data analysis
For national monitoring, we computed the slope index of inequality (SII), which measures the gap between
the most and least deprived neighbourhoods in England, allowing for the gradient in between. We also
computed the relative index of inequality (RII): the SII divided by the England mean. We computed
adjusted indicators for each LSOA in England, along with fractional deprivation rank ‘ridit score’ from
0 (least deprived) to 1 (most deprived). We used the Carr-Hill workload adjustment to need-adjust indicator 1,
SCIENTIFIC SUMMARY
NIHR Journals Library www.journalslibrary.nihr.ac.uk
xxiv
and indirect standardisation to risk-adjust indicators 3, 4, 5, 7 and 8. We used LSOA-level ordinary least
squares regression to model the association between the adjusted indicator and fractional deprivation
rank, and used the slope coefficient to estimate the SII and its associated 95% confidence interval. We
also performed tests of change in the SII over time using time-series cross-section regression with year
interactions. For local monitoring, we used the same approach based on national fractional deprivation
rank, except using only LSOAs within the local CCG area. We term the local slope coefficient the ‘absolute
gradient index’ (AGI), to avoid confusion with the different local slope index approach used to monitor
inequalities in population health in the Public Health Outcomes Framework, which uses local within-area
deprivation rank rather than national deprivation rank. We also constructed a local ‘relative gradient index’
that can be compared with the national RII. We tested the difference between the local AGI and the
national SII, allowing for uncertainty around both variables. In sensitivity analysis we also used more
sophisticated regression approaches including non-linear models and empirical Bayes random-effect
models to shrink the local AGI towards the national SII.
Results
National equity trends
Between 2004/5 and 2011/12, more deprived neighbourhoods gained larger absolute improvements on all
indicators except waiting time, repeat hospitalisation and dying in hospital.
National equity findings in 2011/12
l There was no evidence of ‘pro-rich’ inequality in primary care physician supply. Deprived
neighbourhoods had slightly more GPs relative to measured need than less deprived neighbourhoods.
However, the Carr-Hill formula may underestimate additional needs in deprived neighbourhoods, so
there may be pro-rich inequality that we are unable to measure.
l There was a small amount of pro-rich inequality in primary care physician quality of care, with an
estimated SII gap of 1.45 percentage points (95% confidence interval 1.37 to 1.53 percentage points)
between the most and least deprived neighbourhoods in England.
l There was a small amount of pro-rich inequality in inpatient hospital waiting time, with an estimated
inequality gap of 2.29 days waiting (95% confidence interval 1.95 to 2.62 days).
l There was substantial pro-rich inequality in preventable hospitalisation, with an estimated inequality
gap of 6.50 hospitalisations per 1000 (95% confidence interval 6.40 to 6.59 hospitalisations per 1000).
l There was substantial pro-rich inequality in repeat hospitalisation, with an estimated inequality gap of
6.97 percentage points of people hospitalised (95% confidence interval 6.85 to 7.09 percentage points).
l There was substantial pro-rich inequality in dying in hospital, with an estimated inequality gap of
5.95 percentage points of people dying in hospital (95% confidence interval 5.26 to 6.63 percentage points).
l There was substantial pro-rich inequality in amenable mortality, with an estimated inequality gap of
1.56 amenable deaths per 1000 (95% confidence interval 1.50 to 1.62 amenable deaths per 1000).
l There was substantial pro-rich inequality in overall mortality, with an estimated inequality gap of
5.17 deaths per 1000 (95% confidence interval 5.03 to 5.31 deaths per 1000).
General practitioner supply is a limited measure of primary care access, need in deprived neighbourhoods
may be underestimated because of a lack of data on multimorbidity, and the quality and outcomes
indicators capture only one aspect of primary care quality. Indicators 4, 5, 7 and 8 adjust for age and sex
but not for morbidity and other health risk factors outside NHS control which increase the risk of poor
health-care outcomes in deprived neighbourhoods. So they overestimate the extent of pro-rich inequality
in health-care outcomes for which the NHS can reasonably be held responsible.
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Local equity findings in 2011/12
In 2011/12, > 20% of CCGs performed significantly differently on equity than the national benchmark for
indicators 1–5, with at least 10% better and 10% worse. For indicator 6, dying in hospital, only 8% of
CCGs were significantly different from average: 3% worse and 5% better. For indicator 7, amenable
mortality, 11% were significantly different from average: 8% worse and 3% better. Finally, for indicator 8,
overall mortality, 17% were significantly different from the national average, but most of these were
significantly worse: only 3% were significantly better. Pooling additional years of data did not improve
substantially the ability to detect significant differences, and more sophisticated regression approaches,
including empirical Bayes random-effects models, made little difference to the list of CCGs performing
significantly better or worse than the national average.
Visualisation tools
We developed three main visualisation tools:
1. Equity dashboards: a one-page summary for decision-makers at national and local levels, including a
Microsoft Excel® 2010 (Microsoft Corporation, Redmond, WA, USA) tool that can display findings for
any CCG in England.
2. Equity chart packs: a standard set of slides, with tables and graphs, showing the underlying inequality
patterns and trends in a common format for each indicator, including a portable document format
(PDF)-creating tool that can create slides for any CCG in England.
3. Equity custom graphs: a web-based interactive chart tool that allows users to draw their own
customised graphs and see how equity changes over time by selecting variables and chart styles.
We found that eight or nine indicators could comfortably fit on a single-page ‘equity dashboard’ in a
landscape orientation. The NHS and public health officials we consulted wanted to see information about
average performance alongside equity performance, to put the equity findings into context. They also
wanted equity findings to be presented in ‘real’ units, for example numbers of GPs, hospitalisations and
deaths, as well as percentages, to help them interpret the size and importance of the inequality problem.
Conclusions
Implications for health care
1. NHS actions can have measurable impacts on socioeconomic inequality in both health-care access and
health-care outcomes.
2. Increasing the number of primary care physicians and paying them for the quality of care they provide
has been associated with small impacts on reducing inequality in health-care outcomes, although
the causal link between primary care inputs and health-care outcomes has not been established in
this study.
3. Our methods for monitoring health-care inequalities within local areas can usefully be applied to any
administrative geography comprising 100,000 or more people, both to facilitate quality improvement
and to improve transparency through public reporting.
4. Currently, the most useful indicators for local NHS equity monitoring are primary care supply, primary
care quality and preventable hospitalisation.
5. National NHS monitoring of change over time in NHS equity can usefully be done using a much wider
range of indicators of health-care access and outcomes, including disease-specific indicators.
6. Equity indicators are more useful to decision-makers if they are presented together on the same page,
alongside average performance indicators, and accompanied by graphs showing the underlying
inequality patterns.
7. Variants on our equity indicators could be used for international comparisons of equity in health care
and for evaluating the impacts of interventions on equity in health care.
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Research recommendations
Research is needed to:
1. investigate potential explanations for variation in health-care equity performance between local NHS
areas, so that health-care managers can learn quality improvement lessons
2. perform experimental and quasi-experimental evaluations of the impacts of complex interventions on
socioeconomic inequalities in health-care access and outcomes, including interventions to improve
system-wide co-ordination between different specialties, health-care settings and public services
3. make international health-care equity comparisons using these indicators of health-care access
and outcomes
4. develop broader measures of primary care access and quality that go beyond GP supply and the aspects
of quality captured by the QOF
5. develop better measures of small-area-level need for primary care, by investigating how multiple
morbidity and disadvantage combine to generate additional health-care needs
6. develop convincing methods for risk-adjusting small-area-level health-care outcomes for exogenous
morbidity factors beyond the control of health-care services
7. develop methods for monitoring other social dimensions of health-care inequality
8. improve these indicator methods, for example, by refining and adding indicators, decomposing national
inequality into between-area and within-area components, and exploring the use of statistical process
control methods, direct standardisation methods and non-linear functional forms
9. develop sources of small-area-level data on the supply, utilisation, quality and outcomes of public and
private social care and other goods and services that may influence health-care outcomes.
Funding
Funding for this study was provided by the Health Services and Delivery Research programme of the
National Institute for Health Research.
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Chapter 1 Introduction
[T]he isolation of disparities from mainstream quality assurance has impeded progress in
addressing them.
Fiscella et al., 20001
Overview
This report describes the findings of independent research to develop health equity indicators for
monitoring socioeconomic inequalities in health-care access and outcomes in England. Inequalities of
this kind persist, raising important public policy concerns about both quality of care and social justice.
However, progress in addressing these concerns is hampered because socioeconomic inequalities in
health-care access and outcomes are not yet monitored systematically in England at either national or
local levels.2
We developed an integrated suite of equity indicators for two different kinds of monitoring:
1. annual monitoring of change in national health-care equity
2. annual monitoring of local within-area health-care equity against a national equity benchmark, for
Clinical Commissioning Groups (CCGs) or other subnational areas comprising ≥ 100,000 people.
Our equity indicators are designed to help national and local decision-makers in England discharge the
NHS health inequalities duties introduced in the Health and Social Care Act 2012.3 The local duty for CCGs
is as follows:
Each clinical commissioning group must, in the exercise of its functions, have regard to the need to –
(a) reduce inequalities between patients with respect to their ability to access health services, and
(b) reduce inequalities between patients with respect to the outcomes achieved for them by the
provision of health services.
Health and Social Care Act 2012.3 Contains public sector information licensed under the
Open Government Licence v3.0
The national duty for NHS England is phrased in the same way, and the national duty for the Secretary of
State is as follows:
In exercising functions in relation to the health service, the Secretary of State must have regard to the
need to reduce inequalities between the people of England with respect to the benefits that they can
obtain from the health service.
Health and Social Care Act 2012.3 Contains public sector information licensed under the
Open Government Licence v3.0
Our indicators will also help to monitor the health inequalities elements of the NHS duties as to
promoting integration of care that were introduced in the Health and Social Care Act 2012.3 Improving
the integration of care is a central policy priority for the English NHS, including not only integration
within NHS-funded services across different specialties and different primary and acute care settings,
but also integration between NHS-funded services and other services that impact on patient outcomes.
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NHS England announced in 2013 the establishment of a ‘Better Care Fund’ for integrated care across
health-care and social-care boundaries, and announced in 2014 a programme of ‘new models of care’
or ‘vanguard sites’ for integrating care between specialties and settings.4 The relevant local duties on
integration and inequalities are phrased as follows:
(1) Each clinical commissioning group must exercise its functions with a view to securing that health
services are provided in an integrated way where it considers that this would —
(a) improve the quality of those services (including the outcomes that are achieved from
their provision),
(b) reduce inequalities between persons with respect to their ability to access those services, or
(c) reduce inequalities between persons with respect to the outcomes achieved for them by the
provision of those services.
(2) Each clinical commissioning group must exercise its functions with a view to securing that the
provision of health services is integrated with the provision of health-related services or social care
services where it considers that this would —
(a) improve the quality of the health services (including the outcomes that are achieved from the
provision of those services),
(b) reduce inequalities between persons with respect to their ability to access those services, or
(c) reduce inequalities between persons with respect to the outcomes achieved for them by the
provision of those services.
(3) In this section —
‘health-related services’ means services that may have an effect on the health of individuals but are
not health services or social care services;
‘social care services’ means services that are provided in pursuance of the social services functions of
local authorities (within the meaning of the Local Authority Social Services Act 1970).
Health and Social Care Act 2012.3 Contains public sector information licensed under the
Open Government Licence v3.0
The phrasing of the Health and Social Care Act 20123 makes it clear that the NHS health inequalities
duties include (1) concern for reducing inequalities in the health outcomes or benefits of health care,
as well as concern for reducing inequalities of access to health care, and (2) concern for improving the
co-ordination of health care with social care and other public services which impact on health outcomes.
These two concerns go to the heart of what it means to be a national health service, rather than a
national sickness service, and are also reflected in the NHS Constitution, published in 2012.5 The first
principle of the NHS Constitution is that:
The NHS provides a comprehensive service, available to all . . . At the same time, it has a wider social
duty to promote equality through the services it provides and to pay particular attention to groups or
sections of society where improvements in health and life expectancy are not keeping pace with the
rest of the population.
The NHS Constitution for England 2012.5 Contains public sector information licensed under the
Open Government Licence v3.0
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The fifth principle is that:
The NHS works across organisational boundaries and in partnership with other organisations in the
interest of patients, local communities and the wider population. The NHS is an integrated system of
organisations and services bound together by the principles and values reflected in the Constitution.
The NHS is committed to working jointly with other local authority services, other public sector
organisations and a wide range of private and voluntary sector organisations to provide and deliver
improvements in health and wellbeing.
The NHS Constitution for England 2012.5 Contains public sector information licensed under the
Open Government Licence v3.0
These concerns relate to wider health equity concern for reducing social inequality in population health.
Social inequalities in life expectancy and health raise important concerns about social justice, because
health is essential to human flourishing.6 In economic terms, health is both a consumption good that
people value for its own sake and a capital good that allows people to do the things they value in life.
Health care is, of course, only one of many social determinants of health and survival over the life-course,
along with in utero and childhood circumstances, income, education, working and living conditions,
social support networks, long-term care, lifestyle factors such as smoking, poor diet and physical inactivity,
and many other factors.7–9 However, although health care cannot eliminate social inequalities in health, it
can play a role in helping to reduce them.10–12 Therefore, we sought to ensure that our equity indictors are
relevant from a wider-population health perspective, as well as from a health-care perspective, and that
our indicators are relevant to the integration of care across different specialties, settings and services.
Our equity indicators are intended for use by NHS and local authority decision-makers for quality
improvement purposes, to help policy-makers and managers learn how to improve the delivery of
health-care services including integration with social care and other health-related services. They are also
intended for use by a wide range of organisations which play external scrutiny roles in helping to hold the
NHS to account, including Public Health England and local Health and Wellbeing Boards, health sector
regulators (such as the National Audit Office and the Health Select Committee), professional associations
[such as the NHS Confederation, British Medical Association (BMA) and Royal Colleges], think tanks
(such as the Health Foundation, The King’s Fund and Nuffield Trust), and national and local media
organisations. Our indicators are also intended for public reporting, to facilitate more direct forms of
public accountability. In principle, our equity indicators can also be used to monitor health-care equity in
other high-income countries with well-developed administrative health data sets, to make international
comparisons of equity in health care, and to help evaluate the health-care equity impacts of interventions
in trials and quasi-experimental studies.
The aims of our study were to:
l develop indicators of socioeconomic inequality in health-care access and outcomes at different stages
of the patient pathway
l develop methods for monitoring local NHS equity performance in tackling socioeconomic
health-care inequalities
l track the evolution of socioeconomic health-care inequalities in the 2000s
l develop ‘equity dashboards’ for communicating equity indicator findings to decision-makers in a clear
and concise format.
The main contributions of our study were as follows. First, we have developed the first indicators for local
NHS equity monitoring against a national NHS equity benchmark, including new methods for national
benchmarking as well as a new suite of indicators. Our approach has subsequently been adopted by NHS
England in the Clinical Commissioning Group Improvement and Assessment Framework, starting with
publication of an up-to-date version of one of our key local equity monitoring indicators: inequality in
potentially avoidable emergency hospitalization (NHS England 2016,13 NHS Choices 2016,14 University of
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York 201615). This aspect of our work was also cited by the independent think tank, The King’s Fund,
as being a potentially useful way of incorporating equity into routine CCG performance monitoring by
NHS England, in a report commissioned by the Department of Health,16 and the University College London
Institute of Health Equity are discussing piloting the use of these local equity indicators to monitor progress
in vanguard sites. Second, we have developed a more comprehensive suite of national NHS equity
indicators than the inequalities breakdowns currently produced in the NHS Outcomes Framework,
by including indicators of inequality in health-care access as well as health-care outcomes. Third, by
producing our indicators from 2001/2 to 2011/12, we have provided the first comprehensive assessment
of health-care equity trends during a key period of sustained effort by the NHS to reduce socioeconomic
health inequalities through primary care strengthening. Finally, we have developed a comprehensive suite
of visualisation tools for presenting and communicating our equity indicator findings to decision-makers.
This includes a one-page ‘equity dashboard’ presenting summary information, automated ‘equity chart
packs’ providing in-depth information underpinning the dashboard, and a web-based tool that allows
users to their own graphs. Visualisation is an essential component of equity monitoring, because inequality
is a complex concept and judgements about ‘fairness’, ‘justice’ or ‘equity’ often involve controversial value
judgements about which reasonable people can disagree. A single ‘one-size-fits-all’ headline inequality
measure can therefore be misleading. So, it is essential to show people the underlying inequality patterns
and trends, to help them understand the meaning and importance of the trends, and draw their own
conclusions about equity based on their own value judgements.
We have developed eight general indicators of health-care equity that examine socioeconomic inequalities
in health-care access and outcomes at different stages of the patient pathway: (1) primary care supply,
(2) primary care quality, (3) hospital waiting time, (4) preventable hospitalisation, (5) repeat hospitalisation,
(6) dying in hospital, (7) amenable mortality and (8) overall mortality. We did not include general indicators
of socioeconomic inequality in health-care utilisation, such as the total number of non-emergency inpatient
or outpatient hospital visits, because when diverse health-care services are grouped together it is hard to
tell whether more utilisation reflects better access to care, worse quality of care or worse health.
All eight of our general indicators are potentially suitable for national equity monitoring. However,
we found that the last three indicators do not fully meet the more demanding data requirements for local
equity monitoring. The main issue was that there are relatively few deaths in any given local CCG area in
any given year, making it hard to tell from a statistical perspective whether or not observed differences
in social gradients between different local areas are merely a result of the random play of chance.
We recommend three indicators as a high priority for local equity monitoring against a national equity
benchmark: primary care supply, primary care quality and preventable hospitalisation. Two other indicators
could also be used for local equity monitoring: hospital waiting time and repeat hospitalisation. However,
as explained in Chapters 8 and 9, these indicators may require further validation and refinement before
being used for routine monitoring purposes.
Our general indicators measure socioeconomic inequality across the full range of health-care activity, rather
than focusing on one particular condition. General indicators can be used for local monitoring against a
national benchmark, whereas at the present time disease-specific indicators can only be used for national
equity monitoring of health-care outcomes. This is because the kinds of health-care outcomes we can
currently measure on a comprehensive national basis involve rare events, for example hospitalisations or
deaths. This is not problematic when we examine the total number of events across all disease areas,
which can add up to a large number. But when we focus on one specific disease, the numbers become
too small to detect statistically significant differences between local inequality and the national inequality
benchmark. However, to illustrate the potential use of disease-specific indicators at a national level we
have developed national disease-specific indicators of equity in the areas of coronary heart disease (CHD)
and diabetes, which are presented in Appendices 1 and 2.
Our indicators can be used to assess the degree to which health-care equity in England is getting better or
worse over time. They can also be used to identify local NHS areas that are performing better or worse
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than the national NHS average in reducing within-area socioeconomic inequalities in health-care access
and outcomes. This information can be used to facilitate health-care quality improvement efforts,
to understand why some areas are doing well or badly, to learn lessons, and to share good practice.
However, we would caution against using our equity indicators for setting performance targets with rewards
or penalties attached, at least until further experience and understanding of equity monitoring has been built
up. The Health and Social Care Act 20123 suggests the use of financial payments to reward CCGs that
succeed in reducing inequalities, as one factor to be taken into account when making end of year payments
to CCGs to reward quality. Specifically, section 223k of the act entitled ‘Payments in respect of quality’ states
that NHS England:
may, after the end of a financial year, make a payment to a clinical commissioning group . . . For that
purpose, the Board may also take into account either or both of the following factors – (a) relevant
inequalities identified during that year; (b) any reduction in relevant inequalities identified during that
year (in comparison to relevant inequalities identified during previous financial years).
Health and Social Care Act 2012.3 Contains public sector information licensed under the
Open Government Licence v3.0
The process of paying CCGs for quality was subsequently implemented in a process known
as the ‘quality premium’, although so far health inequality has not been incorporated into this process
(www.england.nhs.uk/resources/resources-for-ccgs/ccg-out-tool/ccg-ois/qual-prem/; accessed 12 July 2015).
We would caution against too ambitious a timescale for incorporating our CCG-level equity indicators into
decisions on this process for two reasons. The first reason is that health-care equity monitoring is still in its
infancy and is less well developed than the monitoring of health-care quality for the average patient. For
example, health-care decision-makers have a reasonably good idea about how to reduce average hospital
waiting times, supported by a strong evidence base from decades of international policy experimentation,
monitoring and evaluation. By contrast, rather less is known about how to reduce socioeconomic
inequality in hospital waiting times or other forms of health-care access and outcome. The second reason
is that the causal links between policy action and health-care outcome are more complex, delayed and
uncertain for some of the health-care outcomes we measure, such as preventable hospitalisation and
amenable mortality, compared with health-care outcomes traditionally used for performance management,
such as rates of antibiotic resistant bloodstream infections in hospitals. This can make it hard
straightforwardly to attribute change in inequality in these outcomes to recent actions taken by CCG
managers or the services they commission. Given the current state of knowledge, therefore, the most
appropriate initial uses of our indicators are (1) to hold the NHS to account, and (2) to improve quality by
helping decision-makers learn how to reduce social gradients in health care and by helping researchers
build a stronger evidence base, rather than (3) to set high-powered financial and managerial incentives.
Throughout the study the research team was guided by an advisory group including academic and clinical
experts, NHS and public health officials, and lay members, whose membership is listed in Appendix 3.
All key decisions around indicator selection and the development of analytical methods and visualisation
tools were taken in consultation with the advisory group. The team is grateful for its advice and support,
although the responsibility for all decisions rests with the research team.
The next two sections of this introductory chapter set out the background to this study and present
the conceptual framework we developed for monitoring equity in health care. Chapter 2 of the report
describes how members of the public were involved in selecting our indicators and designing our
visualisation tools, through a public consultation exercise in York based on an online survey and a citizens’
panel meeting, and through the participation of the two lay members of our advisory group. Chapter 3
describes the indicator selection process, which included reviewing existing indicators used by the NHS to
monitor health-care quality, consulting health indicator experts about technical feasibility and consulting
NHS and public health experts about policy relevance. Chapter 4 describes the data and analytical methods
used for health-care equity indicator production and visualisation at both national and local levels.
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Chapter 5 presents the main results for all eight of our general indicators, including national health-care
equity in 2011/12, national health-care equity time trends during the 2000s and local health-care equity
monitoring in 2011/12 against a national benchmark. Chapter 6 describes the NHS engagement process
we undertook to develop and refine our visualisation tools. Chapter 7 presents our prototype ‘equity
dashboards’. Finally, Chapter 8 discusses our findings and Chapter 9 summarises our conclusions and
research recommendations.
The report also contains extensive appendices. Appendices 1 and 2 present national disease-specific
health-care equity indicators for CHD and diabetes, respectively. Appendix 3 lists the advisory group
members. Appendix 4 contains full technical specifications of our main general indicators. Appendix 5
presents sensitivity analysis around different ways of cleaning our data by trimming outliers. Appendix 6
contains materials from the public consultation exercise. Finally, Appendix 7 contains letters from the
three key NHS organisations we consulted during the development process confirming their interest in
seeing our equity indicators routinely produced and used for NHS quality improvement: the NHS England
Inequality and Health Inequalities Unit, Hull CCG and Vale of York CCG.
Background on equity in health care
Why monitoring health-care equity is important
The World Health Organization (WHO) has called for universal health care and routine monitoring of
health-care equity in all countries.6,17,18 It is fairly obvious why health-care equity monitoring is needed in
countries that lack universal health-care systems. In such countries, many people cannot afford high-quality
health care and have limited protection against the financial risk of catastrophic health-care costs and
impoverishment as a result of ill health. Limited access to health care and limited financial protection are
both typically associated with a low level of wealth, ethnicity, rural location and other social variables
giving rise to equity concerns. Furthermore, there is good evidence that introducing universal health care,
and, in particular, universal primary care, can contribute to reducing wider social inequalities in population
health.10 Therefore, it is important for countries seeking to establish universal health-care systems to
monitor progress in reducing three different kinds of inequality in health care:
1. inequality in health-care financing
2. inequality in health-care access
3. inequality in health-care outcomes.
But why is health-care equity monitoring also important in a high-income country like England, which
introduced universal health care as long ago as 1948? The answer is that important inequalities in health-care
access and outcomes persist in these countries, even though universal health care has succeeded in reducing
them. Monitoring of inequality in health-care financing may also be more important in countries with less
comprehensive and generous systems of universal health care than the English NHS. Detailed local monitoring
of the unequal impact of out-of-pocket health-care costs on household finances can be considered less
important in England, which regularly tops international league tables of fairness in health-care financing and
has succeeded in virtually eliminating the threat of catastrophic health-care costs: relatively few people in
England report financial difficulties in paying health-care bills or face catastrophic medical expenditures.19,20
The fact that social inequalities in health-care access and outcomes persist in universal health-care systems
has been known for some time,21–24 and the findings of our study provide further evidence. Furthermore,
there is a risk that some of these inequalities could potentially worsen in future decades as universal health-
care systems come under increasing financial strain even in high-income countries. Over the next 50 years,
rising care costs may make it increasingly hard for high-income countries to provide fully comprehensive
packages of health care that are fully supported by long-term care and other public services that influence
patient outcomes.25,26 This is not just a short-term issue relating to public sector austerity in the aftermath of
the global economic crisis in 2008. There are also concerns about long-term health-care cost inflation as a
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result of medical innovation, demographic change and wage inflation in a labour-intensive high-skill
industry. Health-care expenditure has absorbed an increasing share of national income in Organisation for
Economic Co-operation and Development (OECD) countries over the past 50 years, and this trend is
projected to continue.27 A recent study forecast that public spending on health care and long-term care as a
share of national income in OECD countries will more than double over the next 50 years, from an average
of 5.5% in 2006–10 to between 9.5% and 13.9% by 2060.26 Faced with tensions between the rising cost
of public care and what people are willing to pay in higher taxes, rich-country governments may face
increasingly hard choices in the coming decades about what services to include in the universal health
package at what level of quality. This has the potential to exacerbate existing inequalities of health-care
access and outcome, especially inequalities related to income, as (1) income inequalities are also projected to
continue growing in the coming decades,28 and (2) financial strain on public health-care systems may
increase the role of privately funded health and social care in future.
In summary, important inequalities in health-care access and outcomes remain, and are at risk of
growing in future decades. That is why it is important to establish systems for health-care equity
monitoring, even in high-income countries with universal health-care systems.
Concepts of equity in health care
This section briefly reviews the main concepts of equity in health care that underpin all empirical measurement
work in this area, including the indicators developed in this study. We focus on equity in health-care delivery,
because relatively few people in England report financial difficulties in paying health-care bills or face
catastrophic medical expenditures. We focus on socioeconomic inequality because (1) this is an important type
of inequality at risk of growing in the coming decades and (2) the available data sources for measuring
socioeconomic inequality in health care are relatively well developed. Socioeconomic inequality is, therefore, a
useful test case to see if robust equity monitoring systems can be developed. Data sources for measuring other
dimensions of equity are improving, and so it may be possible in future to apply similar methods to examine
health-care inequalities relating to ethnicity, mental health, homelessness and other equity-relevant variables.
The literature on socioeconomic inequality in health-care delivery usually adopts a normative perspective
that seeks to distinguish ‘appropriate’ or ‘fair’ inequalities in health care from ‘inappropriate’ or ‘unfair’
inequalities. To mark this distinction, it is common in the literature to use the word ‘inequities’ (in Europe)
or ‘disparities’ (in the USA) to reflect what may be regarded as ‘unfair’ social inequalities in health care.
However, there is considerable variation in usage and the term ‘disparities’ is sometimes used to indicate
the mere fact of variation without any normative implication. However, the term ‘inequity’ always has a
normative connotation and is the term we use in this report. The basic idea is to measure departures from
‘horizontal equity’ in health-care delivery: the equal treatment of people in equal need. We can distinguish
three main kinds of health-care inequality that policy-makers may be concerned to reduce, based on three
different definitions of ‘equal treatment’:
1. inequality of health-care access between people with equal need for health care
2. inequality of health-care utilisation between people with equal need for health care
3. inequality of health-care outcome between people with equal need for health care.
These three types of inequality are progressively more challenging to reduce. Providing equal access to a
service does not guarantee the service will be used equally, and using the same service does not guarantee
the same benefits will be gained. The first and third principles are both central to this report, and so we
compare and contrast them in more detail below. First, however, we review the concept of ‘need for
health care’ which is common to all three principles and raises a host of thorny conceptual issues.
One important preliminary issue is how far ‘need for health care’ may extend beyond traditional
health-care boundaries to include need for other non-health-care goods and services that may improve
health. As mentioned earlier, it is now well known that health care is just one of many important social
determinants of individual health over the life-course, along with childhood development, living and
working conditions, job control, social status anxiety, and all of the lifestyle health behaviours that are
DOI: 10.3310/hsdr04260 HEALTH SERVICES AND DELIVERY RESEARCH 2016 VOL. 4 NO. 26
© Queen’s Printer and Controller of HMSO 2016. This work was produced by Cookson et al. under the terms of a commissioning contract issued by the Secretary of State for
Health. This issue may be freely reproduced for the purposes of private research and study and extracts (or indeed, the full report) may be included in professional journals
provided that suitable acknowledgement is made and the reproduction is not associated with any form of advertising. Applications for commercial reproduction should be
addressed to: NIHR Journals Library, National Institute for Health Research, Evaluation, Trials and Studies Coordinating Centre, Alpha House, University of Southampton Science
Park, Southampton SO16 7NS, UK.
7
causally associated with these social factors.6 It might be stretching things to argue that ‘need for health
care’ is the same thing as ‘need for health’, and that, therefore, it includes need for all the social and
biological determinants of health. This would imply, for example, that health-care providers are responsible
for providing people with the strong genes, loving parents and high incomes they need in order to live
long and healthy lives. However, it might be reasonable to expect health-care staff to deliver preventative
health-care services including not only narrowly medical interventions such as vaccination and immunisation
but also a broader range of screening and disease awareness services to facilitate the early detection of
disease and interventions to help reduce behavioural health risk factors such as smoking, physical inactivity
and poor diet. It might also be reasonable to expect health-care staff from different specialties to work
together in multidisciplinary teams when treating a complex patient with multiple conditions, to co-ordinate
across primary and acute care settings, and to liaise with staff in social care and other public services to help
improve the patient’s prospects for a sustained recovery. So, need for health care may extend to need for
co-ordinated care efforts by health-care providers, need for travel services that allow people to use health
care, and need for social services that help to improve recovery and long-term patient outcomes such as
avoidable episodes of ill health. We return to these boundary issues in more detail below.
Another important debate is about the role of individual preferences, or what we might call ‘subjective
need for health care’ as seen from the patient’s own internal perspective, as opposed to ‘objective need
for health care’ as seen from an external clinical or policy perspective.29 Some authors argue that it is
important to respect individual preferences about how far to seek, accept and adhere to health care that is
only seen as needed from an external perspective.30 By contrast, other authors emphasise that preferences
are socially determined and may reflect entrenched deprivations, and so the focus for the purpose of
assessing unfair inequality should be on ‘objective’ need as assessed from an external perspective.31,32
There is a social gradient in self-reported ill health, such that poorer individuals generally report greater ill
health than richer individuals. However, for a given level of ‘objective’ ill health, as assessed by a clinician
using biomedical measures, richer individuals are likely to report greater subjective ill health than poorer
individuals and to express greater demand for health services that are free at the point of delivery.33,34
Those who wish to respect individual preferences may be content to use ‘subjective’ measures of ill health
and need for health care, or to focus on reducing inequality of health-care access. By contrast, others may
prefer to focus on the more demanding equity objectives of reducing inequality of health-care utilisation
and outcome for people with the same ‘objective need’.
A third conceptual issue is whether need for health care should be defined in terms of severity of illness or
capacity to benefit.35 Severely ill patients are worse off than other patients in a relevant sense, and, to that
extent, may have a greater claim on health-care resources. On the other hand, if a severely ill patient has zero
capacity to benefit from a costly new medical treatment, over and above the benefits they receive from their
existing package of care, then it seems odd to say that they ‘need’ that costly additional treatment. It may be
unfair as well as inefficient to spend money on ineffective health care for severely ill patients rather than
effective health care for less severely ill patients, although it is of course important to adopt a broad view of
what counts as ‘effective’ care that does not merely focus on life extension and biomedical functioning
but also includes broader aspects of quality of life, including being treated with dignity and compassion,
perhaps especially in relation to palliative care for severely and terminally ill patients. In relation to equality
of health-care outcomes, the case for defining need as capacity to benefit is that it may not be possible for
the health-care system to deliver equal outcomes to people with equal severity of illness. For example, imagine
one patient has an incurable disease, while another has an equally severe disease with a fully effective
remedy. Furthermore, assume that the incurable nature of the disease was not caused by a failure on the part
of health-care services to deliver diagnosis, effective treatment and prevention services at an earlier stage in
the patient pathway. In that case, the patient with the incurable disease may have less capacity to benefit
from health care, and so the unequal health-care outcome for these two people with equal severity of illness
may not be the responsibility of the health service and hence not an indicator of unfair treatment.
This raises a fourth, thorny, question: should need for health care (including preventative services) be
assessed from the perspective of the current situation, at whatever point the patient has currently reached in
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the disease pathway, or from an earlier point when severity of illness may be lower but capacity to benefit
greater? This relates to a more general question about time perspective. Should equity in health care be
assessed from a cross-sectional perspective, focusing on health-care delivery this year for health-care needs
this year, or from a longitudinal perspective looking at health-care delivery over a longer time window that
may include past, present and future time periods, perhaps even the individual’s entire life-course?
Unfortunately, empirical studies often have limited ability to address these important conceptual debates
about ‘need’, because they often rely on imperfect need variables such as age, sex and various indicators of
morbidity which are typically only measured at a point in time or across time in just one part of the system
(e.g. primary or secondary care). The basic strategy used in the empirical literature on socioeconomic
inequity in health care is to measure associations between (current) socioeconomic status and (current)
health care after adjusting for (current) need variables. Our study also follows this strategy, and our need
variables are also imperfect. Although we have time series cross-sectional data on small-area populations
going back several years, we do not follow each individual within those small areas longitudinally to assess
their historical levels of need, health-care delivery and socioeconomic status at earlier points in the patient
pathway. The assessment of equity in health care from a longitudinal perspective is an important avenue for
future research using longitudinal or linkable data at an individual level.
Our need variables are especially imperfect in the case of health-care outcomes, in which we are able to
adjust only for age and sex, but not for morbidity. Failure to adjust for morbidity means that we typically
underestimate the risk of poor health-care outcomes in deprived populations. To put this another way,
we typically overestimate short-term capacity to benefit from health care and underestimate level of need
in deprived populations from the cross-sectional perspective of the current indicator year. As discussed
previously, however, capacity to benefit from health care from a longitudinal perspective will be
greater than short-term capacity to benefit because of potential benefits in the past and in the future.
Nevertheless, from the cross-sectional perspective of the current indicator year we typically overestimate
the extent of ‘pro-rich’ socioeconomic inequity in the following three health-care outcomes: preventable
hospitalisation, repeat hospitalisation and amenable mortality. For this reason, we usually refer to
socioeconomic ‘inequality’ in health-care outcomes throughout the report, rather than socioeconomic
‘inequity’. This does not apply to our three indicators of inequality of access, however, that is primary care
supply, primary care quality and hospital waiting time. Indeed, in the case of primary care supply, imperfect
measurement of need generates a bias that works in the opposite direction. In this case, as explained in
Chapters 4 and 8, we typically underestimate need for primary care supply in more deprived populations.
This means that we typically underestimate the extent of pro-rich inequality in primary care supply.
These issues are discussed in more detail in Chapters 4 and 7, and in Appendix 4.
In the health outcomes literature, adjusting for age, sex and other risk factors is usually called ‘risk
adjustment’ rather than ‘need adjustment’. The basic idea is to adjust the observed outcomes for
exogenous risk factors that are beyond the control of the health-care provider, so that the ‘risk-adjusted
outcomes’ can be attributed to the actions of the health-care provider and interpreted as an indicator of
the quality of care. However, in our context we can also think of this as a form of ‘need adjustment’,
for which need is interpreted as short-term capacity to benefit from health care in the current period.
We adjust the observed outcomes from health care for exogenous risk factors that determine short-term
capacity to benefit from health care in the current indicator period. The remaining differences in adjusted
outcomes then reflect ‘unfair’ differences in the benefit achieved by health care rather than ‘fair’
differences in the capacity to benefit from health care. As ‘risk adjustment’ is the more familiar phrase in
relation to health outcomes, however, we use that phrase in the rest of this report.
We now return to the question of why reducing socioeconomic inequality of health-care outcomes is a
more demanding principle of justice than reducing socioeconomic inequalities of access to health care. The
basic reason is that access to health care is just one input into the production of health outcomes.7,9,10,36
One set of issues relates to individual resilience. Poorer patients may tend to recover more slowly and less
completely following health-care intervention because of greater comorbidity, less biological, physiological
and psychological resilience and less supportive home and community environments in which to recover,
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including worse access to supportive informal care from friends and relatives (e.g. in noticing when
public care quality falls short and taking corrective action). Another set of issues relates to individual
health-seeking behaviour. Poorer patients may be less likely to invest time and other resources in
improving their own health by seeking medical information, using medical care and engaging in healthy
lifestyle activities, as they face higher opportunity costs (e.g. time required at the expense of domestic
and work duties, travel costs) relative to their more limited wealth and human capital, have less social
capital to draw on (e.g. support from friends, family and wider social and professional networks) and,
more controversially, may be less able to find enjoyable jobs, and to afford pleasant and fulfilling leisure
activities, and so may see less point investing time and money to gain additional days of life. Other things
being equal, poorer individuals will tend to use less preventative health care when facing no immediate
pain or disability, and to present to health-care providers at a later stage of illness. The quality of medical
care received may also depend in part on the intensity and effectiveness of patient care-seeking behaviour
(e.g. in navigating through a complex health-care system, lobbying providers for the best-quality care) and
self-care behaviour (e.g. in adhering to medication regimes). For all of these reasons, poorer patients tend
to have greater needs for co-ordinated care and support across diverse service providers in order to achieve
good health-care outcomes, including co-ordination between primary, secondary and community care
providers, between specialties, and between health-care and social-care services.
Socioeconomic inequalities in health-care outcomes may therefore arise as a result of socioeconomic-related
differences in (1) the life-course of the patient, because of the accumulated effect of advantage or
disadvantage on the risk of ill health and the prospects of recovery from episodes of ill health; (2) patient
behaviour including health-care-seeking behaviour, self-care behaviour and lifestyle behaviour; (3) the
behaviour of primary, secondary and community care providers in patient encounters; (4) informal health
and community care provided to patients by family and friends; (5) formal long-term care including both
publicly and privately funded care and social services provided in the home as well as in institutions; and
(6) the co-ordination of care between primary, secondary and community care providers, between specialties,
and between health and non-health services. Some of these factors may be considered ‘exogenous’ capacity
to benefit factors that lie entirely outside the remit of the health-care system. Others may be considered
‘endogenous’ factors under the control of the health-care system. Still others may lie in a ‘grey area’ of
overlap, in which the boundaries of responsibility are not clear-cut. These boundary issues can raise
challenging ethical questions for health-care providers. For instance, if a poor patient has a worse
post-surgical outcome than a rich patient as a result of their lack of a supportive home environment in which
to recover, how far should health-care providers be held responsible for stepping in to remedy the situation?
One view is that health-care providers are indeed responsible for stepping in, as the poor patient needs
additional support during their recovery period, whereas the rich patient does not. Another view might be
that providing a supportive home environment including reminders to take medication, follow physiotherapy
regimes and other medical advice is not properly the responsibility of the health service. Our report does not
seek to take a prescriptive ethical view on such matters. Rather, we seek to provide data and evidence to
help decision-makers draw their own conclusions about equity based on their own value judgements.
Monitoring of equity in health and health care in England
This section briefly reviews the recent history of monitoring of equity in health and health care in England
since the early 2000s, and summarises the equity indicators that are already produced by Public Health
England and NHS England. By way of comparison, the section then reviews the system of health-care
equity monitoring in the USA, which at the current time is arguably the most comprehensive in the world,
as explained below.
Monitoring of equity in health care is in its infancy, and remains isolated from mainstream quality assurance.
Although health-care policy-makers, regulators, purchasers and providers have become accustomed to
paying close attention to routine comparative data on health-care quality for the average patient, they lack
routine comparative data on social inequalities in health-care quality.2 This hampers efforts to improve
equity, as what is not measured may be marginalised.1 So, although NHS decision-makers know that
health-care inequalities exist, they do not yet have a routine approach to quantifying the influence of the
NHS on those inequalities. They cannot routinely pinpoint changes in health-care inequalities at local level,
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and do not know what impact their actions are having on such inequalities. Prior to 2015, there was
essentially no routine monitoring of equity in health care in the English NHS. The NHS Outcomes Framework
started producing national breakdowns of inequalities in selected health-care outcomes for internal use in
2015 and plans to start publishing these breakdowns from 2016.37 However, there is currently no national
monitoring of inequality in health-care access and no local monitoring of equity in the NHS.2
By contrast, monitoring of inequality in health is more advanced and monitoring of health inequalities
within local areas started in the early 2010s, as explained below. In the early 2000s, England introduced
national health inequality targets as part of the world’s first cross-government strategy for tackling health
inequality.38,39 However, these targets were limited from a health-care quality improvement perspective.
First, they focused on life expectancy and infant mortality, over which health-care providers have little
direct control as they are strongly influenced by non-NHS social and economic factors (e.g. living and
working conditions) and related lifestyle behaviours (e.g. smoking, diet and exercise). Second, they were
defined in terms of inequalities between local government areas, known as ‘spearhead areas’, and the rest
of the country, thus masking important inequalities within these areas. This second issue was noted in the
2010 Marmot Review8 of health inequalities in England, as follows: ‘around half of disadvantaged
individuals and families live outside spearhead areas . . . By measuring changes only at local authority level,
we cannot tell whether any improvements being made are confined only to the more affluent members of
a generally deprived population.’
Subsequently, in the early 2010s, a more comprehensive and sophisticated set of local authority level
health inequality indicators were developed by the Institute of Health Equity, in collaboration with the
London Health Observatory, known as the ‘Marmot indicators’.40 These include indicators of average
health and the social determinants of health that broadly correspond to the policy recommendations
proposed in Fair Society, Healthy Lives: The Marmot Review.8 Importantly, they also include indicators of
inequality in life expectancy within each local authority level, based on small-area-level data. The Public
Health Outcomes Framework (PHOF) has also produced local as well as national indicators of inequality in
life expectancy.41 These local indicators use a local version of the slope index of inequality (SII), based on
ranking small areas into local deprivation decile groups by deprivation score within the local authority. This
is a different approach to the one used in the present study, which is based on the national deprivation
rank within England as a whole, as explained later in the report in Chapter 4. The primary aim of the PHOF
local health inequality indicators is to compare change over time in each local authority, rather than to
compare local performance against a national benchmark. The PHOF local deprivation approach is not
appropriate for the last task, as local deprivation ranks cannot be compared with national deprivation
ranks for the country as a whole. For that reason, we use national deprivation ranks so that we can
compare the local gradient in health-care outcomes within the local area with the national gradient.
To distinguish our approach from the PHOF approach, we label our local inequality index the ‘absolute
gradient index’ (AGI) rather than the slope index.
In contrast to England, the USA has had a fairly comprehensive system of national health-care equity
monitoring since 2003. The US health-care equity monitoring system was initiated following landmark reports
by the US Institute of Medicine on the safety of care,42 the quality of care43 and racial disparities in both.44
Since 2003, the Agency for Healthcare Research and Quality (AHRQ) has published an annual report on
health-care disparities within the general US population by racial, ethnic and socioeconomic group, and by
state.45 In 2014, this was integrated with the AHRQ annual report on health-care quality to form the National
Healthcare Quality and Disparities Report.46 This report summarises national US time trends in more than
250 different indicators of health-care access, process quality and outcomes. The indicators mostly focus on
indicators of health-care access and process quality, in line with relatively narrowly defined health-care quality
improvement objectives. However, there are also some indicators of health-care outcomes that go under the
heading of ‘care co-ordination’ indicators, such as preventable hospitalisation for ambulatory care-sensitive
conditions. Although these are likely to be more sensitive to variations in health-care access in a US setting,
compared with a country such as England which has universal health care, these indicators may also pick up
concerns for population health improvement and the co-ordination of care across different health-care
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settings and between health care and long-term care. Most of the indicators in the 2014 report published in
May 2015 end in 2012, more than a 2-year data lag, although some indicators such as the proportion of
Americans with health-care insurance are measured up to 2014. The AHRQ also publishes a web-based
‘States Snapshots’ tool for comparing quality and disparities between states.47 This focuses mainly on
comparisons of average quality between states, although also compares racial disparities between states by
dividing the average of the black, Hispanic and Asian scores by the white score, ranking states on this ratio,
and then listing states by quartile group. However, there is still no attempt to compare socioeconomic
disparities between states, or to perform statistical tests of whether or not states are performing significantly
differently from the national average on racial disparity.
Conceptual framework
Our monitoring framework has the following general design objectives:
1. to monitor equity in both health-care access and outcomes, after appropriate need or risk adjustment
2. to monitor overall equity in health care for the general population, while allowing disaggregation by
age, sex and disease category
3. to monitor the equity performance of the health service as a whole, including the integration of care
across different specialties, different primary and acute care settings, and different health care, social
care and other public services
4. to monitor equity at all main stages of the patient pathway
5. to monitor local equity performance against a national equity benchmark
6. to monitor equity trends alongside equity levels, and average performance alongside equity performance
7. to summarise all key findings in a one-page summary (‘equity dashboard’)
8. to provide visual information about underpinning inequality patterns and trends (‘equity chart packs’)
9. to provide a battery of inequality measures that are easy to understand and capture importantly
different concepts of inequality that can trend in different directions
10. to ensure indicators can be understood by members of the general public.
Figure 1 illustrates our framework for monitoring inequality in health-care access and outcomes at key
stages of the patient pathway and shows how our eight general indicators fit into this framework.
1. Primary care
    supply
2. Primary care
    quality
7. Amenable
    mortality
6. Dying in hospital
3. Hospital 
    waiting 
    time
4. Preventable
    hospitalisation
5. Repeat
    hospitalisation B. Primary and
community care
A. Home
D. Death
C. Hospital
FIGURE 1 Conceptual framework for monitoring inequality in health-care access and outcomes at key stages of the
patient pathway.
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As an example, Figure 2 illustrates how we monitor national equity trends using indicator 1, primary care
supply. The top panel shows a breakdown of patients per full-time equivalent (FTE) general practitioners
(GPs) by deprivation quintile group, allowing for need and population change, and the bottom panels
show how this translates into two standard inequality measures that look at the whole of the social
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FIGURE 2 National monitoring of change in equity over time. (a) Indicator 1: primary care supply; (b) RII; and (c) SII.
The top panel shows a breakdown of patients per FTE GPs by deprivation quintile group, allowing for need and
population change, and the bottom panels show how this translates into two standard inequality measures that look
at the whole of the social gradient in health care: the SII and RII. FTE, full-time equivalent; GP, general practitioner;
IMD, Index of Multiple Deprivation; RII, relative index of inequality.
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gradient in health care: the SII and the relative index of inequality (RII). These measures and graphs are
explained in more detail in Chapter 4.
Finally, Figure 3 illustrates our framework for local equity monitoring against a national benchmark.
This figure shows socioeconomic inequality in preventable hospitalisation within a fictional local NHS area
called ‘Any Town’. The basic idea is to compare the social gradient in health care within Any Town against
the social gradient in health care within England as a whole. The social gradient shows the pro-rich link
between socioeconomic status and preventable hospitalisation, after allowing for exogenous risk factors
influencing preventable hospitalisation that are not under the control of the NHS, in this case, age and sex.
As explained above, in Concepts of equity in health care, we would ideally also want to adjust for morbidity,
or, more precisely, that part of morbidity that is not under the control of the NHS, but were unable to do
so because of data limitations. The relevant NHS equity objective is to reduce the social gradient in health
care, both in Any Town and in England as a whole.
Any Town has a population of approximately 200,000 people. Each dot represents one of the
125 neighbourhoods in Any Town, each containing approximately 1500 people. Neighbourhoods are
ranked by deprivation, with more deprived neighbourhoods to the right. The Any Town inequality gradient
is simply a regression line fitted through these 125 dots. The England inequality gradient is a regression
line fitted through all 32,482 neighbourhoods in England. In this example, Any Town is doing better than
England as a whole both for the average patient (a lower average line) and in terms of reducing inequality
(a flatter inequality gradient). In this example, these differences are statistically significant and unlikely to
be merely because of the random play of chance. The NHS may, therefore, be able to learn lessons from
Any Town about how to tackle inequality in preventable hospitalisation.
Any Town gradient
(flatter = better)England inequality
gradient
England average
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FIGURE 3 Local equity monitoring against a national benchmark: preventable hospitalisation in neighbourhoods in
a fictional NHS area (Any Town). Neighbourhoods are ranked by deprivation, with more deprived neighbourhoods
to the right.
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Chapter 2 Public involvement
Introduction
Public involvement was important to our study because one of the main purposes of our indicators is
public reporting for democratic accountability, as well as facilitating quality improvement efforts by
national and local decision-makers. We therefore wanted to select indicators of socioeconomic inequality
in health care that members of the general public will consider meaningful and important. Before selecting
our indicators, we therefore considered it important to ask the general public about what they view as the
most unfair socioeconomic inequalities in health care. We also sought feedback from members of the
public to help refine our visualisation tools for communicating the findings of our indicators and to ensure
that members of the public are capable of understanding our indicators.
This chapter describes how members of the public were involved in this study. They were involved in two
ways. First, through a small-scale public consultation exercise in York conducted at the beginning of the
study to give us a better understanding of what kinds of socioeconomic inequality in health care are of
most concern to members of the public. This involved both an online survey (with 155 responses) and
a full-day citizens’ panel meeting (with 29 participants) to gather more in-depth views. Second, two
members of the public, recruited via our public consultation exercise, gave feedback throughout the
project through their membership of our advisory group.
The primary aim of the public consultation was to identify a list of priority areas for monitoring NHS equity
performance. This was achieved by asking the public to consider different types of socioeconomic
inequality in health and health care and assess which ones they thought were the most unfair. Our key
finding was that the public are concerned to reduce inequality in health-care outcomes, but that their
concern for reducing inequalities of access, specifically, for GP supply and hospital waiting times, is at least
as strong. This finding influenced the selection of equity indicators for our subsequent analysis. At the
inception of the project we had presumed that our indicators would focus on health-care utilisation and
outcomes, which are the focus of much current academic literature on equity in health care. However, as a
result of our public consultation exercise, as well as further development of our conceptual framework in
monitoring equity at multiple stages of the patient pathway, we ensured that both GP supply and hospital
waiting time were selected for inclusion in our suite of equity indicators.
A secondary aim of the public consultation was to identify two lay members of the public to join our
advisory group to contribute further to the indicator selection process and provide feedback on the design
of equity dashboards and other visualisation tools for monitoring equity performance.
This chapter is organised as follows. We start with consultation exercise methods, including the sampling
approach, development of questionnaire and data collection. We then present the main quantitative
results of the public consultation in terms of people’s responses to questions asking them to assess
and rank different kinds of inequality in health and health care by degree of unfairness. The results are
presented separately for our online survey and citizens’ panel. We then discuss the process of recruitment
of lay members and their contribution to the advisory group and, in particular, the design of visualisation
tools. Finally, we conclude by discussing the implications of public involvement for our indicator selection.
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Methods of public consultation
Sampling
The survey was conducted in the York area using two modes of administration: (1) a 1-day face-to-face
citizens’ panel event (n = 29), and (2) an online survey (n = 155). Participants in both forms of public
consultation were recruited in the same way, through advertising and leafleting in the York area as described
below. The citizens’ panel event was held in York city on Saturday, 21 September 2013. The online survey
was administered between July and September 2013, using a web portal called SmartSurvey™ (SmartSurvey
Ltd, Tewkesbury, UK). Citizens’ panel members were paid expenses and an honorarium for devoting a whole
day of their time to this, according to National Institute for Health Research (NIHR) and INVOLVE guidance,
whereas online survey participants were unpaid. The sampling strategies for both approaches are
described below.
The citizens’ panel meeting was advertised in a local monthly magazine called Your Local Link in July and
August 2013. The magazine is free of charge and distributed to all homes and businesses across York
(35 postcode sectors), targeting all sociodemographic groups. In addition, we distributed 810 leaflets door
to door to 10 of the most deprived streets in York [identified as being within the most deprived fifth of
neighbourhoods in England according to the Index of Multiple Deprivation (IMD) 2010] to reach a diverse
groups of participants. We also distributed flyers at two public events as part of the University of York’s
Festival of Ideas which was held in June 2013. Finally, we also put out a University of York press release
about the citizens’ panel event. A selection of our recruitment materials, together with the participant
consent form, is presented in Appendix 6.
A total of 103 individuals made contact with the project administrator for the citizens’ panel event. The
contact was made by telephone, e-mail or completion of an online registration form. Thirty places were
offered after stratifying respondents based on age, sex and socioeconomic background [established using
respondents’ postcode data and information from the Office for National Statistics (ONS)’s neighbourhood
statistics website derived from IMD 2010 deprivation score] and then selecting participants on a
‘first-come-first-served’ basis. A total of 29 participants attended the citizens’ panel event. This resulted
in a sample which was 41.3% male (n = 12) and 58.7% female (n = 17); had approximately one-quarter
from each main age group (18–34 years, 35–49 years, 50–64 years and ≥ 65 years), although slightly
more (around 30%) in the 50–64 years age group; and had respondents in all five deprivation quintile
groups with a mean deprivation rank of around 3, which is about average for the England population
(see Table 1 for more details).
The online survey was publicised on Your Local Link magazine, on door-to-door leaflets, the Centre for
Health Economics website and the JISCMail mailing list for health economists. It was also advertised on
social media from June 2013, particularly using the Twitter (Twitter, Inc., San Francisco, CA, USA;
www.twitter.com) handles of the Centre for Health Economics and the University of York, and Facebook
(Facebook, Inc., Menlo Park, CA, USA; www.facebook.com). In addition, individuals who contacted us for
the citizens’ panel but were not offered a place, were also informed about the online questionnaire.
Questionnaire
The questionnaire focused on socioeconomic inequality in the supply, process and outcomes of health
care. Statements about inequalities in general (non-disease-specific) health and health care were presented
to all participants who were asked to rate them on a scale of 1 to 10, where 1 is not at all unfair and 10 is
extremely unfair (see Appendix 6). In order to elicit views about the unfairness of different kinds of
inequality, we developed a questionnaire based on the following statements about different general kinds
of socioeconomic inequality in health-care access and outcome. Our selection was based on statements
about inequalities that can in principle be monitored using available data, which constrained our choices
considerably, but this was a necessary step as the ultimate aim was to measure and monitor inequality.
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We piloted these statements on a sample of administrative staff members at the University of York. Based
on their feedback, we improved the presentation and clarity of the statements.
l The richest fifth of people in England are more likely than the poorest fifth to have a healthy diet and a
healthy level of physical exercise.
l The richest fifth of people in England are served by more GPs than the poorest fifth.
l The richest fifth of people in England are more likely than the poorest fifth to receive routine screening
tests (e.g. for bowel cancer).
l The richest fifth of people in England are more likely than the poorest fifth to see a medical specialist
when they are ill.
l The richest fifth of people in England wait less time for NHS surgery than the poorest fifth.
l The richest fifth of people in England are less likely than the poorest fifth to die after high-risk surgery
(e.g. heart or cancer surgery).
l The richest fifth of people in England are less likely than the poorest fifth to have an emergency
hospitalisation preventable by good-quality health care.
l The richest fifth of people in England are less likely than the poorest fifth to die from conditions
preventable by good-quality health care.
Respondents were then asked to indicate which of the above inequalities they saw as the most and least
unfair. This rating question and a screenshot of the online questionnaire are reproduced in Appendix 6.
We did not present statements about specific clinical disease areas because it was not possible to provide
members of the public with adequate clinical and epidemiological information about all the different
possible disease area domains that we could select. This would require a series of clinical tutorials that
would take up more than the full day of discussion. Furthermore, asking people to compare disease areas
would likely change the focus of discussions to which diseases are more important, rather than on
socioeconomic inequality and fairness in health and health care within each disease area.
Data collection
There were two samples: the citizens’ panel sample and the online sample. The citizens’ panel event
involved presentations by facilitators to introduce the questionnaire, interactive discussions in small and large
groups, and individual completion of a paper version of the questionnaire. Respondents were split into five
pre-arranged groups (four groups of five and one group of four), which were mixed according to age, sex
and socioeconomic background. The following people each facilitated a group: Shehzad Ali, Miqdad Asaria,
Richard Cookson, Paul Toner and Aki Tsuchiya. A gift payment of £70.00 was offered to all participants of
the citizens’ panel event which was accepted by all except one, who asked to donate it to charity.
The online survey was posted on SmartSurvey with the following web link: www.smart-survey.co.uk/s/
NHSFairness. The survey included the same inequality statements as the citizens’ panel questionnaire and
followed the same format (see Appendix 6). Our online questionnaire was active between June 2013 and
September 2013. Respondents could complete the survey anonymously, or leave their name and e-mail
address to receive a copy of the findings. No financial incentive was offered for taking part in the online
survey because of budget limitations and technical difficulty of arranging payments.
Results of public consultation
Survey sample
In total, 29 individuals participated in the citizens’ panel event in York and 159 individuals completed the
online survey. The baseline characteristics of the sample are presented in Table 1. The majority of
respondents were female: 62.1% in the citizens’ panel and 66.5% in the online group. The age distribution
in both groups was similar and reflects that the survey represented a diverse group of participants. Based on
respondents’ postcode information, we calculated their deprivation level using the IMD 2010 data available
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at the small-area level. Respondents in the two groups were from all five deprivation quintile groups, with
the mean deprivation quintile group rank being 3.2 and 3.3 for the citizens’ panel and online groups,
respectively (i.e. the average person was in the middle of the five deprivation groups). Respondents were
also asked to complete standard questions from the British Attitudes Survey about attitudes to the welfare
state and income redistribution (1 = strongly agree and 5 = strongly disagree). The average score on the
statement ‘The creation of the welfare state is one of Britain’s proudest achievements’ was 1.4 showing a
high level of agreement (93.1% and 94.8% of respondents agree or strongly agree with this statement in
the citizens’ panel and online samples, respectively). This is much higher than the findings of the British
Attitude Survey results for 2014, which found that 56% of respondents agree or strongly agree with this
statement. This reflects the general point that public consultation exercises about equity are more likely to
recruit individuals who care about equity issues.
Ranking of unfair inequalities
All participants responded to the question about the most unfair socioeconomic inequalities in health and
health care. Figure 4 presents the full distribution of responses to the question about the most unfair
inequality. The citizens’ panel group ranked socioeconomic inequality in waiting time for surgery as the
most unfair (31%), whereas the online group ranked inequality in death from conditions preventable by
good-quality health care as most unfair (33%).
TABLE 1 Respondent characteristics of citizens’ panel and online groups
Variable
Sample
Citizens’ panel (n= 29) Online group (n= 155)
Statistic n Statistic n
Baseline
Male (%) 37.9 11 33.5 52
Age, years (%)
< 18 0.0 0 0.6 1
18–34 27.6 8 24.5 38
35–49 20.7 6 23.2 36
50–64 31.0 9 34.8 54
≥ 65 20.7 6 16.8 26
Deprivation quintile (%)
Quintile 1 (most deprived quintile) 13.8 4 16.2 19
Quintile 2 20.7 6 17.1 20
Quintile 3 20.7 6 18.8 22
Quintile 4 20.7 6 19.7 23
Quintile 5 (least deprived quintile) 24.1 7 28.2 33a
Social attitude statementsb (mean) (1 = strongly agree; 5 = strongly disagree)
The creation of the welfare state is one of Britain’s
proudest achievements
1.4 29 1.4 154
Government should redistribute income from the better off to
those who are less well off
3.0 29 2.2 154
a In total, 38 out of 155 online respondents did not provide correct postcode information and hence their deprivation
score was not available.
b 1 suggests most egalitarian and 5 suggests most non-egalitarian.
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However, the following three types of inequalities were identified as the most important unfair inequalities
by both citizens’ panel participants and online survey respondents:
1. The richest fifth of people in England wait less time for NHS surgery than the poorest fifth (31% of
citizens’ panel participants and 19% of online respondents ranked this as the most unfair inequality).
2. The richest fifth of people in England are less likely than the poorest fifth to die from conditions
preventable by good-quality health care (24% of citizens’ panel participants and 33% of online
respondents ranked this as the most unfair inequality).
3. The richest fifth of people in England are served by more GPs than the poorest fifth (21% of citizens’
panel participants and 24% of online respondents ranked this as the most unfair inequality).
Rating of unfair inequalities
We also asked respondents to rate how unfair they think each type of inequality is on a scale of 1–10,
where 1 is ‘not at all unfair’ and 10 is ‘extremely unfair’. All respondents in the citizens’ panel and online
groups completed the rating scale. Table 2 summarises the results of the level of perceived unfairness of
different types of inequality. The table shows that all forms of socioeconomic inequalities in health and
TABLE 2 Rating of unfairness of different types of inequalities in health and health carea
Statements
Sample
Citizens’ panel Online sample
Mean Median
% of
responses
with a score
of ≥ 6 Mean Median
% of
responses
with a score
of ≥ 6
A. The richest fifth of people in England are
more likely than the poorest fifth to have
a healthy diet and a healthy level of
physical exercise
6.69 7 62 6.52 7 60
B. The richest fifth of people in England are
served by more GPs than the poorest fifth
8.07 8 83 8.67 10 91
C. The richest fifth of people in England are
more likely than the poorest fifth to receive
routine screening tests (e.g. for bowel cancer)
8.1 8 83 7.92 9 80
D. The richest fifth of people in England are
more likely than the poorest fifth to see a
medical specialist when they are ill
7.31 8 76 8.02 9 83
E. The richest fifth of people in England wait
less time for NHS surgery than the poorest fifth
8.41 8 86 8.76 10 91
F. The richest fifth of people in England are
less likely than the poorest fifth to die after
high-risk surgery (e.g. heart or cancer surgery)
7.79 9 79 7.51 8 72
G. The richest fifth of people in England are
less likely than the poorest fifth to have an
emergency hospitalisation preventable by
good-quality health care
7.34 8 79 7.99 9 82
H. The richest fifth of people in England are
less likely than the poorest fifth to die from
conditions preventable by good-quality
health care
7.93 9 79 8.05 9 82
a 1= not at all unfair and 10 = extremely unfair.
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health care were considered unfair by both the citizens’ panel and online groups. Based on mean scores,
the citizens’ panel group rated the following inequalities as particularly unfair: waiting time for NHS
surgery; supply of GPs; and routine screening tests. Similarly, based on average scores, the online group
rated the following inequalities as particularly unfair: waiting time for NHS surgery; supply of GPs;
and death from conditions preventable by good-quality health care.
Role of the lay members of the advisory group
Two participants at the citizens’ panel event were invited to join our advisory group as lay members, to
contribute to the research design and, in particular, the process of indicator selection and design of
dashboards and other visualisation tools for monitoring changes in NHS equity performance. The selection
of lay members was based on their interest in the subject of inequalities in health and health care,
willingness to contribute to this project, experience of using NHS health services, ability to communicate
with members of the team and availability to join meetings in York and London. Based on these criteria,
one male and one female participant were invited to join the advisory group.
The lay members attended all three advisory group meetings in London, were involved in additional
face-to-face discussions, and reviewing and commenting on relevant documents. More specifically, the lay
members contributed to the project in the following ways:
l They contributed to discussions on the choice of equity indicators that matter to the general public
and, therefore, should be considered for monitoring equity performance.
l They provided useful advice about dashboard design to improve presentation and interpretation.
The lay members commented on the prototype NHS equity dashboard designs, as a result of which we
revised and simplified the designs to reduce ‘clutter’ on the graphical displays, and added arrows as well as
traffic-light colours to help colour-blind users and people who print out in black and white. The lay
members also commented on the different types of graph in the chart pack, and reassured us that our
graphs were clear and informative to non-expert audiences.
Our lay members agreed in the final project meeting that the current one-page summary dashboard style
presents useful information to NHS and public health experts. However, they thought that this concise
format may not be appropriate for communication to the public, as it provides too much information in a
small space. They advised that public reporting would require a different kind of infographic design
tailored to public audiences. They suggested that the dashboard presentation would be useful to health
experts once they are familiar with the dashboard design and have read the accompanying material, but
proposed that clear notes accompanying the dashboard would be useful to help interpretation.
Conclusion
We conducted a small-scale public consultation exercise in York to inform the choice of priority indicators
of health-care equity. The consultation was conducted through a 1-day citizens’ panel event in York and
an online questionnaire, both of which aimed to gauge the strength of public concern for different types
of socioeconomic inequality in health-care access and outcomes. The consultation showed that the public
considered inequalities in health behaviours, such as healthy diet and healthy level of physical exercises, to
be less unfair than inequalities in health-care access and outcomes. This indicated that, at least from a
public perspective, the focus of NHS equity measurement should be on indicators that are amenable to
changes in the way health care is organised and delivered rather than indicators of individual lifestyle
behaviour; although, of course, the former may influence the latter. The consultation found that the
general public perceived the following three socioeconomic inequalities in health care as particularly unfair:
supply of GPs; hospital waiting time for surgery; and death due to causes preventable by good-quality
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health care. Our finding suggests that the public care about inequalities in both access and outcome, and
that indicators of inequality in access to health care are an essential component of NHS equity monitoring
for the purpose of public transparency and accountability.
The two lay members of our advisory group also provided useful feedback and advice on indicator
selection and on the design of visualisation tools. As well as helping to improve our visualisation tools
in various ways, one of the most helpful pieces of feedback was a negative lesson. It is clear that our
one-page equity dashboard tool is appropriate for communicating to decision-makers, but it is not
appropriate for public reporting. We therefore recommend further work on public reporting of our equity
indicators, involving infographic design specialists and public relations experts.
PUBLIC INVOLVEMENT
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Chapter 3 Indicator selection
Introduction
This chapter describes the iterative process through which we selected our eight main indicators of equity
and our two disease-specific indicator domains (CHD and diabetes). We produced the following prototype
equity indicators at both national and local levels: (1) primary care supply, (2) primary care quality,
(3) hospital waiting time, (4) preventable hospitalisation, (5) repeat hospitalisation, (6) dying in hospital,
(7) amenable mortality and (8) overall mortality. The first seven are indicators of equity in health care;
the eighth is an indicator of equity in health that provides useful contextual information to place the other
indicators into perspective.
The definitions of these indicators are provided elsewhere in the report:
l non-technical overviews of each indicator, summarising what they mean and why they are worth
measuring are in Chapter 5
l short two-line indicator definitions are in Chapter 7
l full technical indicator definitions are in Appendix 4.
We also produced prototype equity indicators at the national level for our two disease-specific domains,
which are described in Appendices 1 and 2.
The indicator selection process included (1) reviewing existing indicators used by the NHS to monitor
health-care quality; (2) consulting with health indicator experts about technical feasibility; (3) consulting
with a diverse range of NHS and public health experts about policy relevance through one-to-one
conversations and an online survey; and (4) consulting with members of the public (see Chapter 2).
Indicator selection decisions were made in consultation with our advisory group, the membership of which
is listed in Appendix 3.
Based on the indicator review and consultation process, we developed (1) an indicator framework around
different stages of the patient pathway, (2) a long list of potential general health-care equity indicators and
(3) a shortlist of potential disease-specific indicator domains, together with examples of potential equity
indicators within each shortlisted domain. In consultation with our advisory group, we then selected for
prototype indicator production (1) a shortlist of general equity indicators and (2) two disease-specific
indicator domains (CHD and diabetes). The final set of indicators and their detailed technical specifications
were subsequently selected and refined in an iterative process of data analysis and reanalysis in response
to feedback from a series of presentations of emerging findings to members of our advisory group and a
range of other health-care and public health experts.
All our indicators have important limitations because of data limitations. We had to do the best we could
with available data that can be broken down at the neighbourhood level, and our findings must be
interpreted with due caution given the data limitations. We have, as part of our research recommendations,
indicated that there is a need to develop better sources of data that will enable researchers to develop
improved measures of health-care access and outcome that can be broken down at the neighbourhood
level or, better still, individual level. The main limitations are summarised in the paragraph below; other
limitations are described in the Appendix 4.
DOI: 10.3310/hsdr04260 HEALTH SERVICES AND DELIVERY RESEARCH 2016 VOL. 4 NO. 26
© Queen’s Printer and Controller of HMSO 2016. This work was produced by Cookson et al. under the terms of a commissioning contract issued by the Secretary of State for
Health. This issue may be freely reproduced for the purposes of private research and study and extracts (or indeed, the full report) may be included in professional journals
provided that suitable acknowledgement is made and the reproduction is not associated with any form of advertising. Applications for commercial reproduction should be
addressed to: NIHR Journals Library, National Institute for Health Research, Evaluation, Trials and Studies Coordinating Centre, Alpha House, University of Southampton Science
Park, Southampton SO16 7NS, UK.
23
Our measure of primary care access, GPs per patient, focuses on GPs rather than practice nurses and other
primary care professionals, and also focuses on ‘inputs’ rather than outputs and outcomes from the patient
perspective, for example, how long it takes to book an appointment and whether or not consultations are
sufficiently long and of high quality. Data on practice nurses are now becoming available at the practice
level. However, the lack of a patient perspective is less straightforward to overcome using existing data,
because GP patient survey data on patient experience of access to care may be subject to sample selection
bias at the practice and neighbourhood level, as explained later. Another limitation is that our measure of
primary care quality focuses on the clinical process quality indicators in the Quality and Outcomes
Framework (QOF), which only capture some limited aspects of primary care quality. Finally, our measures of
health-care outcome were only adjusted for age and sex, not other health risk factors that increase the risk
of poor outcomes in deprived neighbourhoods but may lie outside the control of health services.
The rest of this chapter contains sections on the indicator selection criteria, the indicator review and the indicator
consultation. It concludes with a section describing potential quasi-experiments and additional indicators that
were suggested during the indicator selection process and that may be worth considering in future work.
Indicator selection criteria
Our indicator selection criteria are listed below, together with supplementary notes on how the criteria
were assessed. There are four sets of criteria: (1) general criteria for each individual indicator, (2) technical
criteria for each individual indicator, (3) criteria for selecting an appropriate mix of indicators within each
domain and (4) criteria for selecting the two disease-specific indicator domains.
General criteria for each individual indicator
1. Face validity to NHS and public health stakeholders: the indicator should be considered credible,
meaningful and important by NHS and public health policy-makers, managers, clinicians, patients and
the general public.
2. Sensitivity to health-care intervention: the indicator should potentially respond to health-care
interventions, broadly defined to include actions by health-care organisations to improve the
co-ordination of care between different health-care professionals and between health-care, social
care and public health professionals.
3. Impact on population health: the indicator should potentially impact on population health and social
inequalities in population health.
Supplementary notes
1. These criteria were assessed by the project team and advisory group based on information from our
indicator review and consultation with these stakeholder groups.
2. To help satisfy the first two criteria, we sought, when appropriate, to use standard, well-validated indicators
that the NHS already uses for monitoring average health-care quality. However, we did not treat conformity
to current NHS indicator specifications as an independent and over-riding criterion. So, in some cases, we
selected non-standard indicators, or used indicator specifications that depart slightly from current NHS
technical definitions. For example, our indicator of mortality amenable to health care is based on numbers
of deaths (in total, and per 1000 people) rather than potential years of life lost, because our consultees felt
this was easier to explain to policy-makers, managers and the public. Our definition of hospital waiting time
is based on inpatient waiting time from the point of specialist decision to treat rather than the earlier point
of GP referral to a specialist, as official NHS ‘referral-to-treatment’ waiting time statistics are not available at
the small-area level. And our definition of repeat hospitalisation differs from standard 30-day or 90-day
all-cause emergency readmission statistics, because we wish to capture the quality of co-ordinated care and
rehabilitation services over a longer time period following discharge. All departures from standard NHS
indicator definitions are described and justified in Appendices 1, 2 and 4.
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Technical criteria for each individual indicator
1. Data availability for national monitoring: the indicator should allow annual monitoring of social
deprivation gradients over time from the early 2000s.
2. Statistical confidence for national monitoring: to be useful for monitoring national NHS performance,
national indicators require sufficiently small confidence intervals to be capable of detecting a feasible
change in inequality over a 2-year time period.
3. Data availability for local monitoring: the indicator should allow social deprivation gradients to be
computed for each large subnational area (CCG) and back in time to the early 2000s.
4. Statistical confidence for local monitoring: to be useful for local quality improvement purposes,
indicators at the CCG level require sufficiently small confidence intervals to detect at least 5 or 10 CCGs
with social gradients that are better (flatter) than the national social gradient and 5 or 10 that are
worse (steeper).
Supplementary notes
1. In practice, the data availability criteria restricted our attention to indicators that can be computed using
health data sets providing comprehensive practice-level or small-area-level data on the entire English
population going back to the early 2000s, in particular the primary care workforce census, the QOF,
Hospital Episode Statistics (HES) and ONS mortality register data. Other comprehensive health data sets
were considered but rejected. For example, the National GP Patient Survey from 2006/7 was rejected,
as variations in practice-level response rates might lead to sample selection bias when comparing social
gradients between subnational areas.
2. The statistical criteria were assessed by producing prototype indicators and examining confidence
intervals around social gradients. The size of a feasible change in the national social gradient within
2 years was assessed by examining the historical speed and magnitude of change over time. Confidence
intervals around social gradients depend on nuanced features of the data (including the spread of events
across the gradient as well as the total number of events) and nuanced methodological choices about
inequality index specification, error specification, indicator specification, risk adjustment and data pooling
across years. The size and speed of historical change in the social gradient depends, in addition, on
change in population denominator and adjustment variables as well as change in outcome variables.
3. We found that hospitalisation and mortality rates related to a single condition, even a common
condition such as CHD, are generally too low to allow detection of statistically significant differences
between local and national absolute gradient indices of inequality. Therefore, for local equity
monitoring we focused on general equity indicators which have much higher rates of hospitalisation
and mortality, as they provide an overall system-wide assessment of equity in the full range of NHS
activity across multiple conditions.
Criteria for selecting an appropriate mix of indicators within each domain
1. Coverage of inequality in both access and outcome.
2. Coverage of inequality at all main stages of the patient pathway.
3. Coverage of inequality in multiple domains of the NHS Outcomes Framework. The NHS Outcomes
Framework has five domains: (1) preventing people from dying prematurely, (2) enhancing quality of life
for people with long-term conditions, (3) helping people to recover from episodes of ill health or
following injury, (4) ensuring that people have a positive experience of care and (5) treating and caring
for people in a safe environment and protecting them from harm.
4. Synergy between indicators: we aimed to select a coherent basket of indicators that complement one
another, such that levels and changes in some indicators can potentially be used to help understand
levels and changes in other indicators.
5. Relevance to quasi-experiments: other things equal, we preferred indicators that can potentially be used
for quasi-experimental evaluation of the impacts of NHS interventions.
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Supplementary notes
i. In assessing criterion 1, we interpreted ‘access’ broadly to include measures of structure (e.g. GP
supply), process (e.g. the proportion of diagnosed patients receiving appropriate medical care) and
‘intermediate’ outcomes (e.g. blood pressure control and hospital waiting time) indicative of access.
In this way, three of our seven main indicators of equity in health care can be interpreted as ‘access’
indicators (GP supply, GP quality and hospital waiting time) and four as ‘outcome’ indicators
(preventable hospitalisation, repeat hospitalisation, dying in hospital and amenable mortality).
ii. We assessed criterion 2 using our framework for monitoring inequality at different stages of the patient
pathway (see Chapter 1).
iii. In relation to criterion 3, we only managed to include indicators from the first three domains because
of data availability constraints. Almost all indicators in domains 4 and 5 failed our criterion of data
availability for local equity monitoring because they rely on data from sample surveys and/or
administrative data only provided at the organisational rather than small-area level.
iv. Criterion 4 led us to select diverse indicators that measure distinct concepts. For example, our measures
of access include one ‘structure’ measure (GP supply), one ‘process’ measure (GP process quality) and
one ‘intermediate outcome’ (waiting time). Our measures of outcome include measures of NHS impacts
on both morbidity (preventable and repeat hospitalisation) and mortality (amenable mortality) and a
measure of end-of-life care (dying in hospital). We considered indicators of inequality in early-life care
outcomes, such as low birthweight, birth defects and child mortality, but did not explore these further
because of concerns about small number problems for local equity monitoring and concerns that such
indicators may be more sensitive to socioeconomic variation in maternal health, lifestyle and social
support than socioeconomic variation in the quality of NHS care.
v. We assessed criterion 5 based on our own views about potential quasi-experiments, supplementary by
information from our survey of NHS and public health experts (see below). A suitable quasi-experiment
requires the existence of relevant NHS interventions in the 2000s which (1) were likely to influence
socioeconomic health inequality; (2) allow the construction of a suitable control group as a result of
geographical variation in delivery, such as differential timing of intervention roll-out in different
geographical areas; and (3) are relevant to the design and implementation of potential future
NHS interventions.
Criteria for selecting the two disease-specific indicator domains
1. Substantial disease burden and cost to the NHS: substantial disease burden and cost to the NHS are
measurable although imperfect proxies for two underlying criteria: (1) domains should reflect conditions
that NHS stakeholders consider important (which helps assure general criterion 1, face validity), and
(2) domains should have sufficiently large patient populations to meet technical criterion 2, statistical
confidence for national monitoring.
2. Data availability for national monitoring: the domain should allow the construction of an appropriate
mix of indicators for annual monitoring of social deprivation gradients over time from the early 2000s
(as per technical criterion 1 and the criteria for selecting an appropriate mix of indicators).
3. Availability of quasi-experiments: we wanted our indicators to form a ‘data platform’ for retrospective
‘quasi-experiments’ to provide useful evidence about the effects of past NHS interventions on
health inequality.
4. Synergy between the domains: we had research capacity to examine only two condition-specific
domains in addition to the general domain. So, we sought to select a synergistic pair of domains that
can fruitfully be compared and contrasted.
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Supplementary notes
i. The first criterion was assessed using information on burden of disease in the UK48 and NHS
programme budget expenditure for 2011/12 by disease category.49 Disorders were considered to have a
‘substantial’ burden of disease if they were in one or more of the three published ‘top 25’ burden of
disease lists for the UK in 2010: (1) by years of life lost for both sexes and all ages, (2) by years of life
lost for both sexes and ages 20–54 years, and (3) by years lived with disability for both sexes and all
ages. Diseases were considered to have a ‘substantial’ cost if the NHS spent more than £250M treating
them in 2011/12 (just over one-quarter of 1% of total NHS expenditure) according to programme
budgeting subcategory data (which has to be treated with caution and which underestimates total cost
as most primary care expenditure cannot be attributed). CHD (labelled ischaemic heart disease by the
burden of disease study authors) was the number one cause of years of life lost for all ages and for
ages 20–54 years, the number 19 cause of years lived with disability and absorbed £1890M of NHS
expenditure in 2011/12. Diabetes was the number 26 cause of years of life lost for all ages and for ages
20–54 years, the number 18 cause of years lived with disability, and absorbed £1550M of NHS
expenditure in 2011/12.
ii. The second criterion was assessed based on whether or not a suitable mix of indicators (i.e. covering
both access and outcome and all main stages of the patient pathway) could be constructed using the
comprehensive health data sets listed above.
iii. The third criterion was assessed based on our own views about potential quasi-experiments
supplemented by information from our survey and one-to-one conversations with health-care and
public health experts.
iv. The fourth criterion was assessed subjectively in consultation with our advisory group. Following our
review and consultation process, we produced a shortlist of five candidate disease-specific indicator
domains (colorectal cancer, CHD, diabetes, severe mental illness and stroke), together with example
indicators in each domain. Of these, the two disease-specific domains selected for production were
CHD and diabetes. Once CHD had been selected on the grounds of being the strongest domain on all
of the first three criteria, it was felt that a comparison with diabetes would add more synergy value
than a comparison with any of the other shortlisted domains. This is because diabetes shares many
risk factors with CHD but is growing in burden and cost of illness while CHD is declining, because
well-validated primary care process quality indicators are available for both domains in the QOF, and
because both domains were central to NHS efforts to tackle socioeconomic inequality in adult mortality
in the late 2000s.
Indicator review process
We reviewed available indicators in order to (1) identify a full range of indicators that can potentially
be used for monitoring average health-care quality in the NHS, (2) identify which of these indicators
could feasibly be converted into equity indicators, based on our technical indicator selection criteria,
(3) select candidate indicators based on our general indicator selection criteria and (4) select candidate
disease-specific indicator domains based on our indicator domain selection criteria.
We started by reviewing all indicators currently used for monitoring average health-care quality in the NHS,
as published on the Health and Social Care Information Centre (HSCIC) Indicator Portal (https://indicators.
ic.nhs.uk/webview; accessed 12 July 2015). This web-based portal hosts a wide range of indicators,
including all of the indicators in the NHS Outcomes Framework, the PHOF and the Adult Social Care
Outcomes Framework. We then considered further indicators by (1) checking an unpublished list of
indicators from an internal review by the HSCIC in 2011 and (2) seeking suggestions from advisory group
members, co-applicants and colleagues. Finally, we generated proposals for new equity indicators based
on our own knowledge of available health data sets in England and suggestions from consultees.
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Indicator consultation process
As well as the public consultation process described in Chapter 2, the indicator consultation process
included (1) one-to-one conversations with NHS and public health experts, (2) an online survey of NHS
experts and (3) consultation with members of our advisory group (listed in Appendix 3). Our aim was to
obtain a range of views from NHS and public health experts with appropriately diverse backgrounds and
perspectives, rather than a representative national sample.
Conversations were held with a range of experts, including:
l academic experts in health inequality, primary care, mental health, circulatory disease, cancer,
epidemiology, health geography, sociology of health and health economics
l analysts and health inequality experts at NHS England and the Department of Health, including analysts
supporting the NHS Outcomes Framework
l analysts and health inequality experts at Public Health England
l board members of two CCGs (Vale of York and Hull)
l public health directors in two local authorities (City of York and Hull City Council)
l board members of two NHS hospital trusts (York and Morecombe Bay)
l public health, health policy and performance indicator experts at leading national think tanks
(The King’s Fund and Nuffield Trust).
The conversations focused on the credibility and policy importance of our proposed equity indicators,
the identification of potential new indicators, the visual communication of equity indicator findings and the
perceived impacts of past NHS interventions on socioeconomic inequalities in health. The questions and
topics were tailored to the type and role of the respondent, rather than following a ‘one-size-fits-all’
structured interview format.
The online survey was conducted to supplement these conversations, with a range of views focusing
specifically on the perceived impacts of past NHS interventions on socioeconomic inequalities in health.
This specific focus was chosen to help the research team select equity indicators that NHS experts consider
to be sensitive to NHS health-care delivery and that provide a platform for future ‘natural experiment’
studies of the health inequality impact of NHS interventions. Accordingly, the online survey asked two
main questions:
1. In the boxes below, please list up to THREE national or local NHS interventions in the past decade or so
that you think had a measurable impact on socioeconomic inequalities in health-care access or
outcomes in England.
2. For each NHS intervention, what primary outcome(s) would you use to measure impact on
socioeconomic health inequality?
The survey was e-mailed to 164 senior individuals from diverse organisations and clinical specialties, with
an e-mail addresses identified via the personal contacts of the research team and advisory group, and web
searching. Invitees could respond directly by e-mail, by filling in a Microsoft Word® form (2010, Microsoft
Corporation, Redmond, WA, USA) or by filling in an online survey form via the web-based survey tool
SmartSurvey (SmartSurvey Ltd, Tewkesbury, UK; www.smartsurvey.co.uk). One reminder e-mail was sent to
non-responders. Only 14 response sets were received (a 8.5% response rate). This low response rate is
about average for surveys of this kind, given the challenging and time-consuming nature of these
open-ended questions and that we were seeking responses from busy, senior professionals. The only
impact of this low response rate on our findings was that our list of potential quasi-experiments (see
Potential quasi-experiments) is not exhaustive. The most important element of our consultation was the
face-to-face discussions with stakeholders, as described above, which enabled us to gather more nuanced
information than is possible using a survey about stakeholder views on the selection of indicators and the
visual communication of equity findings.
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Potential quasi-experiments and additional indicators
Potential quasi-experiments
This section lists a selection of NHS interventions implemented in the 2000s that the experts we consulted
suggested may have had an impact on health inequality that could potentially be identified using
quasi-experimental evaluation, based on the indicators of the kind we have developed in this project. This
list helped inform the selection of our two disease-specific domains, as a number of them relate to CHD
and diabetes. It may also provide researchers with useful ideas for future work using quasi-experiments to
identify the effects of NHS interventions on social inequalities in health and health care.
The list includes interventions which have already been at least partially evaluated, but that one or more
experts felt warrant further and more rigorous quasi-experimental evaluation. As well as NHS interventions,
the list also includes some public health interventions that go beyond health-care services and/or NHS
funding, but that may nevertheless impact on some of the health-care outcome indicators we measure in
this project, such as preventable hospitalisation and amenable mortality. The list is as follows:
l the Health Inequality National Support Team programme 2007–9 for improving primary care for
cardiovascular disease and diabetes in disadvantaged adults
l the Equitable Access to Primary Medical Care Programme 2008–10, which invested in opening new GP
practices in under-doctored areas
l the 2-week cancer waiting time target from GP referral to specialist consultation, introduced in 2007
l changes in subnational (primary care trust-level) NHS expenditure during the 2000s and changes in
subnational (CCG-level) NHS expenditure during the 2010s
l the impacts on socioeconomic inequality in preventable hospitalisation and amenable mortality for CHD
and diabetes of the QOF primary care pay-for-performance scheme introduced from 2004
l changes to the QOF incentive payments in the late 2000s
l diffusion of primary percutaneous coronary intervention following emergency admission for acute ST
elevation myocardial infarction, during the 2000s
l the national NHS Bowel Cancer Screening Programme from 2006 (this may be an example of
‘intervention-generated inequality’: this intervention is cost-effective, but may have increased health
inequality because of the lower uptake in deprived groups)
l NHS intensive smoking cessation services in England from 1999
l cuts in particular local areas to community health-care services disproportionately used by
disadvantaged groups, for example community midwifery services and out-of-hours primary
care services
l proactive hospital-based diabetes services introduced in some areas during the 2000s
l screening and brief interventions for alcohol misuse
l early intervention for psychosis including those identified as ‘at risk’.
Additional indicators
We list below a selection of additional equity indicators that were considered but rejected for the particular
purposes of this project. We include this list to explain why some indicator ideas were not selected for
inclusion in our suite of prototype equity indicators, and also to inform the deliberations of future
researchers and analysts seeking to improve our equity indicators and develop new ones.
l Multimorbidity according to patient-level inpatient hospital records: the proportion of the general
population with a hospital record of three or more chronic conditions from hospital visits in the last
2 years. This indicator was rejected for the purposes of this project because of potential selection bias,
as not all people with multimorbidity are admitted to hospital for inpatient treatment. However, it
could nevertheless potentially be useful in future work as a contextual indicator of socioeconomic
inequality in health and to improve the risk adjustment of indicators of equity in health-care outcomes,
such as preventable hospitalisation and amenable mortality.
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l Multimorbidity according to practice-level primary care QOF data: the proportion of people with two
or more chronic conditions based on QOF data. This was rejected because of potential under-recording
in deprived patients which may vary between local areas and over time, potentially leading to bias in
both time series comparisons and local equity monitoring comparisons. In sensitivity analysis, we also
explored ways of using this indicator to improve the risk adjustment of indicators of equity in
health-care outcomes. However, because it is only available at the practice level rather than individual
level, yet is highly correlated with age, we found that adding this variable yielded unstable results
and little explanatory power over risk adjustment for age and sex alone. However, at the national
level this indicator could provide a useful convergent validity check on multimorbidity according to
patient-level inpatient hospital records.
l Multimorbidity according to mortality records: the proportion of people who died in the indicator year
with two or more chronic conditions based on secondary mentions of causes of death. This was
rejected because of lack of reliable coding of causes of death on mortality records and change over
time in coding. It may be possible to improve on this by linking information from hospital records at the
individual level; but again this would still suffer from the bias described above that not all individuals
visit hospital.
l Post-hospital mortality: 12-month mortality after discharge per 1000 hospital discharges. This was
rejected as it yields a somewhat out-of-date indicator: either a 1-year data lag or a focus on patients
admitted the year prior to the indicator year. There is also a risk of indicator revision the year after
initial release, as we found that the HES–ONS mortality link data required to compute this indicator are
sometimes subject to substantial data revision the following year.
l Excess hospital stays: proportion of inpatients with excess length of stay as defined by Healthcare
Resource Group (HRG) trim points. This was rejected because of concerns about time series
comparability. HRG coding systems change over time, and HRG trim points only provide a relative
definition of an ‘excess’ stay for a particular treatment based on the changing year-specific distribution
of stays, rather than an absolute definition based on clinical judgement. Data on ‘delayed discharges’,
which reflect a more accurate and more absolute definition, are currently only available at the hospital
level rather than the patient or small-area level required for equity indicators.
l Experienced access to primary care: the average of a selection of indicators of patient-reported
experiences of primary care access from the National GP Patient Survey. This was rejected for our
purposes, since the National GP Patient Survey only started in 2006/7 and the response rate of about
30% varies substantially between local areas (CCGs), which may hamper local equity comparisons.
This indicator may be useful, however, for future national equity monitoring work.
l Specialist doctor visits: annual probability of a first outpatient visit, adjusted for age and sex, based on
outpatient HES data. This was rejected as whenever diverse forms of utilisation are grouped together it
is hard to tell whether more utilisation reflects better access to care, worse quality of care or worse
health. However, more specialised subindicators may be worth pursuing, in particular, percentage of
first outpatient visits with immediate discharge (potentially reflecting an unnecessary referral),
percentage of first outpatient visits with priority referral and percentage of first outpatient visits the
patient ‘did not attend’.
l High-need service users: rate per 100,000 general population (perhaps distinguishing adults and
children) of patients with multiple unplanned admissions in the same year (say > 10). This was rejected
on the basis of small numbers problems for local monitoring. However, this may be a useful indicator
for national monitoring.
l Hospital complications: annual preventable hospital complications, rate per 100,000 population
adjusted for age and sex. This was rejected as there is no official list of ‘preventable’ complications
across the full range of hospital activity and drawing up a list of this kind would be a major clinical
research task.
l Hospital expenditure: annual expenditure per 100,000 general population (all ages), based on the total
number of outpatient visits and planned and unplanned inpatient admissions weighted by HRG prices.
This was rejected as this groups together diverse forms of utilisation and so it is hard to tell whether
more expenditure reflects better access to care, worse quality of care or worse health.
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l Bed-days following emergency admission: average person-based cumulative time spent in hospital
during 12 months following an emergency admission in April to June (quarter 1). This was rejected as it
is similar to repeat hospitalisation within the indicator year and without further refinement would yield
a longer time lag. In addition, by focusing on bed-days rather than number of admissions, this indicator
may tend to reflect aspects of social care supply that are outside the control of the NHS, as well as the
quality-of-care co-ordination between health-care and social-care settings for which the NHS is at least
partly responsible.
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Chapter 4 Methods
Introduction
This section describes the data and methods underpinning the indicators defined in this study. The section
has the following structure. It starts by (1) describing the data sources used and then goes on to cover
(2) data linkage and aggregation to construct indicators; next, it discusses (3) the data cleaning methods
used on the indicators, before discussing (4) standardisation methods used to adjust indicators for need
and risk factors; finally, it describes (5) the estimation of absolute and relative inequality indices at the
national level and (6) the estimation of absolute and relative inequality indices at the local level. At each
stage alternative approaches that were considered and sensitivity analyses performed are discussed.
Data sources
Small-area geography
The basic small-area geographical unit provided in the data sets used was the 2001 ‘lower-layer super
output area’ (LSOA). There are 32,482 of these small-area neighbourhoods in England, defined by the
2001 census to cover approximately 1500 people each (minimum 1000 and maximum 3000). LSOA
boundary definitions were updated following the 2011 census, resulting in 32,844 small-area
neighbourhoods. These new 2011 LSOAs form the basic building blocks of the higher-level geographies
that we aggregate our results to, such as CCGs. LSOA-level indicator production and adjustment is
conducted at 2001 LSOA level, and the results are then mapped onto 2011 LSOAs for production of
equity measures at the national and CCG levels. The mapping between the 2001 and 2011 LSOAs is
discussed in Linkage and aggregation of data.
Small-area deprivation
We measured the socioeconomic status of each 2001 LSOA neighbourhood using the IMD. This is a widely
used measure that combines a wide range of data sources on multiple aspects of social deprivation.
Seven indicator domains are combined into a single deprivation score for each small area. The indicator
domains comprise ‘income deprivation’, ‘employment deprivation’, ‘health deprivation and disability’,
‘education, skills, and training deprivation’, ‘barriers to housing and services’, ‘living environment
deprivation’, and ‘crime’. Each neighbourhood is ranked relative to one another according to its level of
deprivation. Although in theory there is an element of circularity in including the ‘health deprivation and
disability’ domain, in practice the exclusion of this domain makes little difference, as this domain is only
one small element of the overall index and the domains are all highly correlated. We used the version of
IMD published in 2010, which contains data mostly relating to the year 2007 in the middle of our analysis
period.50 We used the most informative IMD 2010 index available: overall deprivation rank for all 32,482
LSOAs in 2001. We used the same deprivation index for all years to ensure that our findings reflected real
changes in health-care delivery and outcomes, rather than artificial changes in the calculation of the
deprivation index or the composition of neighbourhoods. However, this does raise the issue of how
accurately the deprivation of a neighbourhood in 2007 reflects its deprivation in 2001/2 and 2011/12.
To assess this, we looked at cross-tabulations of change over the 7-year period between IMD 2004
(data for 2001) and IMD 2010 (data for 2007). These show that 84% of LSOAs in the most deprived fifth
remained in the most deprived fifth, that 88% of neighbourhoods in the least deprived fifth remained in
the least deprived fifth, and that only 14% of LSOAs changed rank by the equivalent of one quintile group
or more.
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Small-area population
We used mid-year population estimates from the ONS at 2001 LSOA level. These data provide population
totals by age and sex for each of the 32,482 LSOAs in England for each year between 2001/2 and 2011/12.
These data estimate the total resident population, including homeless people and people living in
institutions such as prisons, barracks and nursing homes. All indicators requiring a general population
denominator focus on this resident population, based on ONS estimates, rather than the NHS-registered
population based on GP practice registers, as explained in Appendix 4.
Attribution Data Set
We used the NHS Attribution Data Set (ADS) of GP-registered populations. These data map patients from
the GP practices that they are registered with to the 2001 LSOAs they live in. We used ADS data for years
2004/5 to 2011/12. We used these data to map primary care supply and quality data provided at the
practice level to small-area level, as described below and in Appendix 4.
General and Personal Medical Services
Our data on primary care supply were obtained from the annual NHS General and Personal Medical
Services (GMS) workforce census, taken on 30 September each year. These data report headcount and
FTE-equivalent numbers of GPs at the practice level for every GP practice in England. The data split the
GPs by type (allowing us to exclude trainees). However, it does not include locum GPs or details of the
supply of emergency primary care services outside of normal office hours. We used GMS data for years
2004/5 to 2011/12.
Quality and Outcomes Framework
We took clinical process indicators in the UK QOF, the primary care pay-for-performance programme
(introduced in 2004) and collected at the GP practice level. Although the QOF indicators capture only a
limited part of clinical practice, by international standards they are, nevertheless, one of world’s most
comprehensive sets of primary care quality indicators. QOF data report the number of patients achieving
the various outcomes, as defined by the indicators, as well as the numbers of patients excluded from
performance calculations for various reasons and so classed as exceptions. In the base-case analysis
reported in Chapter 5 we use the ‘population achievement’ figure which includes ‘exception-reported’
patients in the population denominator and hence treats them as representing poor quality. However,
we also conducted sensitivity analysis using the ‘reported achievement’ figure which excludes
exception-reported patients. We used QOF data for the year 2004/05 and 2011/12. Data on
exception-reported patients were not available in the first year 2004/5 and hence we see a blip in our
‘population achievement’ QOF figures in 2004/5 in which these exceptions are excluded from the
calculation of the primary care quality denominator. Further details including the list of included QOF
indicators are in Appendix 4.
Hospital Episode Statistics
We used inpatient HES data on admitted patient care (APC) to measure hospital waiting time, preventable
emergency hospitalisation, repeat emergency hospitalisation and death in hospital. This data set records
finished consultant episodes (FCEs), that is, the details of the patient’s period of care under the
responsibility of a particular specialist. The HES data include, among other things, details regarding the
patient (age, sex, 2001 LSOA of residence), as well as details about the specific hospital admission:
admission date, type of hospital admission (emergency vs. elective), length of hospital stay, reason for
admission [diagnosis in terms of International Classification of Diseases, Tenth Edition (ICD-10)51], any
procedures undertaken during the admission, outcome of the admission and date of discharge from care
of the specialist. We aggregated these HES data from the FCE level to continuous inpatient spells (CIPSs),
which capture the entire hospital stay for the patient including hospital transfers: details of this
aggregation are provided in Linkage and aggregation of data. HES data are collected in financial years,
that is from April to April. We used HES data from 2001/2 to 2011/12 in our indicators.
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Office for National Statistics mortality
We used mortality data from the ONS estimates. These data tell us the date of death, cause of death
(in terms of ICD-10 code), 2001 LSOA of residence, age and sex of the deceased for every person who
dies in England. We used mortality data for the financial years 2001/2 through to 2011/12.
Linkage and aggregation of data
The GMS and QOF data sets (see General and Personal Medical Services and Hospital Episode Statistics,
respectively) collect data at the GP practice level while our basic geographical unit for our analysis is the
2001 LSOA. The ADS details the LSOAs in which the patients registered with each GP practice live. We use
this information to determine the proportions of the practice-level variables in GMS and QOF to attribute
to each of the LSOAs that the patients registered with the practice live in. Applying this attribution
calculation to each GP practice and then aggregating the practice-level variables attributed from the
different practices at the LSOA level gives us our measures of these primary care supply and quality
indicators at the 2001 LSOA level. Practice-level populations were used only to apportion these practice-
level variables to 2001 LSOAs; the denominators used in the indicators derived at the LSOA level based on
these variables were then derived using ONS data for the LSOA-level population estimates to maintain
comparability with the other indicators.
The HES data set (see Hospital Episode Statistics) provides data at the FCE level; this describes a patient’s
period of care under one consultant. We further aggregate this to the CIPS level, which groups together
the entire hospital stay of the patient, including transfers between consultants and between hospitals.
The CIPs are described in Lakhani et al.52
Patient-level data from HES, ONS mortality data and ONS mid-year population data are then split by sex
and into age groups for ages 0–4, 5–15, 16–24, 25–39, 40–59, 60–74 and ≥ 75 years before being
aggregated into 2001 LSOAs. These age groups were selected to minimise the number of subgroups while
still capturing key life stages and points at which policy interventions are typically targeted in England.
Although 2001 LSOAs were the basic small-area unit of analysis, our target large-area geographies for
indicator production, in particular CCGs, were defined in terms of 2011 LSOA boundaries. While 96.3% of
2001 LSOAs were unchanged between the 2001 and 2011 LSOA boundaries (‘one-to-one’ mappings), the
other 3.7% (1192 out of all 32,482 of the 2001 LSOAs) needed to be mapped between these alternative
LSOA definitions. When two or more 2001 LSOAs were merged to form a single 2011 LSOA (‘many-to-one
mappings’), these multiple 2001 LSOAs were straightforwardly aggregated to form results at the 2011 LSOA
level. When a 2001 LSOA mapped to more than one 2011 LSOA (‘one-to-many’ and ‘many-to-many’
mappings), it was assumed that the 2001 LSOA was split in equal proportions when attributed to the 2011
LSOA. The mappings for 2.7% of small areas (881 out of 32,482 of the 2001 LSOAs) required splitting in
this way. We used this algorithm to produce a set of weights to map results at the 2001 LSOA level to 2011
LSOA level. These weights were then applied to all our indicator results at the 2001 LSOA level before being
aggregated to higher geographical levels.
The IMD 2010 overall deprivation rank scores defined at the 2001 LSOA level were attributed to 2011 LSOAs,
which were then ranked according to attributed score. These integer ranks were then normalised to produce
a fractional rank ‘ridit score’53 between 0 (least deprived) and 1 (most deprived). The IMD deprivation ranks at
larger geographical levels were produced by population-weighted aggregation of the 2011 LSOA-level IMD
deprivation ranks to higher levels of geography, with normalisation to produce a fractional rank between
0 and 1 at the target geographical level. The IMD quintile and decile groups were defined as aggregations
of appropriate sets of deprivation ranked 2011 LSOAs.
DOI: 10.3310/hsdr04260 HEALTH SERVICES AND DELIVERY RESEARCH 2016 VOL. 4 NO. 26
© Queen’s Printer and Controller of HMSO 2016. This work was produced by Cookson et al. under the terms of a commissioning contract issued by the Secretary of State for
Health. This issue may be freely reproduced for the purposes of private research and study and extracts (or indeed, the full report) may be included in professional journals
provided that suitable acknowledgement is made and the reproduction is not associated with any form of advertising. Applications for commercial reproduction should be
addressed to: NIHR Journals Library, National Institute for Health Research, Evaluation, Trials and Studies Coordinating Centre, Alpha House, University of Southampton Science
Park, Southampton SO16 7NS, UK.
35
Data cleaning
The administrative health data we use in this study have the advantage of covering the whole population
of England, but coding errors remain despite all the various cleaning procedures and data quality checks
conducted by data providers. To guard against data quality issues in the source data sets, we trimmed
what we considered to be extreme outliers likely to reflect measurement error from our LSOA-level results.
We first trimmed any infinite values and values that were highly implausible or logically impossible given
the indicator definition (see below). In the case of indicators 3–8, our data-cleaning algorithm consisted of
calculating the mean and standard deviation of each of the indicators at the LSOA level for each year of
data, and dropping results that fell outside six standard deviations either side of the mean (see Figure 81,
Appendix 5). This resulted in the exclusion of < 0.15% of LSOAs in any given year for any given indicator,
and for most indicators the percentage excluded was substantially lower than this. For example, there was
no exclusion for repeat hospitalisation in any year, and the exclusion for preventable hospitalisation was
around 0.01% and for amenable mortality around 0.05% (see Figure 83, Appendix 5). In the case of
indicator 1 (primary care supply), we first excluded patient-per-GP figures above 10,000, which we judged
are likely to reflect data error, before applying the six standard deviation trimming algorithm. This resulted
in excluding around 0.14% of LSOAs each year. In the case of indicator 2 (primary care quality), we
implemented a slightly heavier trim using three rather than six standard deviations, after first excluding any
logically impossible indicator values below zero and above 100. The heavier trim was used because visual
inspection revealed an unexplained cluster of apparent data error in between three and six standard
deviations (see Figure 83, Appendix 5). This resulted in excluding just over 1% of LSOAs each year. We
also checked the distribution of exclusion by deprivation vingtile group (twentieths), and this showed no
clear pattern except in the case of amenable mortality in which exclusion only occurred in the two most
deprived vingtile groups (see Figure 82, Appendix 5). However, the largest exclusion proportion was
0.25% in the most deprived twentieth, which we judged not to be problematic.
We also conducted sensitivity analysis using a heavier trim of three standard deviations for all indicators
(see Figures 84–86, Appendix 5). This did give rise to an issue of potentially disproportionate trimming
within the most deprived 5% to 10% of small areas for indicators with small-event counts at the LSOA level,
that is preventable hospitalisation, repeat hospitalisation, amenable mortality and all-cause mortality (see
Figure 85, Appendix 5). This may be a result of disproportionate numbers of extremely high-need patients in
the most deprived areas, suggesting that a three standard deviation trim results in trimming away some
accurate data as well as data errors. At the national level, this would lead to a slight underestimate of the
social gradient, and at the CCG level this might lead to bias in CCGs with a disproportionately high fraction
of exclusions. Hence we opted for a ‘light-trim’ policy of six standard deviations for these indicators.
Finally, we produced results on the raw untrimmed data and were reassured to find very similar numerical
results, even though some of the graphical summaries were severely distorted by extreme outliers.
Adjustment for need and risk factors
We adjusted indicators for observable need or risk factors, such as age and sex, which (1) are correlated
with deprivation (a factual matter) and (2) may be considered ‘fair’ or ‘legitimate’ sources of variation in
the indicator for which the NHS should not be held responsible (a value judgement). For example, GP
supply was adjusted for age, sex and population ill health on the basis of the value judgement that small
areas with additional health-care needs should have additional GP supply. By contrast, GP quality and
hospital waiting time were not adjusted for age and sex, on the basis of the value judgement that age and
sex are not legitimate justifications for poor-quality or longer hospital waiting times. The standardisation of
the various indicators is described in detail here.
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The GP supply indicator was need-adjusted using the workload adjustment aspect of the 2007 version
of the Carr-Hill formula for primary care resource allocation produced by the Formula Review Group
established by NHS Employers and the BMA.54 Full details of the implementation of the Carr-Hill formula
used and the weights it contains can be found in Appendix 4. In brief, this formula provides weights for
age, sex, health deprivation and transient patient populations and is used to adjust population sizes for
need. We were unable to implement the transient patient population element of the adjustment, however,
because of a lack of patient-level data on registration status, linked to age and sex, covering all practices in
the country. The adjustment is applied by using the weights to upscale or downscale populations at LSOA
level to create need-adjusted populations and then normalise these scaled populations so that they sum to
the total population pre-adjustment. We also conducted robustness checks using an alternative need
formula: the 2013/14 Nuffield index of general and acute hospital need which provides need-adjusted
populations at practice level based on hospital utilisation.55 We used the ADS to attribute these adjusted
populations to LSOA levels and found that this alternative adjustment gave very similar results to the
Carr-Hill formula. However, as explained in more detail in Chapter 8, we believe that the Carr-Hill formula
underestimates additional needs for primary care supply in deprived neighbourhoods. This is because it
allows only for morbidity and does fully allow for the ways in which multiple morbidity and disadvantage
combine to generate additional health-care needs.
For the mortality, amenable mortality, preventable hospitalisation and repeat hospitalisation indicators we
used indirect standardisation for age and sex groups at the LSOA level. We then translated these indirectly
standardised rates to LSOA-level event counts. The standardisation procedure used is laid out in the
following formulae:
ad justed countlsoa = ad justed ratelsoa × populationlsoa (1)
ad justed ratelsoa =
observedlsoa
expectedlsoa
× ratenational (2)
observedlsoa =∑
sex
∑ageeventslsoa,age, sex (3)
expectedlsoa =∑
sex
∑ageexpectedlsoa,age,sex (4)
expectedlsoa,age, sex = ratenational,age, sex × populationlsoa,age,sex (5)
ratenational,age, sex =
∑lsoaeventslsoa,age,sex
∑lsoapopulationlsoa,age,sex
(6)
ratenational =
∑lsoa∑sex∑ageeventslsoa,age, sex
∑lsoa∑sex∑agepopulationlsoa,age, sex
(7)
populationlsoa =∑
sex
∑agepopulationlsoa,age, sex. (8)
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The waiting times indicator was indirectly standardised in a similar manner at LSOA level but instead of
standardising for age and sex this indicator was standardised for the specialty code of the treating consultant.
This was done in order to risk-adjust waiting time for the specialty of the admission, on the basis of the value
judgement that a difference in the patient’s specialty of treatment may be a legitimate justification for a
longer waiting time, but not a difference in their age or sex. This implies the following further value
judgements: (1) the NHS should not be held responsible for eliminating waiting time differences between
specialties and (2) the NHS should not be held responsible for eliminating socioeconomic patterning in the
specialty of treatment. A more sophisticated, but also more computationally burdensome, adjustment could
adjust for admission-level diagnostic and procedure codes. The current procedure of indirect standardisation
at LSOA level was already computationally burdensome because of the large size of the administrative health
data sets employed, taking several days of high-performance computing time. So we felt that for the purposes
of this project adjusting for the treating consultant’s specialty was a sufficient proxy for these CIPS-level codes
and opted to leave more detailed need adjustment of this indicator for future research in this area.
In line with the current NHS Outcomes Framework indicators,56 the risk adjustment process we have used
when we have access to patient-level data rely largely on indirect standardisation in favour of direct
standardisation. This allowed us to reliably produce adjusted event count data at the LSOA level, adjusted
for the event rates of the 14 age–sex subgroups in each LSOA. Direct standardisation, while generally
preferable for calculating national-level indicators,57 and as used in the NHS PHOF,58 was found to be not
sufficiently stable for use at this LSOA level of disaggregation as a result of the small numbers (often zeros)
within each LSOA–age–sex band. Adjusting our indicators at the LSOA level rather than at deprivation
decile level allowed us to create comparable inequality measures at national and subnational levels:
a key objective of our programme of work.
There were other more sophisticated regression-based standardisations accounting for a range of variables
and their correlations that we considered at individual patient event level32,57 rather than the indirect
standardisation we opted for at LSOA level. These more sophisticated approaches were considered to be
excessively computationally burdensome for the scale, and scope, of the indicators considered here,
without delivering a commensurate gain in accuracy. So, we felt taking such approaches would limit the
likelihood of our proposed indicators being operationalised.
However, perhaps the most important factor missing from our risk adjustment process was a measure
of individual-level morbidity and particularly multimorbidity. So, we would suggest identifying and
standardising for such variables as a key research priority going forward.
National inequality indicators
The details of the specific indicator definitions and how these indicators were constructed are provided
elsewhere in this report. In this section we describe how these indicators were used to calculate inequality
indices at the national level.
The primary indicator we used in our analysis is our implementation of the SII as a measure of absolute
inequality; and we also used the corresponding RII. We chose this indicator as an appropriate compromise
between simple indicators that are easy for users to understand but potentially misleading, such as the gap
between top and bottom groups, and more sophisticated indicators that are hard for users to interpret,
such as the absolute concentration index.53,59 The slope index captures the whole social gradient, rather
than selecting two arbitrary groups for comparison. It also has a reasonably simple interpretation as the
modelled health-care gap between the most and least deprived neighbourhoods, allowing for the social
gradient in-between. This indicator is also already used routinely in England for monitoring inequalities in
health by the PHOF, and has been proposed for routine use by the NHS Outcomes Framework for
monitoring national inequalities in health-care outcomes.60
METHODS
NIHR Journals Library www.journalslibrary.nihr.ac.uk
38
Mathematically, the absolute concentration index is the slope index multiplied by twice the variance of the
socioeconomic variable, as measured on its original raw scale.59 Thus, the main limitation of the slope index
compared with the absolute concentration index is that it uses only information on the fractional rank of the
deprivation variable, and does not also take account of variance in the deprivation score measured in its
original raw scale. This is an important limitation when cardinal measures of socioeconomic status are
available, such as income. However, the IMD is only measured on an ordinal scale in the first place, and so
converting this variable into a fractional rank does not throw away any important information.
To compute the SII we start by taking the standardised indicator data at LSOA level, cleaned to ensure
data quality (see Data cleaning), and for each year of data we calculated an ordinary least squares
regression of LSOA-level outcome variable against LSOA-level deprivation fractional rank (measured on a
0–1 scale as described in Linkage and aggregation of data). The coefficient on deprivation fractional rank
in this regression gave us the SII for the year, and the standard error on this coefficient gave us the
standard error around the SII. The SII can be interpreted as the modelled difference in event count
between the least deprived and most deprived LSOAs in the country, taking into account the distribution
of the outcome variable across the deprivation range. For all of our indicators, a positive SII value indicates
pro-rich absolute inequality in the outcome, whereas a negative SII indicates a ‘pro-poor’ absolute
inequality in the outcome. This is straightforward in almost all cases, as almost all of our outcomes are
defined as undesirable events. As we have defined our deprivation score to run from 0 for least deprived
to 1 for most deprived, a positive linear association thereby implies that more deprived small areas have
worse outcomes. The one exception is primary care quality, which is a desirable outcome. In this case,
we simply invert the SII by multiplying by –1.
Our approach differs a little from some of the other commonly used definitions of the SII, in which the
indicators are first aggregated to deprivation decile group level and then the slope through the decile
group points is calculated.58 We felt that given the availability of the data at the LSOA level for these
indicators we were better able to capture the within-decile variation and uncertainty in our SII estimate by
using LSOA-level linear regressions of outcomes against LSOA deprivation rank as opposed to national
decile-level regressions.
The SII is also used to calculate a ‘real inequity gap’, based on a counterfactual situation of full equality in
which all neighbourhoods do as well as the least deprived neighbourhood in terms of modelled
achievement on the indicator. The real inequity gap is measured in the same units as the indicator and is
calculated as 0.5 × SII × population. This is depicted by the shaded area in Figure 5, which also shows the
national average and deprivation decile average values of the indicator as well as the SII slope. We did this
because of feedback from our consultation process that policy-makers and members of the public find it
easier to understand and relate to ‘raw’ physical units (e.g. numbers of deaths) rather than rates and
proportions, as explained in Chapter 3.
We also calculated national average levels of the outcome variables and inequality trends in these variables
for display in the indicator dashboards, as the year-on-year difference between this year’s figure and last
year’s figure, with colour coding to show whether or not the trend was significant. We found that a simple
1-year trend was easier for users to understand than a more complex trend involving more than 1 year;
although, to guard against the risk of over-reacting to a possible 1-year ‘blip’, we advise that dashboard
users also consult the in-depth graphical analysis underpinning the numbers reported in the dashboards,
which show the year-on-year trend over several years.
As an example, the 2011/12 SII trend can be calculated simply as:
SII trend½2011=12 = SII½2011=12−SII½2010=11. (9)
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Alternative trend measures were also considered, including differences between multiyear moving
averages, linear regressions of SII against time, and pooled time series cross-section regressions involving
year dummies interacted with deprivation rank. However, the simple single-year change in SII was chosen
for its simplicity and the fact that the value calculated as a trend in a particular year would be fixed and
not be revised as further years of data become available.
We analogously calculated the same range of indicators on a relative scale by presenting our absolute
inequality results as a proportion of the national average achievement for the indicator. As almost all of
our indicators are measures of undesirable outcomes, these can be seen as relative shortfall indicators
rather than relative attainment indicators.61 A relative attainment indicator could be calculated by inverting
the outcomes, for example calculating the number of people having emergency hospitalisations results in a
relative shortfall indicator, while calculating the number of people not having emergency hospitalisations
would result in a relative attainment indicator.
Although we fitted a linear model for our base-case results, we also tested the robustness of our
conclusions to using alternative non-linear functional forms including log-linear or exponential models,
Poisson and negative binomial models. These non-linear models still allow the computation of a slope
index, by predicting outcomes for the most and least deprived neighbourhood and taking the gap. We
were reassured to see that these alternative model specifications produced the same basic national
inequality trends as the linear model, and very similar patterns at the CCG level. Measuring inequality is
not solely a statistical exercise in finding the best-fitting model but is also partly a normative judgement.
For example, consider the situation depicted in Figure 5 in which there is a clear non-linear ‘uptick’ in
adverse outcomes within the two most deprived decile groups. This is the case, for example, for
preventable hospitalisation and amenable mortality. In this case, a log-linear model would give a lower
estimate of the predicted absolute gap than the linear model. It would also be less sensitive to health-care
indicator improvements in the most deprived decile groups. This is because a log-linear model allows a
closer fit to the non-linear ‘uptick’. In effect, it assumes that more deprived areas should have more than a
linear increase in event rates. This is partly a normative judgement, implying that a non-linear ‘uptick’ in
event rates in the most deprived end of the spectrum is normal and so NHS organisations should not be
held to account for eliminating it. By contrast, the linear model gives greater weight to inequality at the
two extremes of the distribution, and so is more sensitive to changes at the most deprived end of
the spectrum. Mathematically, the ordinary least squares linear model yields a weighted average of the
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FIGURE 5 Generic national absolute inequality graph showing the SII slope, inequality gap, national and decile
averages for the indicator.
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gradient between each point and the mean point, with greater weight given to points that lie further from
the mean. Gradients towards the more extreme end of the spectrum thus receive higher weight, and
hence the slope index is more sensitive to change the further one moves towards the tails of the
deprivation spectrum. In practice, then, use of the linear slope index rather than a non-linear slope index
embodies the value judgement that the index ought to be more sensitive to change towards the most and
least deprived ends of the spectrum than change in the middle.
We chose to use the linear model for our base-case estimates of the SII as this is the simplest, easiest to
understand, and most widely used form of the measure in the inequalities literature. When different kinds
of non-linearity are evident in the different years of the data for the different indicators, these could each
in theory be modelled using the best-fitting non-linear model for that particular instance. However, we
found that the linear model provides a useful general method to measure inequality and adequately
captures the inequality trends across indicators and over time in a comparable manner.
We also produced results using heteroscedasticity robust standard errors and were reassured to find that
these had little effect on our estimated standard errors in both the national- and CCG-level analyses.
We chose to use unadjusted standard errors, in the absence of compelling empirical evidence for
heteroscedasticity at the national level or theoretical reasons for expecting heteroscedasticity within some
subnational areas but not others.
We did not apply LSOA-level population weights either to the computation of the deprivation ridit score or
to the linear regression in our base-case results. This again was on grounds of simplicity of communication
to policy-makers, as LSOAs do not vary dramatically in population size and application of population
weights made little difference to the results.
Finally, we did not allow for influential outliers at the CCG level using robust regression methods that
apply an iterated reweighted least squares algorithm based on a particular weighting function. Rather,
we propose that individual CCGs should visually inspect their own within-CCG small-area-level and
practice-level scatterplots with a view to identifying and understanding the role of ‘unusual’ local
neighbourhoods and GP practices on a case-by-case basis.
Local inequality indicators
We constructed CCG-level indicators using similar methods as we used to construct the national inequality
indicators. Our absolute inequality indicator at the CCG level is based on running local-level regressions
using just those LSOAs that fall within a CCG, and modelling the ‘social gradient’ relationship between
the outcomes of these LSOAs and its national deprivation ranks. The deprivation rank we used was the
national deprivation rank rather than recomputed local within-CCG deprivation rank. We did this in order
to allow us to compare the within-CCG inequality gradient with the national inequality gradient in a
straightforward manner. We labelled this indicator, the AGI, to distinguish it from variants of the SII at
local level that use the local deprivation rank. We also calculated a relative version of this indicator at the
CCG level, analogous to the national RII, that we called the relative gradient index (RGI). To maintain
comparability with the national RII, this was computed as the AGI divided by the national mean level
of the indicator. Dividing by the local mean would potentially bias comparisons against the national RII
benchmark by decreasing measured local relative inequality in areas with higher-than-average mean
levels of the indicator outcome (e.g. relatively deprived CCGs with above-average levels of preventable
hospitalisation), and vice versa. National- and local-level results were graphically combined to compare the
CCG with the national-level results as shown in Figure 6.
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This approach differs from the PHOF approach58 to calculating within-CCG SIIs. The PHOF approach uses
local deprivation ranks recalculated in CCGs, and then deprivation decile-level regressions based on these
local ranks. This difference is because of the difference in purpose between health-care equity indicators
and public health equity indicators. The main difference is that our health-care equity indicators aim to
compare local health-care inequalities against a national benchmark, whereas the public health equity
indicators focus on comparing the same local area over time. For our purpose of making comparisons
against a national benchmark, using a common deprivation scale between the national- and CCG-level
indicators is appropriate. A second difference is that our indicators focus on role of the NHS in reducing
the link between deprivation and ill health, rather than in reducing deprivation and income inequality
per se. By contrast, the PHOF indicator seeks to pick up the success of local government both in reducing
the deprivation–health link and also in reducing deprivation and income inequality per se. Our more
specific focus is reasonable insofar as changes in local prosperity are largely caused by factors outside NHS
control; although, of course, NHS actions can have consequences for people’s wealth by protecting
them against catastrophic health-care costs and keeping them economically productive. To measure the
deprivation–health link specifically, we need to use the absolute national deprivation rank rather than
the relative within-CCG deprivation rank. In principle, our measure will then not be sensitive to
‘gradient-preserving’ changes in local economic prosperity if this leads to precisely corresponding changes
in health and health care along the national social gradient.
We also plotted the full range of CCG-level inequality results against the national inequality result on a
caterpillar plot, showing data for the most recent year to help us identify areas that performed significantly
better or worse than the national average in terms of inequality. An example of such a plot is shown
in Figure 7.
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FIGURE 6 Absolute inequality graph for a hypothetical CCG showing the AGI slope, inequality gap, within-CCG
LSOA-level results, national and CCG average for an example indicator (e.g. preventable hospitalisation per 1000
general population).
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As a final analytical tool we produced plots of CCG-level average achievement and inequality achievement
by deprivation to get some understanding of the contributions between-CCG and within-CCG inequality
to the national inequality results. An example of such a plot is shown in the Figure 8.
As with the national inequality indicators, we tested a range of alternative regression models to ensure the
robustness of our results. We also tested using a random-effects specification of our model with CCG-level
random slopes and intercepts. We found that for those indicators in which we had small event counts at
the CCG level (in particular, amenable mortality and all-cause mortality), the random-effects specification
had trouble converging. However, for the indicators in which the random-effects specification did
converge we found that the magnitudes of inequality results were, as would be expected, shrunk towards
the national average. However, the trends and rankings of CCGs in terms of inequality remained very
similar to those observed with the standard linear model. Our base-case results at local level are, therefore,
produced using the standard linear model as (1) this could be applied in a consistent manner across the
full suite of indicators and (2) this is a simpler approach that is easier for decision-makers to understand
and interpret.
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FIGURE 7 The CCG-level caterpillar plot comparing absolute inequality at the CCG level in terms of AGI to absolute
inequality at the national level in terms of SII.
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Chapter 5 Results
Introduction
This chapter presents the main results at both the national and local level. Detailed results for each of
our eight indicators of equity are presented one by one, in the same format, and then a final section
summarises our findings on local equity monitoring for all eight indicators.
Detailed results for each indicator follow a common format. An introductory section first explains what the
indicator means, why it was selected and how it was defined, with special attention to any departures from
standard NHS indicator definitions. The main results are then presented graphically, using the same four
types of graph. The key findings are then summarised. The four types of graph are as follows: first, national
equity time trend graphs showing trends in (1) indicator levels by quintile group of deprivation, (2) the SII and
(3) the RII. We present annual time trends for our full period of 2001/2 to 2011/12 when possible, although
this is not possible for primary care supply and quality whose data series only start in 2004/5 (as explained in
Appendix 4). We first present unadjusted time trends and then adjusted time trends, after allowing for need
or risk factors. Second, a national equity gradient graph for 2011/12 showing adjusted indicator levels by
decile groups of deprivation, the social gradient (the slope of which is the SII), and the area under the social
gradient, representing the inequity gap (see Chapter 4). Third, a local equity performance graph for 2011/12
in the form of a caterpillar plot showing equity (AGI) by CCG in 2011/12 in rank order, with confidence
intervals. Fourth, a local performance deprivation correlation graph for 2011/12 in the form of a CCG-level
scatterplot of performance against deprivation at the CCG level, for both equity performance (e.g. the AGI in
patients per GP) and average performance (e.g. the average level of patients per GP).
We start by presenting contextual information on population trends from 2001/2 to 2011/12 by
deprivation group, age group and sex, before turning to the results for our eight equity indicators.
Population
Equity is a population-level concept, relating to unfair inequality within the relevant population of interest.
To help interpret trends in equity over time, it is therefore important to understand the nature of changes
in population size and sociodemographic composition over time. Our equity indicators are based on ONS
mid-year estimates of population, which estimate the total resident population including homeless people
and people in institutions such as nursing homes, prisons and barracks. We present contextual information
on national population trends by age, sex and deprivation group in the form of two matrix plots. The first
plot, Figure 9, has a fixed population range on the y-axes, to facilitate comparisons between age groups
(rows). The second plot, Figure 10, has variable population ranges on the y-axes, to facilitate comparisons
between deprivation groups (columns).
The population matrix plots show that (1) more deprived areas have younger populations than
more-affluent areas and (2) old age populations have been increasing over time in the most affluent areas,
while population at younger ages has been increasing over time in more deprived areas.
The bulk of the population is between 25 and 74 years of age. There has been substantial growth over the
period in the populations aged 40–59 years and 60–74 years for all deprivation groups. This growth has
been most pronounced in the more-affluent groups where we also see a substantial decline in the
numbers aged 25–39 years. Women and men follow largely the same trends within each age and
deprivation group. Men tend to outnumber women up until the 16–24 years age group, after which
women outnumber men, with the sex difference becoming more noticeable in older age groups.
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These deprivation-related demographic variations and trends have important implications for risk and need
adjustment. The risk of adverse health-care outcomes (such as hospitalisation and mortality) tends to
increase with age. The impact of deprivation-related demographic variation, that is point (1) above, will
therefore be to increase the risk of adverse events in affluent areas, and hence to reduce the unadjusted
socioeconomic gradient in health-care outcomes. Similarly, the impact of deprivation-related demographic
change, that is point (2) above, will be to increase the relative risk of adverse events in affluent areas
compared with deprived areas, and hence to reduce the unadjusted socioeconomic gradient in health-care
outcomes over time. Without age adjustment, therefore, socioeconomic inequality in health outcomes may
appear to reduce over time in a pro-poor direction, even if the NHS did nothing to improve inequality.
This would be misleading as the resulting inequality would reflect the impact of demographic change
rather than the impact of the NHS. Therefore, we considered it relevant to adjust for age in our analysis.
In a cross-sectional analysis, adjusting for age increases the SII and RII for health-care outcomes, as more
deprived areas are younger and hence less at risk of poor outcomes. In a time series analysis, adjusting for
age adds a growth trend to SII and RII over time, by removing the impact of ageing in affluent areas on
reducing the social gradient over time.
Age is, of course, not the only factor that influences the risk of adverse health-care outcomes. In particular,
morbidity may have larger and potentially opposing impacts, as deprived populations are more sick than
affluent populations and more at risk of adverse events. Unfortunately, however, we were not able to
adjust for morbidity because of lack of time-varying individual-level data on both age and morbidity, as
explained in Chapter 4. The morbidity-unadjusted gradient in health-care outcomes that we observe will
therefore be substantially larger than the ‘true’ morbidity-adjusted gradient. Furthermore, there is some
evidence that socioeconomic inequalities in morbidity have widened during the 2000s.62 If so, this would
have the impact of appearing to increase socioeconomic inequalities in the non-morbidity-adjusted
health-care outcomes that we observe.
Primary care supply
Access to primary care is a foundation stone of health-care quality, and makes a crucial contribution both to
patient experience and improvement in population health outcomes. There is evidence that improved access to
primary care can help to prevent illness, manage chronic conditions more effectively and reduced unnecessary
utilisation of secondary care,12,63 although evidence on the impact of marginal changes in primary care supply
on mortality in high-income countries is mixed.12,64,65 We use a simple and objective measure of access to
primary care: the number of patients per primary care physician. Measures of patients’ subjective experiences
of primary care access are also available, based on the annual National GP Patient Survey. However, this survey
goes back only to 2006/7 and has a response rate of around 30%, which varies substantially between
practices, which may hamper comparisons in social gradients between subnational areas.
Previous studies in high-income countries, including the UK, have found significant geographical variations
in the distribution of primary care physicians.66–72 Data from England between 1974 and 2006 showed
substantial and persistent geographical inequalities in supply of GPs relative to need between NHS
administrative areas.73–75 However, these studies focused on large areas, which made it difficult to
accurately pinpoint primary care shortages in specific disadvantaged neighbourhoods.
Our indicator of primary care supply evaluates socioeconomic inequality in GP supply between small-area
populations from 2004/5 to 2013/14. We use LSOA-level data, which allows us to capture changing
patterns of socioeconomic inequality in much finer detail than previous studies. We define GP supply as
the number of patients per FTE GP, excluding registrars and retainers, adjusted for age, sex and
neighbourhood ill health using the Carr-Hill workload adjustment (see Appendix 4 for details).
The numerator is the total number of people alive at mid-point in the current financial year, while the
denominator is the number of FTE GPs attributed to each small area in the current indicator year.
Further technical details of how this index was computed are presented in Appendix 4.
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Unadjusted trends (Figure 11) show that there has been a significant divergence in GP supply between
the most deprived fifth of areas and the other areas in the country from 2006/07 onwards. As 2006/07 the
most deprived fifth of areas experienced a sustained trend of increasing GP supply (decreasing numbers
of patients per GP), while GP supply in all the other areas decreased over time. However, we prefer the
need-adjusted findings because in cross-section the unadjusted findings come up with the potentially
misleading message that people living in deprived neighbourhoods have substantially more GP supply
than others. This is a potentially misleading finding, because it fails to allow for the fact that deprived
neighbourhoods tend to suffer more ill health than affluent neighbourhoods, and so have greater
health-care needs.
Adjusting these results for need using the Carr-Hill workload adjustment changes the levels of these lines,
but we see a similar equity trend in Figure 12. We see a sustained reduction in both absolute and relative
inequality, as measured by the SII and RII over the period, and by 2010/11 need-adjusted GP supply actually
becomes pro-poor. This is also evident in the social gradient graph for 2011/12 shown in Figure 13, in
which we see the lowest numbers of patients per GP in the most deprived areas and a negative inequity
gap. The caterpillar plot in Figure 14 shows that there are substantial numbers of areas significantly more
and less equal than the mean. The correlation plot in Figure 15 shows that by 2011/12 there is little
evidence of a social gradient between CCGs: there is no association between mean patients per GP and
deprivation at the CCG level. By contrast, there is some evidence that more deprived CCGs do better at
reducing deprivation-related inequality in GP supply within their own patch; there is a clear, although weak,
negative association between equity in patients per GP (AGI) and deprivation at the CCG level.
When reading these results it is important to keep in mind that GP supply is just one aspect of primary
care access. Just because a patient is registered with a practice that has a relatively low number of patients
per GP, this does not guarantee the patient will have relatively good access to adequately long primary
care consultations at a convenient time, or that they will receive relatively high-quality care during
their consultations.
Primary care quality
Primary care remains the most effective and cost-effective way of delivering accessible care in a time of rising
prevalence of chronic conditions and multimorbidity.76 This indicator focuses on clinical process indicators of the
quality of primary care, based on the proportion of patients diagnosed with a particular condition receiving
appropriate medical care for that condition. The quality of primary care can be measured using structures
(such as the supply of GPs), processes (such as vaccination, investigation and prescribing) or outcomes (such as
mortality, morbidity and patient satisfaction).77 Combinations of these measures have been used in the
literature to assess contribution of primary care in improving population health.12 International studies have
demonstrated that improving the process quality of primary care is associated with reduced emergency
admissions, improved patient outcomes and reduced costs to the health-care system.78–80 Moreover, small
improvements in primary care process quality can have significant effects on population health at low cost.81
Improving the quality of primary care has been incentivised in several countries, primarily using financial
incentives.82 In the UK, the QOF scheme was launched in 2004 to monitor and improve the quality of primary
care.83 This is one of the largest pay-for-performance programmes in the world with over £10B invested
since inception.65 The QOF programme rewards primary care practices based on their performance on a
comprehensive set of indicators that measure primary care quality. In total, 146 indicators are used that cover
the management of chronic disease, public health measures, quality and productivity of service, and patients’
experiences with respect to care.84 To measure the public health impact of primary care quality, Ashworth et al.85
developed a composite indicator using 20 QOF indicators weighted by their importance in terms of their
potential for mortality reduction.85 The resulting measure, termed the ‘Public Health Impact’ score, was proposed
as a measure of primary care quality in terms of population health. We recognise that the QOF only captures
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FIGURE 11 Unadjusted equity time trends in patients per GP. (a) Indicator 1: primary care supply (unadjusted);
(b) SII; and (c) RII. Notes: (1) the solid black line shows the most deprived quintile and the solid blue line shows the
least deprived quintile; (2) negative SII indicates pro-poor distribution, while a positive SII indicates a pro-rich
distribution in absolute terms; and (3) negative RII indicates pro-poor distribution, while a positive RII indicates a
pro-rich distribution in relative terms.
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FIGURE 12 Adjusted equity time trends in patients per GP. (a) Indicator 1: primary care supply; (b) SII; and (c) RII.
Notes: (1) the solid black line shows the most deprived quintile and the solid blue line shows the least deprived
quintile; (2) negative SII indicates pro-poor distribution, while a positive SII indicates a pro-rich distribution in
absolute terms; and (3) negative RII indicates pro-poor distribution, while a positive RII indicates a pro-rich
distribution in relative terms.
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FIGURE 14 Caterpillar plot of the AGI of inequality in patients per GP in 2011/12 at the CCG level. Notes: (1) CCGs
are ranked from least equitable (left) to most equitable (right); (2) the dotted horizontal line shows the national
average, CCGs to the left with confidence intervals above this line have worse than average equity performance,
and vice versa; and (3) In this unusual case, there are many negative SIIs (at face value indicating pro-poor
inequality) as well as positive SIIs indicating pro-rich inequality. However, as we underestimate need in deprived
neighbourhoods, as explained in Chapters 4 and 6 and Appendix 4, we do not interpret negative SIIs as
representing pro-poor inequality but rather as indicating no measurable pro-rich inequality.
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FIGURE 13 National social gradient in patients per GP in 2011/12: adjusted. Notes: (1) dots represent decile groups,
the inverted U-shape pattern indicates that neighbourhoods in the middle of the socioeconomic spectrum have less
primary care physician supply than the most and least deprived neighbourhoods, after adjusting for differences in
need; (2) the slope of the line is the SII. In this case, the slope is negative showing pro-poor inequality in patients
per GP favouring deprived areas; and (3) the shaded area shows the inequity gap. In this case, this gap is negative
indicating that bringing all neighbourhoods to the level of the least deprived would require losing some GPs in
deprived neighbourhoods.
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FIGURE 15 Scatterplots of CCG performance on patients per GP in 2011/12 against deprivation, showing both mean
performance and equity performance (AGI). (a) Mean; and (b) AGI.
DOI: 10.3310/hsdr04260 HEALTH SERVICES AND DELIVERY RESEARCH 2016 VOL. 4 NO. 26
© Queen’s Printer and Controller of HMSO 2016. This work was produced by Cookson et al. under the terms of a commissioning contract issued by the Secretary of State for
Health. This issue may be freely reproduced for the purposes of private research and study and extracts (or indeed, the full report) may be included in professional journals
provided that suitable acknowledgement is made and the reproduction is not associated with any form of advertising. Applications for commercial reproduction should be
addressed to: NIHR Journals Library, National Institute for Health Research, Evaluation, Trials and Studies Coordinating Centre, Alpha House, University of Southampton Science
Park, Southampton SO16 7NS, UK.
53
part of primary care quality, and that there are valid concerns with using QOF as a measure of primary care
quality.86–88 We therefore advise that this indicator be interpreted cautiously, in the light of these limitations.
Our indicator evaluates socioeconomic inequality in primary care quality between small-area populations
from 2004/5 to 2013/14. We selected 16 out of the 20 indicators proposed by Ashworth et al.,85 for which
data were available throughout our period of analysis in a consistent format. We define primary care
quality as weighted average of clinical process quality from 16 indicators in the QOF, with weights
proportional to importance in terms of the estimated number of lives saved per 100,000 patients.85
For each clinical indicator in QOF, the number of patients deemed appropriate for that indicator is the
denominator and the number of patients for whom the indicator was met is the numerator. We use
‘population achievement’ which puts exception-reported patients back into the population denominator
thereby assuming such patients represent poor quality, but as a robustness check we also analysed
‘reported achievement’ which excludes exception-reported patients from the population denominator.
Further technical details of how this index was computed are presented in Appendix 4.
There are no ‘adjusted’ results to present for this indicator, because the population denominator for each
indicator already defines the ‘at-risk’ patient population as patients diagnosed with the relevant condition.
No further risk adjustment was performed, on the basis of the value judgement that age, sex and other patient
characteristics are not legitimate reasons for failing to deliver high-quality care to the ‘at-risk’ patient population.
Primary care quality in terms of QOF steadily improved over the study period as shown in Figure 16. Both
absolute and relative inequality in this measure of primary care quality steadily decreased, and was almost
eliminated by 2011/12 as shown in Figure 17. The caterpillar plot in Figure 18 shows that in 2011/12 there
are substantial numbers of CCGs significantly more and less equal to the national level of absolute
inequality. The correlation plots in Figure 19 show that by 2011/12 there is no sign of a social gradient in
this primary care quality measure between CCGs, if anything, more deprived CCGs tend to have slightly
better GP supply (fewer patients per GP), and that CCG equity performance on primary care quality, as
measured by QOF, is not associated with deprivation at the CCG level.
Hospital waiting time
Hospital waiting time is a major health policy issue in many countries, including the UK, and an important
indicator of health system performance.89,90 Moreover, this indicator was identified by our citizens’ panel
participants as an important measure of equity in the NHS (see Chapter 3). Prolonged hospital waiting time is
known to be associated with poor health outcomes, increased risk of complications, reduced quality of life
and high patient dissatisfaction. For example, a systematic review of waiting time for radiotherapy found that
the risk of local recurrence of cancer increased with increasing waiting time.91 In another example, a recent
English NHS study found that waiting time for hip and knee replacement surgery had a statistically significant
negative impact on the health gains from surgery.92 Similar evidence on the impact of hospital waiting time
has been found for other conditions, including chronic pain,93 cataract94 and heart transplantation.95
We measure hospital waiting time in terms of days from outpatient decision-to-treat to inpatient
admission-for-treatment. This is often termed the inpatient waiting time in the literature. Another
commonly used indicator is the outpatient waiting time, defined as the period between referral from a GP
to the outpatient appointment with a specialist. A third and more comprehensive indicator used in the
NHS since the late 2000s is the referral-to-treatment waiting time, which measures the time from referral
from a GP to inpatient admission-for-treatment, including adjustment to allow for ‘clock stop’ periods of
waiting attributable to patient choices (e.g. not attending an appointment) rather than NHS supply.
This can be further divided into admitted and non-admitted waiting times, by distinguishing patients
who are admitted for inpatient treatment from patients whose course of treatment ends at the outpatient
stage without requiring inpatient admission.
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FIGURE 16 National equity trends in primary care quality: adjustment not necessary. (a) Indicator 2, primary care
quality; (b) SII; and (c) RII. Notes: (1) the solid black line shows the most deprived quintile and the solid blue line
shows the least deprived quintile; (2) negative SII indicates pro-poor distribution, while a positive SII indicates a
pro-rich distribution in absolute terms; (3) negative RII indicates pro-poor distribution, while a positive RII indicates
a pro-rich distribution in relative terms; and (4) data on the number of exception-reported patients were not
provided prior to 2005/06, which explains the blip in the trends between 2004/05 and 2005/06. This blip disappears
when using ‘reported achievement’ after excluding exception-reported patients.
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FIGURE 17 National social gradient in primary care quality in 2011/12: adjustment not necessary. Notes: (1) dots
represent decile groups; (2) the slope of the line is the SII; and (3) the shaded area shows the inequity gap.
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FIGURE 18 Caterpillar plot of the AGI of inequality in primary care quality in 2011/12 at the CCG level.
Notes: (1) CCGs are ranked from least equitable (left) to most equitable (right); and (2) the dotted horizontal line
shows the national average. CCGs to the left with confidence intervals above this line have worse than average
equity performance, and vice versa.
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FIGURE 19 Scatterplots of CCG performance on primary care quality in 2011/12 against deprivation, showing both
mean performance and equity performance (AGI). (a) Mean; and (b) AGI.
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However, we focus on inpatient waiting time because it is considerably quicker and easier to compute,
and less subject to bias due to coding and linkage error. Computing referral-to-treatment times can be
done by linking outpatient and inpatient HES at individual level across multiple years and has been done
for the particular case of hip and knee replacement.96 However, this is time-consuming in terms of both
coding time and computational time, has never previously been done across all possible procedures and
specialties, and would be subject to an unknown degree of coding bias and selection bias due to linkage
failures. It would also be impossible, using HES data, to fully implement the complex ‘clock stop’ rules
required to replicate official NHS statistics on referral-to-treatment times; and so the resulting indicator
would still not precisely match official NHS statistics. The use of inpatient waiting time is also more
internationally comparable, and is consistent with the definition of waiting time used in most OECD
countries to measure health-system performance.89
By all measures, average hospital waiting times have declined significantly from 2001/2 in England.97,98
Siciliani et al.89 report that waiting times for many procedures have more than halved, and that this can partly
be attributed to the ‘targets and terror’ policy introduced from 2000 as well as increased capacity.99,100
However, there is evidence to suggest that there remains significant socioeconomic inequalities in waiting
time. For instance, Laudicella et al.101 found that elective hip replacement patients in the poorest two
socioeconomic quintiles wait about 7% longer than patients in the least deprived quintile across England.
In another study, Moscelli et al.102 found significant differences in waiting times between public hospitals in
non-emergency heart revascularisation procedures in England (up to 35% difference between the most and
least deprived population quintiles). These inequalities all arose within hospitals rather than across hospitals,
and after allowing for differences in the number and type of diagnoses as a marker for severity.
Our indicator evaluates socioeconomic inequality in inpatient hospital waiting time between small-area
populations from 2001/2 to 2013/14. We define hospital waiting time as the number of days from
outpatient decision-to-treat to inpatient admission-for-treatment (i.e. the inpatient waiting time). We allow
for differences in waiting times by specialty type by adjusting for the main specialty of the treating
consultant. We do not additionally allow for age and sex, on the basis of the value judgement that
(at least in most cases) age and sex are not a legitimate justification for making people wait longer for
needed treatment. Further technical details of how this index was computed are presented in Appendix 4.
Inpatient hospital waiting time decreased substantially across all areas in the country from 2003/4 to
2008/9, after which it began to creep up again, as shown in Figures 20 and 21. Inequality appeared to be
slightly pro-poor at the start of our period in 2001/2, and to become even more pro-poor up to 2003/04,
after which time more affluent areas steadily started to catch up (Figures 22 and 23), with some evidence
of pro-rich inequality emerging by 2011/12, as depicted in the social gradient graph in Figure 24. The
caterpillar plot in Figure 25 shows that substantial numbers of CCGs are performing significantly better
and worse than the national average in terms of the AGI of inequality. The correlation plots in Figure 26
show no sign of correlation between mean waiting time and inequality in mean waiting time and
CCG-level deprivation.
Preventable hospitalisation
Preventable hospitalisation refers to emergency hospital admissions that can be prevented by timely and
effective provision of primary care. This is an important indicator of primary care access and quality
that is widely used in the international literature.103–105 In England, data from 2001 to 2013 showed that
preventable hospitalisations make up one in every five hospital admissions, and have increased by 48%
in the last 12 years.106 Common causes of preventable hospitalisations include urinary tract infection/
pyelonephritis, pneumonia, chronic obstructive pulmonary disease (COPD), convulsions and epilepsy, and
ear, nose and throat infections. Studies suggest that preventable hospitalisation can be reduced by
improving primary care supply and quality.107 These hospital visits not only result in poor outcomes, but
also result in increased cost to the health-care system.108 For instance, a recent study concluded that
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FIGURE 24 National social gradient in inpatient hospital waiting time in 2011/12. Notes: (1) dots represent decile
groups; (2) the slope of the line is the SII; and (3) the shaded area shows the inequity gap.
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FIGURE 25 Caterpillar plot of AGI of inequality in inpatient hospital waiting time in 2011/12 at the CCG level.
Notes: (1) CCGs are ranked from least equitable (left) to most equitable (right); and (2) the dotted horizontal line
shows the national average. CCGs to the left with confidence intervals above this line have worse than average
equity performance, and vice versa.
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better management of patients in primary care could save £1.42B in England by reducing preventable
hospitalisation.109 Similar cost estimates have been published for other countries.110,111 Studies have also
found that preventable hospitalisations are associated with the socioeconomic status of patients.112,113
Our indicator evaluates socioeconomic inequality in preventable hospitalisation between small-area
populations from 2001/2 to 2013/14. We defined preventable hospitalisation as the proportion of people
with an emergency admission for a chronic ambulatory care-sensitive condition, admissions that are
potentially avoidable if these chronic conditions are appropriately managed in primary care.114 This
indicator could also be described as ‘emergency hospitalisation sensitive to primary care’. We depart from
the corresponding NHS Outcomes Framework definition by defining the indicator numerator as the
number of people with one or more events, rather than the number of events. This is because (1) we have
a separate measure of repeat hospitalisation and so want to focus this measure on the incidence of
hospitalisation (the proportion of people hospitalised) rather than the intensity (how many times each
individual is hospitalised); and (2) following advice from the two lay members of our advisory group, we
believe that members of the public find it slightly easier to understand and relate to proportions (e.g. ‘X
people per 1000’ or ‘a chance of X in 100’) than event rates. We focused on chronic rather than acute
ambulatory care-sensitive conditions, as the former are likely to be more sensitive to changes in primary
care supply and quality. We used the same list of chronic ambulatory care-sensitive conditions as the NHS
Outcomes Framework (indicator 2.3i). Our definition of preventable hospitalisation uses all ages in both
numerator and denominator, as does the NHS Outcomes Framework definition. However, the international
OECD definition only includes age ≥ 15 years, that is, we include children but the OECD definition does
not. We then indirectly standardised each year of data for age and sex at the LSOA level. Further technical
details of the standardisation procedure are in Chapter 4, and further indicator definition details are
presented in Appendix 4.
There has been a slight fall in preventable hospitalisation over the study period, although substantial
inequality persisted throughout. Looking at the age–sex breakdowns in the matrix plot in Figures 27 and
28, the main exception to this trend was in children aged 5–15 years within the most deprived quintile
group for whom preventable hospitalisation rose during the 2000s. The unadjusted trends in Figure 29
show improvement in inequality in terms of SII and RII. However, this is misleading because of the
disproportionate ageing of the affluent population, which is associated with a higher rate of hospitalisation
in this quintile group. After age adjustment, the pro-rich trend disappears for both SII and RII, as shown in
Figure 30. This inequality is seen both between CCGs and within CCGs, as depicted by the correlation
plots in Figure 31. Inequality lines up closely with deprivation, as shown by decile points on the scatterplot
Figure 32 which all lie along the social gradient line. The caterpillar plot in Figure 33 shows there are
substantial numbers of CCGs performing significantly better and worse than the national average in terms
of the AGI of inequality.
In the unadjusted trends, which do not allow for age and sex, both the SII and RII decline (get better) over
time. This difference compared with the adjusted trends is because of demographic change over time:
affluent neighbourhoods aged during the 2000s, while there was an increase in younger populations in
deprived neighbourhoods. This demographic shift increased preventable hospitalisation in richer
neighbourhoods relative to poorer neighbourhoods and hence reduced pro-rich inequality in the
unadjusted trends. We think the age- and sex-adjusted trends give a more accurate picture of NHS equity
performance, on the basis that the NHS should not receive credit for an apparent reduction in pro-rich
inequality resulting from demographic change largely outside the control of the NHS.
A final point to note is the uptick in preventable hospitalisation in 2003/4, which was particularly strong in
the two most deprived quintile groups. The cause of this is not known. However, one speculation is that
this may be related to change in the supply of GP out of hours care. This uptick in preventable emergency
hospitalisation happened around the time of the introduction of the new GP contract which, among other
things, allowed GPs to opt out of providing ‘out-of-hours’ cover for emergency care outside normal GP
practice working hours. This speculation may be worth exploring in future quasi-experimental studies.
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FIGURE 31 Scatterplots of CCG performance on preventable hospitalisation in 2011/12 against deprivation,
showing both mean performance and equity performance (AGI). (a) Mean; and (b) AGI.
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FIGURE 32 National social gradient in preventable hospitalisation in 2011/12. Notes: (1) dots represent decile
groups; (2) the slope of the line is the SII; and (3) the shaded area shows the inequity gap.
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FIGURE 33 Caterpillar plot of the AGI of inequality in preventable hospitalisation in 2011/12 at the CCG level.
Notes: (1) CCGs are ranked from least equitable (left) to most equitable (right); and (2) the dotted horizontal line
shows the national average. CCGs to the left with confidence intervals above this line have worse than average
equity performance, and vice versa.
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Repeat hospitalisation
Repeat emergency hospitalisation is known as an important routine indicator of health system
performance.115–118 Repeat hospitalisation may be a result of one or a combination of several factors including
(but not limited to) quality of care during previous hospitalisation (including early discharge), comprehensive
discharge planning,119 primary and community care after discharge (including outpatient follow-up)120 and the
patients’ own social support systems and health behaviours. Therefore, repeat hospitalisation is an important
indicator of the quality-of-care co-ordination between hospital care, primary care and community care settings.
Studies suggest that greater deprivation is associated with an increased risk of emergency readmission.
For instance, in a study in Greater Manchester, Lyratzopoulos et al.121 found that deprivation was
significantly and independently associated with increased risk of emergency medical readmission at 3 and
12 months after initial discharge. Other studies using specific patient groups found similar socioeconomic
patterns of hospital readmissions.122 Repeat hospitalisation not only results in poor health outcomes for
patients, it also significantly increases the cost of care for the health-care system. Therefore, reducing
repeat hospitalisation is one of the key indicators used to assess hospital performance and the impact of
health service organisation for the average patient.116,123
Our indicator evaluates socioeconomic inequality in repeat hospitalisation between small-area populations
from 2001/2 to 2013/14. We define repeat hospitalisation as a proportion of inpatients with one or more
subsequent any-cause emergency readmission in the same year. We focus on all-cause rather than
cause-specific repeat hospitalisation and on within-year rather than 30-day or 90-day repeat hospitalisation
for the following reasons: (1) we are interested in whole-system co-ordinated care, beyond the primary
cause of hospital admission and the immediate post-hospital period; and (2) all-cause repeat hospitalisation
within the indicator year provides a larger number of events for the purpose of detecting statistically
significant differences between CCG-level and national-level absolute inequality gradients.
The denominator for this indicator is the total number of people with an inpatient admission from any
cause in a given year. The numerator is the number of people with one or more repeat hospitalisations
from any cause in the same calendar year. We used repeat hospitalisation within the indicator year
rather than following patients across years because this is less time-consuming in terms of coding and
computational burden. In addition, 12-month readmission would result in a less up-to-date indicator by
either imposing a 1-year data lag or a focus on patients admitted the year before the indicator year.
The drawback of our approach is that it may produce biased estimates of the national social gradient in
12-month readmission, although this is unlikely substantially to hamper comparisons between CCGs and
over time. The advantage is that this is a simpler, less computationally expensive and timelier approach.
We indirectly standardised each year of data for age and sex at the LSOA level. Further technical details of
how this index was computed are presented in Appendix 4.
Rates of repeat hospitalisation have increased substantially over the study period as shown in Figures 34
and 35, coupled with an increase in both absolute and relative inequality in Figures 36 and 37. By 2011/12
there was substantial inequality in repeat hospitalisation, as depicted by the national social gradient
graph in Figure 38. The unadjusted trends in Figure 36 show improvement in inequality; however, this is
misleading because of disproportionate ageing of the affluent population over time. After age adjustment,
the underlying worsening inequality trend becomes clear for both SII and RII, as shown in Figure 37.
As discussed in more detail in Chapter 8, the increase in repeat hospitalisation and associated increase
in inequality may partly be a sign of success related to increasing multimorbidity as a result of people living
longer, although may also partly be a result of shorter lengths of stay in hospital, hospital payment reforms
that gave hospitals financial incentives to increase emergency admissions, and, especially towards the
end of the 2000s, reductions in social care supply and quality because of financial pressures on local
authorities. This inequality appears to be present between CCGs as well as within CCGs, as shown in
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Figure 39a for 2011/12. Equity performance on repeat hospitalisation shows a slightly positive association
with deprivation at the CCG level, although most of this association is driven by a handful of CCGs with
unusually high and low equity performance. The caterpillar plot in Figure 40 shows there are substantial
numbers of CCGs performing significantly better and worse than the national average in terms of the AGI
of inequality.
Dying in hospital
Dying in hospital is a useful indicator of the quality of end-of-life care planning.124 It is directly related to
care pathway planning and the availability of palliative care and community nursing care at home.125,126
Moreover, socioeconomic factors including low levels of social support are associated with increased
hospital deaths.125 A recent systematic review of studies on adult preferences for place of death found that
most people prefer to die at home.127 Specifically, in England, 64% of respondents of a population survey
stated that they preferred to die at home rather than in hospital.128 However, almost half of the deaths in
England occur in hospitals (47.2% in 2014/15).129 This may be because of a combination of factors,
involving health and social services and individual and social factors. Dying in hospital is also a financial
concern because of high expenditure of end-of-life care in hospitals.
In keeping with our other indicators, we use a general version of this indicator that covers the full
spectrum of health-care activity, rather than focusing exclusively on cancer or other specific terminal
illnesses. Our indicator measures socioeconomic inequality between small-area populations in the
proportion of all deaths that occur in hospital. The numerator for this indicator is the number of deaths
from any cause that occurred in hospital in a given year, measured using HES data. The denominator is the
total number of deaths from any cause in a given year, irrespective of the place of death, measured using
ONS mortality data. The indicator was measured for years 2001/2 to 2011/12. Further technical details of
how this index was computed are presented in Appendix 4.
There are no ‘adjusted’ results to present for this indicator, on the basis of the value judgement that age,
sex and other patient characteristics are not legitimate reasons for differential rates of deaths in hospital.
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FIGURE 38 National social gradient in repeat hospitalisation in 2011/12. Notes: (1) dots represent decile groups;
(2) the slope of the line is the SII; and (3) the shaded area shows the inequity gap.
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FIGURE 39 Scatterplots of CCG performance on repeat hospitalisation in 2011/12 against deprivation, showing
both mean performance and equity performance (AGI). (a) Mean; and (b) AGI.
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The proportion of deaths in hospital has been falling over time in all deprivation groups as shown in
Figures 41–43. However, substantial inequality between deprivation groups persists over time with those
living in more deprived areas more likely to die in hospital (Figure 44). The correlation plot in Figure 45
shows that this inequality occurs between CCGs, in that more deprived CCGs have higher rates of dying in
hospital. However, there is no obvious correlation between the absolute equity gradient within CCGs and
deprivation at the CCG level. The caterpillar plot in Figure 46 shows that very few CCGs are statistically
distinguishable from the national mean in terms of their absolute gradient in inequality.
Amenable mortality
Amenable mortality is a standard indicator used internationally to monitor the performance of the
health-care system as a whole, and is considered to be particularly useful for monitoring the performance
of primary care and the co-ordination of care between primary and secondary services.58,130,131 Amenable
mortality refers to deaths that could be avoided by the health-care system through prevention and
treatment, given medical knowledge and technology available at the time of death.132,133 The concept was
first formalised by Rutstein et al.,134 based on treatable causes of death, and subsequently broadened to
include causes preventable by health care which led to the use of the term ‘amenable mortality’.135,136
The concept of ‘amenable mortality’ is narrower than that of ‘preventable mortality’, however, which also
includes mortality preventable by public health measures outside the health-care system.137
Amenable mortality makes up a significant proportion of total deaths, even in high-income countries.
Nolte and McKee138 found that, in 2006/7, amenable mortality accounted for nearly one-quarter of all
deaths among people aged < 75 years in 16 high-income countries, including the UK, where the figure
was slightly above average, at 26.8%. The relationship between amenable mortality and socioeconomic
status has also been investigated in several studies.139–142 In England, socioeconomic inequality in amenable
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FIGURE 40 Caterpillar plot of AGI of inequality in repeat hospitalisation in 2011/12 at the CCG level. Notes:
(1) CCGs are ranked from least equitable (left) to most equitable (right); and (2) the dotted horizontal line shows
the national average. CCGs to the left with confidence intervals above this line have worse than average equity
performance, and vice versa.
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FIGURE 44 National social gradient in dying in hospital in 2011/12. Notes: (1) dots represent decile groups;
(2) the slope of the line is the SII; and (3) the shaded area shows the inequity gap.
(a)
0.5
0.4
Least deprived Most deprived
Deprivation
Pr
o
p
o
rt
io
n
 o
f 
d
ea
th
s 
in
 h
o
sp
it
al
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mortality increased among both men and women between 1990 and 2010; the RII for men increased from
2.21 in 1990 to 2.83 in 2010, and for women increased from 1.67 in 1990 to 2.18 in 2010.143
This indicator measures socioeconomic inequality between small-area populations in amenable mortality.
We defined amenable mortality as the proportion of people dying from causes considered amenable to
health care. The numerator for this indicator is the number of deaths from causes considered amenable
to health care. The denominator is the total number of deaths from any cause in a given year. We used
the list of causes of death considered amenable to health care from the NHS Outcomes Framework
(indicator 1.1),144 which in turn is based on a list produced by the ONS. The NHS Outcomes Framework
turns the resulting mortality counts into an estimate of ‘potential years of life lost’ from premature deaths
aged < 75 years. However, we have used a simple all-age mortality rate including deaths in those aged
≥ 75 years, as (1) our approach is more comprehensive (people aged > 75 years experience by far the
highest rate of amenable mortality) and (2) based on advice from two lay members of our advisory group
and a media expert, we believe that mortality rates are easier for the public to understand than ‘potential
years of life lost’. We indirectly standardise amenable mortality for age and sex at the LSOA level.
Further technical details of how this index was computed are presented in Appendix 4.
Amenable mortality has fallen in all deprivation groups over time, with some sign of an accelerated decline
from 2004/5 when the primary care pay-for-performance contract was implemented (see Figures 47–50).
Once adjusted for age and sex, there is a clear reduction in absolute inequality but a clear rise in
relative inequality. The difference is because of the substantial declining trend in the mean over time.
Relative inequality is absolute inequality divided by the mean, and so the smaller the mean, the larger
the relative inequality. Inequality appears highly pronounced between CCGs (Figure 51). There is also a
slight positive association between equity performance on amenable mortality and deprivation at the CCG
level, although this is much weaker than the association with average levels of amenable mortality
(Figure 52). The caterpillar plot in Figure 53 shows that rather few CCGs are statistically distinguishable
from the national mean in terms of their absolute inequality performance on amenable mortality.
Overall mortality
Overall all-age all-cause mortality refers to the number of deaths for all ages and all causes in a given
year as a proportion of the total number of people alive at the start of the year. We use all-age all-cause
mortality as a contextual indicator of inequality in health, to help interpret levels and trends in our seven
health-care equity indicators. Change in this indicator over time may partly reflect change in NHS delivery,
but will also reflect change in the socioeconomic patterning of risk factors and health behaviours because
of wider social determinants of health outside the health-care system.
In the past, some international studies have used all-cause mortality to measure and compare the
performance of health-care systems. For instance, the WHO has reported all-cause mortality rates to compare
health outcomes across countries.145 However, it is by now well established that health care is only one of
many social determinants of health,6 and so any credible measure of the role of health care in tackling these
wider health inequalities has to focus on indicators that are more directly sensitive to health-care delivery.
In the UK, the ONS produces annual statistics for all-cause mortality by age and sex groups.146 This
provides an important indication of the overall mortality trend and provides the basis for exploring
cause-specific mortality.147 A number of studies have explored socioeconomic inequalities in all-cause
mortality. Studies conducted in high-income countries, including the UK, found statistically significant
evidence of higher rate of all-cause mortality in lower socioeconomic groups.148–152 In the case of England,
although population-level all-cause mortality rates have been decreasing, area-level deprivation is
associated with higher rates of all-cause mortality.153
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FIGURE 51 National social gradient in amenable mortality in 2011/12. Notes: (1) dots represent decile groups;
(2) the slope of the line is the SII; and (3) the shaded area shows the inequity gap.
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FIGURE 52 Scatterplots of CCG performance on amenable mortality 2011/12 against deprivation, showing both
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FIGURE 52 Scatterplots of CCG performance on amenable mortality 2011/12 against deprivation, showing both
mean performance and equity performance (AGI). (a) Mean; and (b) AGI.
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FIGURE 53 Caterpillar plot of AGI of inequality in amenable mortality in 2011/12 at the CCG level. Notes: (1) CCGs
are ranked from least equitable (left) to most equitable (right); and (2) the dotted horizontal line shows the
national average. CCGs to the left with confidence intervals above this line have worse than average equity
performance, and vice versa.
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This indicator measures the socioeconomic inequality between small-area populations in all-cause mortality
rate. We define all-cause mortality as the number of deaths per 1000 people from all causes at all ages.
The numerator for this indicator is the number of deaths from any cause that occurred in a given year.
The denominator is the total number of people alive at the start of a given year. The indicator was
measured for years 2001/2 to 2011/12. As the age and sex structure of each area can affect the mortality
rate, using the crude mortality rate would be inappropriate. Hence, in line with the literature, we adjust
the mortality rate by taking account of the age and sex structure of the population. Further technical
details of how this index was computed are presented in Appendix 4.
The trend in overall mortality is similar to that in amenable mortality, having fallen in all deprivation groups
over time as shown in Figures 54 and 55. Once adjusted for age and sex, absolute inequality in overall
mortality shows a rise during the early 2000s followed by a fall from 2008 onwards (Figures 56 and 57).
Relative inequality shows a similar pattern, except inequality merely flattens out from 2008 onwards: the
difference between the two, as before, being the declining mean. Inequality appears to be highly prominent
between areas as shown in Figure 58. The caterpillar plot in Figure 59 shows that very few CCGs are
statistically distinguishable from the national mean in terms of their absolute inequality performance on
overall mortality. As with amenable mortality, there is a positive association between equity and deprivation
at the CCG level, although this is much weaker than the association between deprivation and average
mortality as shown in Figure 60.
Summary of findings on local health-care equity monitoring
In 2011/12, in individual statistical comparisons at the 95% level, well over 20% of CCGs were found to
perform significantly differently on equity than the national benchmark, including at least 10% better and
10% worse, using annual data for the following five general indicators: (1) primary care supply, (2) primary
care quality, (3) hospital waiting time, (4) preventable hospitalisation, and (5) repeat hospitalisation (Table 3).
This was not possible for the remaining three indicators. For indicator (6), dying in hospital, only 8% of CCGs
were significantly different from average: 3% worse and 5% better. For indicator (7), amenable mortality,
11% were significantly different from average: 8% worse and 3% better. Finally, for indicator (8), overall
mortality, 17% were significantly different from the national average, but most of these were significantly
worse: only 3% were significantly better. Pooling additional years of data did not improve substantially the
ability to detect significant differences.
Note that our overall findings on the total number of CCGs differing from the national mean must be
treated with appropriate caution, as we did not perform any statistical correction for multiple testing and
neither did we use statistical control limits to explore the normal range of variation in the SII in order to
distinguish ‘general-cause’ variation from ‘special-cause’ variation worthy of concern.154 Rather, we simply
examine whether or not each individual CCG is statistically different from the national mean at the 95%
level of statistical significance. We might of course expect that up to 5% of CCGs might pass this test by
chance, because of the normal ‘general-cause’ variation, although not the 20% we observe. We leave the
further refinement of our statistical methods for future research, as to our knowledge an appropriate
statistical formula for setting control limits for social gradients has not previously been developed.
DOI: 10.3310/hsdr04260 HEALTH SERVICES AND DELIVERY RESEARCH 2016 VOL. 4 NO. 26
© Queen’s Printer and Controller of HMSO 2016. This work was produced by Cookson et al. under the terms of a commissioning contract issued by the Secretary of State for
Health. This issue may be freely reproduced for the purposes of private research and study and extracts (or indeed, the full report) may be included in professional journals
provided that suitable acknowledgement is made and the reproduction is not associated with any form of advertising. Applications for commercial reproduction should be
addressed to: NIHR Journals Library, National Institute for Health Research, Evaluation, Trials and Studies Coordinating Centre, Alpha House, University of Southampton Science
Park, Southampton SO16 7NS, UK.
101
20
01
/2
0306090030609003060900306090030609003060900306090
20
11
/1
2 20
01
/2
20
11
/1
2 20
01
/2
20
11
/1
2 20
01
/2
20
11
/1
2 20
01
/2
20
11
/1
2
Y
ea
r
IM
D
 g
ro
u
p
75+60–7440–59
All-cause mortality (per 1000)
Age group (years)
25–3916–245–150–4
Q
1 
(m
o
st
 d
ep
ri
ve
d
)
Q
2
Q
3
Q
4
Q
5 
(l
ea
st
 d
ep
ri
ve
d
)
Se
x
Fe
m
al
e
M
al
e
FI
G
U
R
E
54
M
at
ri
x
p
lo
t
sh
o
w
in
g
u
n
ad
ju
st
ed
tr
en
d
s
in
o
ve
ra
ll
m
o
rt
al
it
y
b
y
ag
e,
se
x
an
d
d
ep
ri
va
ti
o
n
(f
ix
ed
ax
es
fo
r
co
m
p
ar
is
o
n
s
ac
ro
ss
ag
e
g
ro
u
p
s)
.
RESULTS
NIHR Journals Library www.journalslibrary.nihr.ac.uk
102
20
01
/2
6070809010
010152025302460.
5
1.
0
1.
5
0.
2
0.
4
0.
6
0.
04
0.
08
0.
12
0.
16234
20
11
/1
2 20
01
/2
20
11
/1
2 20
01
/2
20
11
/1
2 20
01
/2
20
11
/1
2 20
01
/2
20
11
/1
2
Y
ea
r
IM
D
 g
ro
u
p
75+60–7440–59
All-cause mortality (per 1000)
Age group (years)
25–3916–245–150–4
Q
1 
(m
o
st
 d
ep
ri
ve
d
)
Q
2
Q
3
Q
4
Q
5 
(l
ea
st
 d
ep
ri
ve
d
)
Se
x
Fe
m
al
e
M
al
e
FI
G
U
R
E
55
M
at
ri
x
p
lo
t
sh
o
w
in
g
u
n
ad
ju
st
ed
tr
en
d
s
in
o
ve
ra
ll
m
o
rt
al
it
y
b
y
ag
e,
se
x
an
d
d
ep
ri
va
ti
o
n
(f
re
e
ax
es
fo
r
co
m
p
ar
is
o
n
s
ac
ro
ss
d
ep
ri
va
ti
o
n
g
ro
u
p
s)
.
DOI: 10.3310/hsdr04260 HEALTH SERVICES AND DELIVERY RESEARCH 2016 VOL. 4 NO. 26
© Queen’s Printer and Controller of HMSO 2016. This work was produced by Cookson et al. under the terms of a commissioning contract issued by the Secretary of State for
Health. This issue may be freely reproduced for the purposes of private research and study and extracts (or indeed, the full report) may be included in professional journals
provided that suitable acknowledgement is made and the reproduction is not associated with any form of advertising. Applications for commercial reproduction should be
addressed to: NIHR Journals Library, National Institute for Health Research, Evaluation, Trials and Studies Coordinating Centre, Alpha House, University of Southampton Science
Park, Southampton SO16 7NS, UK.
103
11 10 9 8
All-cause mortality (per 1000)
20
01
/2
20
04
/5
20
03
/4
20
02
/3
20
05
/6
20
06
/7
20
07
/8
(a
)
20
08
/9
20
09
/1
0
20
10
/1
1
20
11
/1
2
Q
1 
(m
o
st
 d
ep
ri
ve
d
)
Q
2
Q
3
Q
4
Q
5 
(l
ea
st
 d
ep
ri
ve
d
)
IM
D
 g
ro
u
p
Y
ea
r
FI
G
U
R
E
56
U
n
ad
ju
st
ed
n
at
io
n
al
eq
u
it
y
tr
en
d
s
in
m
o
rt
al
it
y.
N
o
te
s:
(1
)
th
e
so
lid
b
la
ck
lin
e
sh
o
w
s
th
e
m
o
st
d
ep
ri
ve
d
q
u
in
ti
le
an
d
th
e
so
lid
b
lu
e
lin
e
sh
o
w
s
th
e
le
as
t
d
ep
ri
ve
d
q
u
in
ti
le
;
(2
)
n
eg
at
iv
e
SI
Ii
n
d
ic
at
es
p
ro
-p
o
o
r
d
is
tr
ib
u
ti
o
n
,
w
h
ile
a
p
o
si
ti
ve
SI
Ii
n
d
ic
at
es
a
p
ro
-r
ic
h
d
is
tr
ib
u
ti
o
n
in
ab
so
lu
te
te
rm
s;
an
d
(3
)
n
eg
at
iv
e
R
II
in
d
ic
at
es
p
ro
-p
o
o
r
d
is
tr
ib
u
ti
o
n
,
w
h
ile
a
p
o
si
ti
ve
R
II
in
d
ic
at
es
a
p
ro
-r
ic
h
d
is
tr
ib
u
ti
o
n
in
re
la
ti
ve
te
rm
s.
(c
o
n
ti
n
u
ed
)
RESULTS
NIHR Journals Library www.journalslibrary.nihr.ac.uk
104
3 2 1
20
04
/5
20
03
/4
20
02
/3
20
01
/2
20
05
/6
20
06
/7
20
07
/8
Y
ea
r
20
08
/9
20
09
/1
0
20
10
/1
1
20
11
/1
2
(b
)
SII
2030
20
04
/5
20
03
/4
20
02
/3
20
01
/2
20
05
/6
20
06
/7
20
07
/8
Y
ea
r
20
08
/9
20
09
/1
0
20
10
/1
1
20
11
/1
2
(c
) RII (%)
FI
G
U
R
E
56
U
n
ad
ju
st
ed
n
at
io
n
al
eq
u
it
y
tr
en
d
s
in
m
o
rt
al
it
y.
N
o
te
s:
(1
)
th
e
so
lid
b
la
ck
lin
e
sh
o
w
s
th
e
m
o
st
d
ep
ri
ve
d
q
u
in
ti
le
an
d
th
e
so
lid
b
lu
e
lin
e
sh
o
w
s
th
e
le
as
t
d
ep
ri
ve
d
q
u
in
ti
le
;
(2
)
n
eg
at
iv
e
SI
Ii
n
d
ic
at
es
p
ro
-p
o
o
r
d
is
tr
ib
u
ti
o
n
,
w
h
ile
a
p
o
si
ti
ve
SI
Ii
n
d
ic
at
es
a
p
ro
-r
ic
h
d
is
tr
ib
u
ti
o
n
in
ab
so
lu
te
te
rm
s;
an
d
(3
)
n
eg
at
iv
e
R
II
in
d
ic
at
es
p
ro
-p
o
o
r
d
is
tr
ib
u
ti
o
n
,
w
h
ile
a
p
o
si
ti
ve
R
II
in
d
ic
at
es
a
p
ro
-r
ic
h
d
is
tr
ib
u
ti
o
n
in
re
la
ti
ve
te
rm
s.
DOI: 10.3310/hsdr04260 HEALTH SERVICES AND DELIVERY RESEARCH 2016 VOL. 4 NO. 26
© Queen’s Printer and Controller of HMSO 2016. This work was produced by Cookson et al. under the terms of a commissioning contract issued by the Secretary of State for
Health. This issue may be freely reproduced for the purposes of private research and study and extracts (or indeed, the full report) may be included in professional journals
provided that suitable acknowledgement is made and the reproduction is not associated with any form of advertising. Applications for commercial reproduction should be
addressed to: NIHR Journals Library, National Institute for Health Research, Evaluation, Trials and Studies Coordinating Centre, Alpha House, University of Southampton Science
Park, Southampton SO16 7NS, UK.
105
12 11 10 9 8
All-cause mortality (per 1000)
20
01
/2
20
04
/5
20
03
/4
20
02
/3
20
05
/6
20
06
/7
20
07
/8
7
(a
)
20
08
/9
20
09
/1
0
20
10
/1
1
20
11
/1
2
Q
1 
(m
o
st
 d
ep
ri
ve
d
)
Q
2
Q
3
Q
4
Q
5 
(l
ea
st
 d
ep
ri
ve
d
)
IM
D
 g
ro
u
p
Y
ea
r
FI
G
U
R
E
57
A
d
ju
st
ed
n
at
io
n
al
eq
u
it
y
tr
en
d
s
in
m
o
rt
al
it
y.
N
o
te
s:
(1
)
th
e
so
lid
b
la
ck
lin
e
sh
o
w
s
th
e
m
o
st
d
ep
ri
ve
d
q
u
in
ti
le
an
d
th
e
so
lid
b
lu
e
lin
e
sh
o
w
s
th
e
le
as
t
d
ep
ri
ve
d
q
u
in
ti
le
;
(2
)
n
eg
at
iv
e
SI
I
in
d
ic
at
es
p
ro
-p
o
o
r
d
is
tr
ib
u
ti
o
n
,
w
h
ile
a
p
o
si
ti
ve
SI
Ii
n
d
ic
at
es
a
p
ro
-r
ic
h
d
is
tr
ib
u
ti
o
n
in
ab
so
lu
te
te
rm
s;
an
d
(3
)
n
eg
at
iv
e
R
II
in
d
ic
at
es
p
ro
-p
o
o
r
d
is
tr
ib
u
ti
o
n
,
w
h
ile
a
p
o
si
ti
ve
R
II
in
d
ic
at
es
a
p
ro
-r
ic
h
d
is
tr
ib
u
ti
o
n
in
re
la
ti
ve
te
rm
s.
(c
o
n
ti
n
u
ed
)
RESULTS
NIHR Journals Library www.journalslibrary.nihr.ac.uk
106
5.
75
5.
50
5.
25
5.
00
4.
75
20
04
/5
20
03
/4
20
02
/3
20
01
/2
20
05
/6
20
06
/7
20
07
/8
Y
ea
r
20
08
/9
20
09
/1
0
20
10
/1
1
20
11
/1
2
(b
)
SII
505560
20
04
/5
20
03
/4
20
02
/3
20
01
/2
20
05
/6
20
06
/7
20
07
/8
Y
ea
r
20
08
/9
20
09
/1
0
20
10
/1
1
20
11
/1
2
(c
) RII (%)
FI
G
U
R
E
57
A
d
ju
st
ed
n
at
io
n
al
eq
u
it
y
tr
en
d
s
in
m
o
rt
al
it
y.
N
o
te
s:
(1
)
th
e
so
lid
b
la
ck
lin
e
sh
o
w
s
th
e
m
o
st
d
ep
ri
ve
d
q
u
in
ti
le
an
d
th
e
so
lid
b
lu
e
lin
e
sh
o
w
s
th
e
le
as
t
d
ep
ri
ve
d
q
u
in
ti
le
;
(2
)
n
eg
at
iv
e
SI
Ii
n
d
ic
at
es
p
ro
-p
o
o
r
d
is
tr
ib
u
ti
o
n
,
w
h
ile
a
p
o
si
ti
ve
SI
Ii
n
d
ic
at
es
a
p
ro
-r
ic
h
d
is
tr
ib
u
ti
o
n
in
ab
so
lu
te
te
rm
s;
an
d
(3
)
n
eg
at
iv
e
R
II
in
d
ic
at
es
p
ro
-p
o
o
r
d
is
tr
ib
u
ti
o
n
,
w
h
ile
a
p
o
si
ti
ve
R
II
in
d
ic
at
es
a
p
ro
-r
ic
h
d
is
tr
ib
u
ti
o
n
in
re
la
ti
ve
te
rm
s.
DOI: 10.3310/hsdr04260 HEALTH SERVICES AND DELIVERY RESEARCH 2016 VOL. 4 NO. 26
© Queen’s Printer and Controller of HMSO 2016. This work was produced by Cookson et al. under the terms of a commissioning contract issued by the Secretary of State for
Health. This issue may be freely reproduced for the purposes of private research and study and extracts (or indeed, the full report) may be included in professional journals
provided that suitable acknowledgement is made and the reproduction is not associated with any form of advertising. Applications for commercial reproduction should be
addressed to: NIHR Journals Library, National Institute for Health Research, Evaluation, Trials and Studies Coordinating Centre, Alpha House, University of Southampton Science
Park, Southampton SO16 7NS, UK.
107
12
10
8
A
ll-
ca
u
se
 m
o
rt
al
it
y 
(p
er
 1
00
0)
6
Least deprived Most deprived
Small-area deprivation rank
FIGURE 58 National social gradient in mortality in 2011/12. Notes: (1) dots represent decile groups; (2) the slope of
the line is the SII; and (3) the shaded area shows the inequity gap.
A
G
I a
ll-
ca
u
se
 m
o
rt
al
it
y 
(p
er
 1
00
0)
0
10
20
30
Least equitable Most equitable
CCG equity rank
FIGURE 59 Caterpillar plot of AGI of inequality in mortality in 2011/12 at the CCG level. Notes: (1) CCGs are ranked
from least equitable (left) to most equitable (right); and (2) the dotted horizontal line shows the national average.
CCGs to the left with confidence intervals above this line have worse than average equity performance, and
vice versa.
RESULTS
NIHR Journals Library www.journalslibrary.nihr.ac.uk
108
(a)
11
9
13
7
Least deprived Most deprived
Deprivation
A
ll-
ca
u
se
 m
o
rt
al
it
y 
(p
er
 1
00
0)
20
(b)
10
0
Least deprived Most deprived
Deprivation
A
ll-
ca
u
se
 m
o
rt
al
it
y 
(p
er
 1
00
0)
FIGURE 60 Scatterplots of CCG performance on all-cause mortality in 2011/12 against deprivation, showing both
mean performance and equity performance (AGI). (a) Mean; and (b) AGI.
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TABLE 3 The number and percentage of CCGs detected as performing significantly better or worse than the
national benchmark for health-care equity in 2011/12
Indicator number Indicator
Performance
Worse Better Neither
Count % Count % Count %
1 Primary care supply 39 18 41 19 131 62
2 Primary care quality 60 28 39 18 112 53
3 Hospital waiting time 38 18 21 10 152 72
4 Preventable hospitalisation 45 21 60 28 106 50
5 Repeat hospitalisation 33 16 36 17 142 67
6 Dying in hospital 7 3 10 5 194 92
7 Amenable mortality 17 8 6 3 188 89
8 Overall mortality 29 14 6 3 176 83
RESULTS
NIHR Journals Library www.journalslibrary.nihr.ac.uk
110
Chapter 6 Development of equity visualisation
tools
Introduction
We now turn from the data analytical ‘engine room’ of our equity indicators to the communication and
knowledge translation ‘front-end’. This chapter describes how we developed visualisation tools for
communicating our equity findings to decision-makers and health experts. We developed three main
visualisation tools:
l Equity dashboards: a one-page summary for decision-makers at national and local levels, including an
interactive spreadsheet tool [based in Microsoft Excel® (Microsoft Corporation, Redmond, WA, USA)]
that can display a dashboard for any CCG in England.
l Equity chart packs: a standard set of slides with tables and graphs showing the underlying inequality
patterns and trends in a common format for each indicator, including a portable document format
(PDF) file-creating tool [based in the free statistical programming language, R (The R Foundation for
Statistical Computing, Vienna, Austria)] that can create a chart pack for any CCG in England.
l Equity custom graphs: a web-based interactive chart tool [based in free software provided by Google
Charts (Google Inc., Mountain View, CA, USA)] that allows the user to draw their own customised
graphs and see how equity changes over time by selecting from a wide range of variables and
chart styles.
A key objective of our study was to develop visualisation tools for presenting equity findings to
decision-makers and health experts in a clear, concise and informative manner. Effective communication is
essential if findings are to be used in practice to inform decision-making. However, effective communication
of findings about equity performance is more challenging than effective communication of findings about
average performance, for two reasons. First, inequality is a more complex than the average concept, as it
depends in more complex ways on the underlying distributional patterns. There are just three main ways of
computing the average of a distribution (the mean, median and mode), whereas there are hundreds of
different inequality indices reflecting different aspects of inequality, many of which of themselves have an
infinite variety of subspecies based on one or more continuous input parameters.155 Second, conclusions
about how far inequality is ‘unfair’ or ‘equitable’ involve controversial value judgements and empirical
beliefs about the causes of inequality about which reasonable people can disagree.
One key role for our equity indicators is to facilitate external NHS scrutiny, as well as to facilitate internal
NHS management. In designing our visualisation tools, we therefore sought feedback from a range of
intended decision-making audiences including not only NHS commissioning organisations (i.e. NHS
England and CCGs) but also organisations with key NHS scrutiny and oversight roles such as Public Health
England and Health and Wellbeing Boards. Our equity indicators are also intended for public reporting to
enhance democratic accountability, and so we consulted the two lay members of our advisory group.
Developing ‘infographics’ for public reporting requires specialised artistic and design skills beyond the skill
set of our academic research team, and this was not part of the funding for the research grant. In
discussions with the lay members of our advisory group, we concluded that specialised work of this kind
will indeed be necessary in future to communicate equity indicator, as members of the public who are
unfamiliar with using statistics and graphs may struggle to understand our dashboards and chart packs.
We therefore recommend future work to develop suitable ‘infographic’ tools for public communication,
which will require funding to pay for specialised media and artistic design skills.
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The development of our visualisation tools has benefited from comments from many different people,
including those who participated in the following presentations and meetings to national and local NHS
and public health audiences:
l presentations to our advisory group in November 2013, November 2014 and September 2015 (see
membership in Appendix 3)
l teleconference meeting with experts from the Royal College of General Practitioners on our GP supply
indicators, September 2014
l presentation to analysts at NHS England, Quarry House, Leeds, March 2015
l presentation to analysts at Public Health England, York, June 2015
l meeting with the chairperson of Hull CCG, April 2015
l presentation to NHS and public health officials across the health system in York at Vale of York CCG,
May 2015
l presentation to NHS and public health officials across the health system in Hull at Hull CCG, June 2015
l meeting with the Chief Economist, Public Health England, York City Council, July 2015
l meetings with the health inequalities lead of the Equality and Health Inequalities Unit on various
occasions in 2015, including a meeting with other senior officials from NHS England, Leeds, July 2015
l meeting with analysts at Public Health England, Wellington House, October 2015.
We have also benefited from comments from health indicator experts from a range of disciplines, including
those who participated in the following meetings:
l seminar at the Institute for Health Policy, Management and Evaluation, University of Toronto, Toronto,
ON, Canada, May 2015
l seminar at the Canadian Institute for Health Information, Ottawa, ON, Canada, May 2015
l seminar at the WHO Collaborating Centre for Knowledge Translation and Health Technology
Assessment in Health Equity, Ottawa, ON, Canada, May 2015
l seminar at the Centre for Health Economics and Policy Analysis, McMaster University, Hamilton, ON,
Canada, May 2015
l conference talk at the Health Services Research Network Annual Conference, Nottingham, July 2015
l meeting with indicator experts at The King’s Fund, London, July 2015
l conference talk at the Society for Social Medicine Annual Scientific Meeting, Dublin, September 2015
l seminar presentation to the Partnership of Junior Health Analysts at the HSCIC, Leeds, September 2015
l seminar presentation to City University School of Health Sciences Seminar Series, October 2015
l conference talk at International Society for Pharmacoeconomics and Outcomes Research 18th Annual
European Congress, Milan, Italy, November 2015
l seminar presentation to the Centre for Health Economics Seminar Series, University of York,
November 2015.
The rest of this chapter describes the development of our three visualisation tools in turn.
Development of equity dashboards
Our basic design strategy was to review existing dashboard tools for presenting health equity indicators in the
form of a one-page summary, as used by leading health organisations in the UK and internationally, to design
our own tools by adapting an existing design that the research team felt would be helpful for our particular
purposes, and then progressively to revise our design in the light of feedback from members of our intended
audiences. Two lessons rapidly became clear following feedback from a range of professional stakeholders.
First, dashboards are more likely to be useful if they summarise all the key information on a single page.
Second, equity dashboards are more useful to decision-makers if they present information about averages
health-care performance alongside information about social inequality in health-care performance.
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The main dashboards that we considered were the Marmot indicators for local authorities in England, the
Yorkshire and Humber Public Health Observatory Health Inequalities Dashboards, the WHO Handbook on
Health Equity Monitoring and the AHRQ State Quality Dashboards. Of these, the research team concluded
that the style of the Marmot indicators was the most suitable for our purposes. The Yorkshire and Humber
Public Health Observatory style packed a lot of information into a small space using ‘sparklines’ and other
compact graphing formats. However, we felt this was too compact and complex for decision-makers as
opposed to analysts. The AHRQ style was the opposite extreme in being too simple for our purposes: a
large dial in the middle of the page summarising overall performance across multiple indicators. The WHO
and Marmot styles lay somewhere between these two extremes. However, the WHO style did not include
information about trends and levels on the same page, or any benchmarking information. By contrast,
the Marmot indicators included information on both current levels and trends, on both average and equity
performance, and a spine plot allowing comparisons between the local area and national or other equity
benchmarks. We therefore adopted the Marmot indicator style as the basis for our dashboard.
However, we made two major modifications to the dashboard design. First, in response to feedback from
decision-makers about readability, we de-cluttered the dashboard and made it easier to read. We reduced
the space taken up by explanatory notes which take up the entire top half of the page in the Marmot
indicators. To make more horizontal room, we created three-word summary titles for each of the indicators
rather than using long descriptors. We then put the explanatory notes and longer descriptors on a
separate one-page set of indicator notes to be read in conjunction with the dashboard. We also enlarged
the font size to 14 points, enlarged the spine plot and allowed larger margins around each cell in the
table. This was done to give particular consideration to those who struggle to read text and numbers that
are displayed in small font sizes or compact graphics.
Our second major design modification was to add traffic-light background colours to indicate good and
bad performance, and arrows to indicate whether or not performance is getting better (an upwards arrow)
or worse (a downwards arrow). This was suggested to us by a number of decision-making audiences as
being a helpful way quickly to orientate users towards the key findings. Arrows were suggested by the lay
members of our advisory group, as being helpful for people who are colour blind. We also received
feedback that an upward arrow will naturally be interpreted as ‘improving’ equity performance, even
though it implies that inequality is reducing. We experimented with a variety of colour schemes for the
traffic lights, but the feedback was that standard red, amber and green colours were easier to interpret
than other colour schemes.
Using our modified Marmot indicators dashboard style, we found that up to eight or nine indicators could
comfortably fit on a single page in landscape orientation. Two further important pieces of feedback from
the decision-makers we consulted are as follows. First, it is important to present information about
average performance alongside equity performance. For example, when presenting information about
socioeconomic inequality in preventable hospitalisation within a particular CCG, it is important also to
present information about the mean level of preventable hospitalisation in that CCG compared with the
England mean. This information helps to put the equity findings into context. For example, good equity
performance may be less impressive in a context of poor average performance; and deteriorating equity
performance may be less worrying in a context of improving average performance in which all social
groups are becoming better off. Furthermore, decision-makers want to know this information anyway, as
in reality average performance is often more important to them than equity performance. Second, it is
important to present at least one equity finding in ‘real’ units rather than rates or percentages, for example
numbers of GPs, hospitalisations and deaths. Non-specialists find it easier to understand real units than
rates or percentages. Furthermore, decision-makers deal in real units on an everyday basis, and so
presenting findings in real units helps them to understand both the scale of the equity problem and the
scale of the required policy response. We therefore developed an equity measure in real units, that we call
the inequity gap, as described in Chapter 4.
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We re-scaled proportions in ways that are (1) easy to read and understand but also (2) help to ensure a
degree of consistency across indicators. So, for indicators with proportions larger than 0.01, we re-scaled
in terms of percentages, whereas in other cases we used rates per 1000 population. We also carefully
considered the orientation for printing, in thinking about how the printed version would need flipping for
easy reading, and we piloted the notes pages with various audiences to ensure they were clear.
Development of equity chart packs
Feedback from the professional stakeholders we consulted emphasised the importance of clear
visualisation of detailed underling patterns, alongside summary indices in the dashboard. We therefore
developed a suite of four main graphs to provide in-depth information about the inequality patterns and
trends underpinning our dashboards. First, a matrix graph comprising a panel of line graphs presenting
basic descriptive statistics on the indicator by age, sex, deprivation group and year. Second, a scatterplot at
decile group level to show the basic cross-sectional shape of the social gradient in health care. Third, a
panel of line charts to show equity time trends. Fourth, a caterpillar plot to show equity performance
comparisons between local areas. All four types of graphs are presented in Chapter 6, and the second,
third and fourth types of graph are described in more detail in Chapter 4.
For presenting basic descriptive statistics and time trends, we followed the standard practice in the health
equity literature of presenting information on socioeconomic status using five quintile groups. This is
generally sufficient to capture the shape of the social gradient in health care, which is usually fairly linear,
although with some important exceptions for some indicators in some years, and does not vary much
within particular quintile groups. However, for showing the shape of the current social gradient we opted
for decile groups, as we found that for some health-care outcomes there were non-linear patterns that
only became apparent within the top and bottom quintile groups.
For the descriptive statistics, we designed a matrix plot comprised a panel of time series line charts by
age and deprivation group, with separate male and female lines on the line charts. This enabled us to
present all of this information on a single chart. When we presented this to analysts we received positive
feedback that this is a useful way of presenting a large amount of information in a small space, and that
information on age–sex breakdowns is important for decision-makers.
For the time trends, we used a panel of three line charts showing trends by deprivation quintile group on
top, and then trends in two inequality indicators underneath. We experimented with various ways of
distinguishing the five quintile group lines using different colours, line widths, line styles, line shades and
marker shapes. In the light of feedback from decision-makers and the lay members of our advisory group,
we decided (1) not to overcomplicate the graph with multiple ways of distinguishing the lines and
(2) to avoid use of colour in the chart packs, partly because of the risk of political overtones, partly because
people may be colour blind, and partly because some people may wish to print out the chart packs in
black and white. We then arrived at a fairly simple system based on different shades of grey and marker
shapes, although also a different line style for the three middle quintiles. This system focuses attention on
comparing the most and least deprived quintile groups, while allowing the reader to distinguish the middle
three lines on closer inspection.
For the equity performance charts, we opted for caterpillar plots rather than funnel plots. This was for two
reasons. First, there is evidence that clinicians, patients and members of the public generally find caterpillar
plots easier to understand.156–158 Second, funnel plots are most useful when there is a relationship between
volume (on the x-axis) and outcome (on the y-axis). It is reasonable to expect a volume–outcome
relationship in the case of outcomes, such as hospital surgical mortality. However, there is no reason to
expect a relationship between the size of a local area and the extent of inequality; and indeed we
observed no such relationship.
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When presenting the results to local decision-makers, a common theme was that they would like to see
scatterplots at neighbourhood level and practice level, (1) so that they can identify which neighbourhoods
and practices in their local area are performing well or badly, and (2) so they can get a clearer sense of the
(substantial) variation in performance that is not driven by socioeconomic status. However, we were unable
to share data of this kind because it may risk disclosing individual-level personal information in which there
are counts of events at the neighbourhood level of less than five. This is something that the NHS would
need to consider carefully when producing these indicators, that is how to provide local decision-makers
with the information they require about individual GP practices and small-area neighbourhoods, without
compromising data security. One partial solution, for example, may be to create anonymised local
scatterplots by censoring counts below five and/or by adding a ‘jitter’ to the scatterplot, whereby each dot
is given a small random perturbation.
Development of equity custom graphs
We reviewed the purpose-built web-based tools that various large international and national organisations
have created for allowing users to draw their own custom graphs, including The World Bank DataBank, the
OECD Data Lab, the WHO Equity Monitor, the US Institute for Health Metrics and Evaluation, and the Public
Health England public health profiles (http://fingertips.phe.org.uk; accessed 12 July 2015). We concluded
that it would not be possible to replicate these tools within our limited resources. Instead, we opted to use
the freely available chart development software provided by Google Charts (https://developers.google.com/
chart; accessed 12 July 2015), which is based on the ‘gap minder’ tool created by Hans Rosling for displaying
inequality trends over time (www.gapminder.org; accessed 12 July 2015).
We created a prototype Google Charts tool for our two primary care indicators: primary care supply and
primary care quality. We did not add information on the other indicators as the purpose of this work was
proof of concept rather than to create a fully comprehensive and up-to-date tool. Our prototype tool is
available at http://health-inequalities.blogspot.co.uk (accessed 12 July 2015). The indicators are provided
for the years 2004/5 to 2011/12 at the level of England and the four NHS regions, although we did not
publish indicators at lower levels because of risk that some of the information might be disclosive. The tool
includes a battery of equity measures at both quintile and decile group levels and a range of variables
including individual clinical performance indicators for different types of primary care as well as the
composite score. Feedback from analysts and decision-makers who viewed our graphs created in Google
Charts was uniformly positive, and people particularly liked the ability of this software to show how equity
patterns changed over time.
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Chapter 7 Prototype equity dashboards
This chapter shows example ‘equity dashboards’ for 2011/12. These dashboards are designed to providedecision-makers with concise summary information on all eight of our general indicators on a single
page. The dashboards provide information about overall NHS performance on the indicator, as well as
equity performance, and about the 1-year trend in performance since last year as well as current levels
of performance.
We present example dashboards (1) for England and (2) for one anonymous local CCG called ‘Any Town
CCG’ (Figures 61 and 62). In each case, we start by presenting the dashboard and indicator notes in
two pages in landscape format and then present notes on how to read the dashboard.
Notes on how to read the national dashboard
To understand the dashboard, it may be helpful to start by considering ‘preventable hospitalisation’,
which is a classic indicator of health-care outcome. All of the other indicators of health-care outcome
(indicators 4–8) can be interpreted in a similar way. The ‘Average’ columns show overall NHS performance
on this indicator. The current level is 5.84 preventable hospitalisations per 1000 population and there is
a downward trend since last year of –0.18. This downwards trend is coloured dark green meaning that
health outcomes are getting better and that this is a statistically significant finding. The ‘Equity’ columns
show equity performance on the SII. The current SII is 6.5, meaning that the most deprived neighbourhood
in England has 6.5 more preventable hospitalisations than the least deprived, allowing for the gradient in
between. The SII trend is –0.41, which means that the SII is lower this year than last year, that is, inequality
is getting less. This box is also coloured dark green, meaning that this is a statistically significant finding.
The overall equity trend arrow shows ‘not clear’, meaning that we cannot draw any clear conclusion about
whether overall equity is getting better or worse. Finally, the inequity gap shows that inequality in England
is associated with 171,119 preventable hospitalisations.
Now we turn to primary care supply, which is a classic indicator of health-care access. This has a similar
interpretation, although there are two important differences from all the other indicators: the current SII is
negative. At face value, this could be interpreted as suggesting that there is pro-poor inequality, that is
deprived neighbourhoods have more GP supply relative to need than affluent neighbourhoods. However,
we do not draw this conclusion because we believe that our need-adjustment underestimates need in
deprived neighbourhoods, as explained in Chapter 4 and in Appendix 4. So we report the inequity gap as
showing ‘no gap’ rather than a negative gap. All of the other columns can be interpreted in the same way
as usual, however. So the average level of performance is 1687 patients per GP, with a significant trend in
red of 13.0, showing that the number of patients per GP increased by 13.0 since last year. And the trend
is –8.94 and in yellow, showing that the change in SII since last year is not statistically significant. If this
change was statistically significant, we would interpret this as a beneficial reduction in pro-rich inequality,
rather than a harmful increase in pro-poor inequality, because we believe that need in deprived areas is
underestimated. However, assessments of need always rely on value judgements as well as empirical facts,
and so we present the current negative SII so that decision-makers can draw their own conclusions based
on their own value judgements about need.
Finally, we turn to primary care quality, which is different from all the other indicators in that it presents an
attainment measure (more is better) rather than a shortfall measure (more is worse). This only influences
the interpretation of average performance, however, as we have inverted the SII to ensure that a positive
value means pro-rich inequality as with the other indicators. So, average performance is 77.4%, and
the positive trend of 1.97 percentage points is coloured in dark green, an increase in quality means
that overall performance is getting better, unlike all the other indicators in which an increase means
overall performance is getting worse. The positive SII of 1.45 means that the most affluent neighbourhood
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has 1.45 percentage points more quality than the most deprived neighbourhood, allowing for the gradient
in between, and the non-significant trend of 0.06 coloured yellow means that that we cannot draw any
clear conclusion about the SII trend. Finally, the same applies to the overall equity trend arrow which
shows that the trend is ‘not clear’.
We now turn to the example local dashboard (Figures 63 and 64).
Notes on how to read the local equity dashboard
Let us start, as before, with preventable hospitalisation. The ‘Average’ column shows overall performance
for the CCG and England as a whole. This CCG has 5.89 hospitalisations per 1000, which is slightly higher
(worse) than the England average of 5.84. However, this is coloured yellow and so the difference is not
significant. The spine plot shows that preventable hospitalisation is not significantly different from the
England average; the confidence intervals overlap with the central spine representing the England average.
There is no overall equity trend. Finally, the inequity gap is 693, showing that socioeconomic inequality is
associated with 693 excess preventable hospitalisations in this CCG area.
Inequality measures
SII: this shows the gap between the 
most and least deprived 
neighbourhoods in England
A positive current SII implies ‘pro-rich’ 
inequality favouring less deprived areas
A positive SII trend implies the mean 
SII is larger (more unequal) than the mean SII
 in the year before that
A clear overall inequality trend requires a 
statistically significant trend in the same direction 
for both the SII and the RII which is the SII 
divided by the mean. The SII and RII can move 
in different directions when the mean is changing
Not clear means that RII and SII trends are not 
significant or they move in different directions
Indicator definitions
1. Primary care supply: patients per FTE GP,
    excluding registrars and retainersa,b
2. Primary care quality: clinical performance
    in the QOF (weighted by public health 
    impact)
3. Hospital waiting time: days from 
    outpatient decision-to-treat to inpatient
    admission-for-treatmentc
4. Preventable hospitalisation: proportion
    of people with an emergency admission
    for an ambulatory care sensitive 
    conditiona
5. Repeat hospitalisation: proportion of 
    inpatients with subsequent emergency 
    readmission the same yeara
6. Dying in hospital: proportion of deaths
    in hospital
7. Amenable mortality: proportion of 
    people dying from causes considered 
    amenable to health carea
8. Mortality: proportion of people dying 
    from any causea
FIGURE 62 National equity dashboard notes. a, Adjusted for age and sex each year; b, adjusted for neighbourhood
ill health in 2007; and c, adjusted for treating consultant specialty each year.
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Now turning to primary care supply, the ‘Average’ column shows that this CCG has significantly worse
supply than the England average: 1974 patients per GP compared with an England average of 1687. The
spine plot, however, shows that this CCG is doing significantly better than the England average on equity
in primary care supply; the point estimate is comfortably in the light-green zone to the left, and the
confidence intervals do not overlap the England average spine.
Finally, turning to primary care quality, this CCG has slightly but significantly worse primary care quality
than the England average: an average of 76.4% compared with 77.4%. Furthermore, this CCG is doing
significantly worse than the national average on equity in primary care quality; the point estimate is in the
dark green zone to the right, and the confidence interval does not overlap the England spine.
Inequality measures
The deprived population shows how many 
people in this CCG live in one of 
England's most deprived fifth of areas 
(with % of the CCG population in brackets)
Equity performance is the SII: 
the gap between the most and least 
deprived areas in England. 
A positive SII implies ‘pro-rich’ inequality
The black diamond shows this CCG's SII with 95% CI
The vertical black line shows the SII for England
A clear overall equity trend requires a 
statistically significant trend in the same 
direction for both the SII and the RII: 
the SII divided by the mean
The Inequity Gap shows the gap between this 
CCG and the England average, in terms 
of ‘real’ units of improvement needed within 
its deprived population (e.g. hiring 
more GPs, preventing more deaths).  
‘No gap’ means the deprived population 
in this CCG is already doing better 
than the England average
Indicator definitions
1. Primary care supply: patients 
    per FTE GP, excluding registrars and 
    retainersa,b
2. Primary care quality: clinical
    performance in the QOF (weighted by 
    public health impact)
3. Hospital waiting time: days from 
    outpatient decision-to-treat to inpatient
    admission-for-treatmentc
4. Preventable hospitalisation: proportion
    of people with an emergency admission
    for an ambulatory care sensitive 
    conditiona
5. Repeat hospitalisation: proportion of 
    inpatients with subsequent emergency 
    readmission the same yeara
6. Dying in hospital: proportion of deaths
    in hospital
7. Amenable mortality: proportion of 
    people dying from causes considered 
    amenable to health carea
8. Mortality: proportion of people dying 
    from any causea
England
WorstBest
CCG
(95% CI)
25th
percentile
75th
percentile
England
WorstBest
CCG
(95% CI)
25th
percentile
75th
percentile
FIGURE 64 The CCG equity dashboard 2011/12 local indicator notes. a, Adjusted for age and sex each year;
b, adjusted for neighbourhood ill health in 2007; and c, adjusted for treating consultant specialty each year.
CI, confidence interval.
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Chapter 8 Discussion
Summary of findings
In this study, we have developed health equity indicators to help the English NHS discharge its duty to
consider reducing inequalities in health-care access and outcomes. We have developed new methods for
local NHS equity monitoring against a national NHS equity benchmark. We have illustrated these methods
by applying them to CCGs in the year 2011/12, although they could also readily be applied to local
authorities or other geographical areas comprising more than 100,000 people. We have also developed a
framework for monitoring national NHS indicators of equity at all main stages of the patient pathway.
This framework goes beyond the existing inequalities breakdowns in the NHS Outcomes Framework by
including indicators of access as well as outcomes. By producing these indicators from 2001/2 to 2011/12,
we have provided the first comprehensive assessment of health-care equity trends during a key period of
sustained effort by the NHS to reduce health inequalities through primary care strengthening. Finally, and
importantly, we have developed a suite of visualisation tools for communicating equity indicator findings to
national and local decision-makers, including equity dashboards providing a one-page summary of both
overall and equity performance on multiple indicators, and equity chart packs providing more detailed
information. Clear communication is essential in this controversial area, as inequality is a complex concept
and so headline statistics are even more liable than usual to be misleading when taken out of context.
Our equity indicators and visualisation tools were selected and designed in consultation with a range of
expert stakeholders, including NHS and public health officials at national and local levels and health
indicator experts from a variety of disciplinary backgrounds. We also consulted members of the public,
because one of the main purposes of our indicators is public reporting for democratic accountability,
as well as facilitating quality improvement efforts by national and local decision-makers. Members of the
public were involved through a public consultation exercise in York, based on an online survey and a
1-day citizens’ panel meeting, and the two lay members of our advisory group.
The main findings are summarised below under three headings:
1. national equity findings in 2011/12
2. national trends during the 2000s
3. local equity findings in 2011/12.
National equity findings in 2011/12
Our study presents the first comprehensive national picture of inequality in health-care access and
outcomes in the NHS. Our findings for 2011/12 are summarised below, and a one-page tabular summary
is also provided in Chapter 7 the form of a prototype national NHS equity dashboard.
l There was no evidence of pro-rich inequality in primary care supply. Deprived neighbourhoods had
slightly more GPs relative to measured need than less deprived neighbourhoods. However, the Carr-Hill
formula may underestimate need in deprived areas, so there may still be some pro-rich inequality that
we are unable to measure until more accurate and up-to-date measures of need for GP supply
become available.
l There was a small amount of pro-rich inequality in primary care quality, with an estimated gap of
1.45 percentage points (95% confidence interval 1.37 to 1.53 percentage points) in population
achievement of primary care quality between the most and least deprived neighbourhoods in England.
l There was a small amount of pro-rich inequality in overall inpatient hospital waiting time, with an
estimated gap of 2.29 days waiting (95% confidence interval 1.95 to 2.62 days waiting) between the
most and least deprived neighbourhoods in England.
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l There was substantial pro-rich inequality in preventable emergency hospitalisation, with an estimated
gap of 6.50 hospitalisations per 1000 (95% confidence interval 6.40 to 6.59 hospitalisations per 1000)
between the most and least deprived neighbourhoods in England. This implies a relative inequality
gap of 111% of the national average hospitalisation rate, and that deprivation was associated
with an inequity gap of 171,119 excess preventable hospitalisations in England (95% confidence
interval 168,574 to 173,663 hospitalisations).
l There was substantial pro-rich inequality in repeat emergency hospitalisation, with an estimated gap of
6.97 percentage points of people hospitalised (95% confidence interval 6.85 to 7.09 percentage points
of people hospitalised) between the most and least deprived neighbourhood in England. This implies a
relative inequality gap of 48% of the national average hospitalisation rate, and that deprivation was
associated with an inequity gap of 289,140 excess repeat hospitalisations in England (95% confidence
interval 284,192 to 294,089 repeat hospitalisations).
l There was substantial pro-rich inequality in dying in hospital, with an estimated gap of 5.95 percentage
points of people dying in hospital (95% confidence interval 5.26 to 6.63 percentage points) between
the most and least deprived neighbourhoods in England. This implies a relative inequality gap of 14%
of the national average hospitalisation rate, and that deprivation was associated with an inequity gap
of 13,593 people in England dying in hospital rather than other settings (95% confidence interval
12,023 to 15,162 people).
l There was substantial pro-rich inequality in mortality amenable to health care, with an estimated gap
of 1.56 amenable deaths per 1000 (95% confidence interval 1.50 to 1.62 amenable deaths) between
the most and least deprived neighbourhoods in England. This implies a relative inequality gap of 61%
of the national average amenable mortality rate, and that deprivation was associated with an inequity
gap of 41,123 excess amenable deaths in England (95% confidence interval 39,624 to 42,622
amenable deaths).
l There was substantial pro-rich inequality in overall mortality, with an estimated gap of 5.17 deaths
per 1000 (95% confidence interval 5.03 to 5.31 deaths) between the most and least deprived
neighbourhoods in England. This implies a relative inequality gap of 60% of the national average
mortality rate, and that deprivation was associated with an inequity gap of 135,996 excess deaths in
England (95% confidence interval 132,302 to 139,691 deaths).
The observed inequalities in preventable hospitalisation, repeat hospitalisation and mortality amenable to
health care are large. However, as discussed in Chapter 1, this is partly because we were unable to adjust
these health-care outcomes for neighbourhood-level morbidity and other risk factors outside the control
of the NHS. Our figures for inequality in health-care outcomes thus overestimate the extent of pro-rich
inequity for which the NHS can be held accountable. Although the NHS can be held responsible for
reducing inequalities in these outcomes, it cannot be held responsible for completely eliminating them.
However, our health-care outcome figures are adjusted for age and sex. Age and sex are both observable
risk factors largely outside NHS control. The social patterning of births, deaths and migration may partly be
driven by NHS factors, for example if NHS actions help to reduce circulatory death rates more rapidly in
more deprived populations. However, we believe that the age- and sex-adjusted figures are more useful
for NHS purposes than the unadjusted figures, as changes in demographic structure are mainly driven by
non-NHS factors. This point is also relevant below when we consider national trends during the 2000s.
As explained below, we focus on the age- and sex-adjusted trends, in order to hold the NHS to account
for changes as a result of NHS action rather than changes attributable to demographic trends outside
NHS control.
National trends during the 2000s
Below we provide a brief summary of the national trends in all the age- and sex-adjusted indicators
that were presented in detail in Chapter 5, including trends in both average performance and
equity performance.
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Average trends
During the 2000s, health-care access and outcomes improved for all socioeconomic groups on all
indicators except repeat hospitalisation (as explained below). The indicator series for primary care supply
and quality (indicators 1 and 2) started in 2004/5 and continued until 2011/12. Average levels of primary
care supply improved from 2004/5 until 2006/7 and remained stable thereafter. Average levels of
population achieved primary care quality continued rising throughout the period, although there were
breaks in the data series in several years because of changes in data availability on exception reporting and
indicator definitions (as explained in Chapter 5 and Appendix 4). All other indicator series started in 2001/2
and continued until 2011/12. For waiting time (indicator 3), preventable hospitalisation (indicator 4) and
overall mortality (indicator 8) the improvements began after 2003/4, following slight deteriorations the
previous 2 years. Waiting times fell dramatically until 2008/9, but rose slightly thereafter. Preventable
hospitalisation and overall mortality continued falling to the last observed year, 2011/12, although the
decline in overall mortality slowed in the 2 years after 2009/10. For dying in hospital (indicator 6), average
improvements began from 2005/6 and continued throughout the period to 2011/12. For amenable
mortality (indicator 7), the improvements began from 2001/2 and continued throughout the period to
2011/12. However, the pace of improvement picked up from 2003/4 onwards for the most deprived
two-fifths of neighbourhoods.
In a striking exception to the general trend of improving outcomes, however, repeat hospitalisation
(indicator 5) gradually increased in all socioeconomic groups from 2001/2 to the end of the period in
2011/12. This may partly reflect an increase in premature discharges from hospital, as hospitals reduced
length of stay in the 2000s in response to financial incentives and waiting time targets.159 It may also
reflect hospital payment reforms that gave hospitals financial incentives to increase emergency admissions.
In addition, especially towards the end of the 2000s, it may reflect reductions in social care supply and
quality as a result of financial pressures on local authorities. However, it is possible that this also reflects
(1) increased morbidity in patients admitted for emergency inpatient treatment, as a result of people
surviving longer with multiple chronic conditions, causing an increase in post-hospital adverse events; and
(2) reduced post-hospital mortality, causing an increase in the proportion of post-hospital adverse events
leading to readmission rather than death. Therefore, the increase in average levels of repeat hospitalisation
may partly be a consequence of success in reducing mortality, rather than a signal of failure to improve the
quality of co-ordinated primary, secondary and social care after emergency hospital admission.
Equity trends
For four of the eight indicators (primary care supply and quality, preventable hospitalisation and amenable
mortality), there were significant and sustained reductions in absolute socioeconomic inequalities.
This began after 2003/4 for indicators 4 and 7 and was observed from the start of the series in 2004/5 for
indicators 1 and 2. For primary care supply and quality, socioeconomic inequalities decreased substantially in
both absolute and relative terms, and measurable inequality was virtually eliminated by 2010/11. Absolute
inequality in preventable hospitalisation and amenable mortality rose from 2001/2 to 2003/4, but then
gradually fell thereafter all the way to 2011/12. This was a smooth fall for amenable mortality, but there was
some year-on-year volatility around the underlying trend for preventable hospitalisation. However, for both
preventable hospitalisation and amenable mortality, the reduction in absolute inequality did not translate
into a reduction in relative inequality as a proportion of the mean, because the mean was also falling.
The unadjusted trends in preventable hospitalisation and amenable mortality prior to adjustment for age and
sex showed a larger reduction in absolute inequality, sufficiently large to translate into a reduction in relative
inequality. However, as noted in Chapter 5, this difference is because of demographic change during the
2000s: affluent areas experienced population ageing, whereas deprived areas experienced an influx of
younger people. We therefore prefer the age- and sex-adjusted figures, on the basis that demographic shifts
are largely exogenous factors beyond the control of the NHS. However, a counterargument is that it is
possible NHS activities may have had some small influence on these demographic patterns by influencing
socioeconomic trends in births, deaths and migration. So we present both sets of figures, adjusted and
unadjusted, so that readers can draw their own conclusions.
DOI: 10.3310/hsdr04260 HEALTH SERVICES AND DELIVERY RESEARCH 2016 VOL. 4 NO. 26
© Queen’s Printer and Controller of HMSO 2016. This work was produced by Cookson et al. under the terms of a commissioning contract issued by the Secretary of State for
Health. This issue may be freely reproduced for the purposes of private research and study and extracts (or indeed, the full report) may be included in professional journals
provided that suitable acknowledgement is made and the reproduction is not associated with any form of advertising. Applications for commercial reproduction should be
addressed to: NIHR Journals Library, National Institute for Health Research, Evaluation, Trials and Studies Coordinating Centre, Alpha House, University of Southampton Science
Park, Southampton SO16 7NS, UK.
125
Hospital waiting time showed a slightly pro-poor pattern for most of the period, with a negative slope
index in 2001/2 that fell even further to 2003/4 but rose thereafter and ultimately became slightly pro-rich
in 2011/12. In 2003/4, at its most pro-poor point, the slope index fell to –5 days, indicating that people in
the most deprived neighbourhood were waiting on average up to 5 days less than people in the least
deprived neighbourhood. There was no reduction in either absolute or relative inequality in dying in
hospital, despite the reduction in average levels from 2005/6 onwards. For repeat hospitalisation, both
absolute and relative inequality steadily increased from 2001/2 to 2011/12. Finally, for overall mortality,
there was no sustained pattern of decline in the absolute inequality gap from 2003/4, in contrast to
amenable mortality. Rather, there were statistically significant one-off changes from 2005/6 to 2006/7 (an
increase) and between 2008/9 and 2009/10 (a reduction). In terms of relative inequality, however, overall
mortality showed a sustained increase from 2001/2 to 2006/7 which stabilised thereafter, which is a similar
pattern to amenable mortality.
Local equity findings in 2011/12
In 2011/12, it was possible to detect well over 20% of CCGs performing either significantly better or
significantly worse on equity than the national benchmark, including at least 10% in each category, using
annual data for the following five general indicators: (1) primary care supply, (2) primary care quality,
(3) hospital waiting time, (4) preventable hospitalisation and (5) repeat hospitalisation. This was not
possible for the remaining three indicators. For indicator 6, dying in hospital, only 8% of CCGs were
significantly different from average: 3% worse and 5% better. For indicator 7, amenable mortality, 11%
were significantly different from average: 8% worse and 3% better. Finally, for indicator 8, overall
mortality, 17% were significantly different from the national average, but most of these were significantly
worse: only 3% were significantly better. Pooling additional years of data did not improve substantially the
ability to detect significant differences.
Strengths and weaknesses of the study
Strengths
We selected our health equity indicators and visualisation tools in consultation with members of the public,
NHS and public health officials, and health equity experts from a range of disciplines. We measured inequality
at multiple stages of the patient pathway, including inequality in both health-care access and health-care
outcomes. We constructed comprehensive indicators spanning the entire range of activities of the health-care
system, as well as condition-specific indicators that only provide information about inequality in one particular
disease area. We developed the first methods for local equity monitoring against a national equity benchmark,
and we provided the first comprehensive assessment of national trends in socioeconomic inequality in health
care and outcomes during the 2000s. We also developed a comprehensive new suite of visualisation tools for
communicating health equity findings to decision-makers. Our equity indicator methods and visualisation tools
are flexible, allowing different indicators to be incorporated and monitoring to be performed at different
geographical levels that may be more appropriate for addressing particular aspects of variation in health-care
access and outcomes.160 Our approach is also generalisable beyond the English NHS, as it can be applied to
other countries, with well-developed administrative health data sets and our methods for monitoring local equity
against a national benchmark can in principle be applied to other public services. With the exception of hospital
waiting time and repeat hospitalisation, we used standard, well-validated indicators that are already used for
monitoring overall health-care performance in England and other high-income countries. We used data on the
entire population of England, including workload and quality data on all primary care practices in England and
outcomes data on all individuals in England. We structured these data in a consistent, longitudinal format that
permits inequality comparisons over time and between indicators. We used inequality measures based on the
entire socioeconomic gradient across all 32,482 small areas of England, rather than gaps or ratios between two
arbitrarily selected parts of the distribution such as the top and bottom fifth. We examined inequality in both
absolute and relative terms, because absolute and relative inequality can change in opposite directions when the
mean is changing over time.161 One of our measures, the RII, can also be compared between indicators
measured on different scales to help assess the relative magnitude of different kinds of inequality.
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Weaknesses
Our study does not include data on privately funded health care, which accounts for just over 15%
of total health expenditure in the UK.162 We also lack detailed national data on changing patterns of
multimorbidity at the small-area level, and how multiple morbidity and disadvantage combine to generate
additional health-care needs.163 One consequence is that our study may underestimate additional needs
for primary care in deprived neighbourhoods, which are likely to suffer from a greater burden of
multimorbidity.164 Another consequence is that, like all previous studies, we cannot disentangle how far
observed national trends in preventable hospitalisation and amenable mortality are a result of national
trends in multimorbidity outside the control of the NHS. We therefore recommend the development of
small-area-level measures of multimorbidity as a research priority for the NHS, to enable more informative
monitoring of health-care outcomes and more accurate targeting of health-care resources to meet
health-care needs. Another limitation is that the administrative health data sets we use do not contain
information on individual socioeconomic characteristics. We therefore used the IMD, a well-established
method of assigning socioeconomic characteristics based on neighbourhood of residence. This method
rests on the assumption that individuals conform to the socioeconomic profile of their residential
neighbourhood, which is of course not always the case. However, the small areas we use are relatively
small and homogeneous in size, around 1500 people each with a minimum of around 1000 and maximum
of around 3000, and so our measurements are more accurate than those possible using the postcode
geographies available in some other countries. In general, use of larger geographical areas tends to find
shallower socioeconomic gradients in health and health care, as population average differences in income
and social advantage are diluted by the use of larger and more socioeconomically heterogeneous
populations. Finally, our measure of primary care quality is based on indicators drawn from the UK primary
care pay-for-performance scheme, which captures only a limited part of clinical practice.165 Under this
scheme, improvements in quality were most rapid in practices with low baseline performance, and these
practices were concentrated in more deprived areas.166 It is possible that aspects of primary care quality
that were not financially incentivised and monitored did not follow the same pattern, and inequalities in
these may have persisted or even widened. Another limitation is the flip side of one of the strengths of our
study, which is our use of general indicators that span the entire range of health-care activity and thereby
paint an overall picture of NHS equity performance. A limitation of indicators of this kind, of course, is that
they cover a heterogeneous range of activities and so may mask differential patterns between different
specialties and disease areas. A final weakness is that we were unable to control for small-area-level
variations in the supply and quality of social care. At least two of our health-care outcome indicators are
likely to be sensitive to social care supply and quality outside the control of the NHS, as well as the quality
of co-ordinated care for which health-care staff are partly responsible. Unfortunately, data on social care
supply and quality are not currently available at the small-area level, in striking contrast to the detailed
neighbourhood statistics available for health care and other public services.
Comparison with other studies
Primary care supply
Two previous national studies have examined variation in primary care supply between large administrative
areas of England. Gravelle and Sutton73 found substantial and persistent between-area variation in
physician supply between 1975 and 1995. Goddard et al.74 extended this time series by adding the years
1996 to 2006 and found that variation between administrative areas increased between 1995 and 2006.
Our results agree with these previous studies showing large and widening pro-rich inequalities up until
2006/7, after which we see this trend reverse with inequalities narrowing over the remainder of our study
period, by the end of which we observe pro-poor inequality in need-adjusted primary care supply. Whereas
the previous studies examined overall variation between large and socioeconomically diverse administrative
areas, our study adds value by looking specifically at socioeconomic-related inequality between small areas.
We are able accurately to attribute GP supply to small areas, based on the location of patients registered
to each GP practice, and so can paint a much finer-grained picture of the socioeconomic distribution of
the primary care workforce than has previously been possible.
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Primary care quality
One previous national study examined trends in socioeconomic inequality in primary care process quality
from the UK pay-for-performance programme.166 This study only covers the first 3 years of our 8-year study
period (2004/5 to 2006/7), but agrees with our findings of reductions in socioeconomic inequality. We find
that this reduction in inequality continued but slowed down thereafter and levelled off from 2010/11 to
2011/12.
Waiting time
Most previous studies of inequality in waiting time have used disease-specific indicators focusing on
particular specialties or procedures, rather than general indicators covering the whole range of hospital
activity which are then adjusted for disease-specific differences in waiting times. To our knowledge, the
only other previous study using a general indicator was a cross-sectional study using individual-level data
on men aged ≥ 67 years from Norway in 2004/5, which found very little evidence of socioeconomic
differences in waiting time after adjusting for all primary and secondary diagnoses, severity and hospital
supply.167 By contrast, previous disease-specific studies have generally found pro-rich inequality in waiting
time for publicly funded inpatient hospital treatment in a range of high-income countries with universal
health systems.168,169 Previous disease-specific studies have also found a trend of reducing socioeconomic
inequality in the English NHS during the 2000s, for a handful of common non-emergency hospital
procedures such as hip replacement, knee replacement cataract, heart bypass and coronary
angioplasty.169,170 Our findings using a general waiting time indicator are thus diametrically opposed to
previous findings using disease-specific waiting time indicators. Our indicator did adjust for differences in
waiting times between specialties, although not for within-specialty differences between procedures or
disease categories. The disease-specific studies are more reliable, as they focus cleanly on a fairly
homogeneous procedure and some of them also include controls for waiting time prioritisation by severity
(the number and type of diagnoses) and for cross-sectional differences in hospital supply (hospital fixed
effects). However, the disease-specific studies are more vulnerable to selection bias because they have only
examined a selected handful of specific hospital procedures which may not be representative of waiting
time differentials across all areas of hospital activity. Both types of study are also subject to selection bias
relating to the decision to seek privately funded care, which is partly motivated by the desire to gain a
shorter waiting time than publicly funded NHS care.
Preventable hospitalisation
One previous national study examined socioeconomic inequality in preventable hospitalisation in England
covering years 2001/2 to 2012/13.171 This study found similar trends to those we observe, showing a
gradual decrease in the rate of chronic ambulatory care-sensitive emergency admissions for the average
patient and substantial and persistent socioeconomic inequalities in ambulatory care-sensitive emergency
admissions over the period.
Repeat hospitalisation
To our knowledge, no previous study has examined socioeconomic inequality in repeat emergency
hospitalisation within the same year, or time trends therein. However, many disease-specific studies of
30-day emergency readmission rates have used socioeconomic status as a control variable in regressions
performed for purposes other than measuring socioeconomic inequality. These studies have consistently
found substantial and significant cross-sectional associations between socioeconomic status and 30-day
emergency readmission following both emergency and non-emergency hospitalisation.172,173 The selection
of an appropriate duration for this indicator illustrates a tension between capturing the quality of
co-ordinated care across different primary and acute care providers over a long time period, versus
pinpointing precisely at which point on the patient pathway inequality arises, that is which primary or
acute service provider is responsible for generating inequality at what point in time.
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Dying in hospital
Previous cross-sectional studies have found socioeconomic inequalities in dying in hospital, and interpreted
this as an indicator of differences in the quality of end-of-life care.174 To our knowledge, however, no
previous study has examined trends in these socioeconomic inequalities over time.
Amenable mortality
One previous national study examined socioeconomic trends in amenable mortality175 in England from
2001/2 to 2011/12. However, this study was conducted at a large-area level (324 local authorities), which
may potentially mask changing patterns of inequality within these large areas, and it excluded mortality in
people aged > 75 years. This study found both average levels and absolute measures of inequality in
amenable mortality to have fallen over this period. Our finer-grained analysis looking at much smaller areas
(32,482 LSOAs) and including amenable mortality in those > 75 years of age confirms this basic pattern,
but reveals a widening of relative inequality that was not apparent in the previous study. Furthermore, our
inclusion of this older section of the population results in a higher overall rate of amenable mortality and
the more detailed level of analysis we employ reveals wider socioeconomic inequalities.
Overall mortality
Numerous studies have found socioeconomic inequality in overall mortality and life expectancy in low-,
middle- and high-income countries.36,106,176 Previous studies have found reductions in absolute socioeconomic
inequality in overall mortality in England in the 2000s177 and reductions in both absolute and relative
inequality in life expectancy.178 This is all in line with our findings. The reason that relative inequality in life
expectancy and mortality moved in different directions during the 2000s is that the means of these two
variables were moving in different directions. Mortality is a shortfall measure (more is worse) which is falling
over time, whereas life expectancy is an attainment measure (more is better) which is rising over time.179
Implications for clinicians, policy-makers and managers
The 2000s was a period of sustained large-scale expenditure growth in the English NHS,180 during which
tackling health inequality was a high priority for the NHS.38,106,181 As has been documented in previous
studies, this decade saw substantial increases in overall NHS capacity and utilisation, and the average
patient experienced significant improvements in health-care access, quality and outcomes.182 Our study
shows that the NHS also succeeded in achieving substantial reductions in inequality in primary care supply
and quality from 2004/5 to 2011/12. By 2010/11, measured pro-rich inequity in primary care supply
relative to need had been eliminated and measured pro-rich inequity in primary care quality had been
nearly eliminated. Plausibly, these changes can partly be attributed to the substantial investments in
primary care in the mid to late 2000s, including the pay-for-performance programme from 2004/5 and the
additional funding for new GP practices in ‘under-doctored’ areas of the country in the form of the
Equitable Access to Primary Medical Care programme announced in 2006.166,183 However, these two
measures are imperfect and so we cannot conclude there is no remaining important pro-rich inequality in
primary care supply and quality. There may remain a degree of pro-rich inequity in primary care supply,
because the Carr-Hill formula only allows for morbidity but does not examine how multiple morbidity and
disadvantage combine to generate additional health-care needs. So, the Carr-Hill formula is likely to
underestimate need in deprived neighbourhoods. There may also remain a degree of pro-rich inequality in
primary care quality because QOF indicators do not capture all-important aspects of primary care quality.
The NHS also succeeded in making small reductions in absolute socioeconomic inequalities in health-care
outcomes from 2003/4 to 2011/12. Absolute inequalities in preventable hospitalisation and amenable
mortality decreased from 2003/4 to 2011/12, and the rate of increase in relative inequalities slowed from
the mid-2000s, but substantial inequalities remained in 2011/12.
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Although small, the observed reductions in absolute inequality in health-care outcomes during the 2000s
are real and impressive for two reasons. First, there is some evidence of widening socioeconomic
inequalities during the 2000s in the clustering of smoking, poor diet, physical inactivity and other
unhealthy behaviours among lower socioeconomic groups.62 This would have made it more difficult to
reduce absolute inequality in both preventable hospitalisation and amenable mortality. Second, there were
no comparable reductions in absolute socioeconomic inequality in non-amenable mortality during the
period. This makes it plausible to attribute the reductions to the sustained improvements in health-care
access and quality that occurred in the 2000s, rather than to wider trends in the social determinants of
health outside the control of health-care services. It is hard to be certain about the causality, however,
given that this is an observational study without a control group. Furthermore, there is uncertainty about
how long it takes for improvements in health-care delivery to feed through into reductions in preventable
hospitalisation and amenable mortality. It is reasonable to expect some short-term impact within a year or
two,80 although the length of lag is likely to vary by disease and type of intervention; for example,
reductions in mortality because of improved management of heart disease and diabetes may be more
rapid than reductions as a result of earlier diagnosis and referral for suspected cancer.
It may not be surprising that the reductions in absolute inequality in health-care outcomes were small,
given what is already known about the social determinants of health and the role of health care as just
one input into the production of health.7,9,10,36 Socioeconomic inequalities in health-care outcomes result
not only from inequalities of access to health care, but also from socioeconomic-related differences in
morbidity, patient self-care and lifestyle behaviour, home and work environments, social care and other
public services that impact on health.8
Therefore, our study provides further confirmation that reducing inequality in health-care outcomes is more
complex and challenging than reducing inequality of access to health care.184 Further reductions in
socioeconomic inequalities in health-care outcomes are likely to require complex interventions to improve
the co-ordination of care between specialties, between primary and acute care settings, and between
health-care and social-care providers. There is a growing body of evidence about effective interventions to
reduce preventable hospitalisation and amenable mortality.171,184–187 Effective interventions may tend to
reduce inequalities, if they disproportionately benefit ‘high-need service users’ in the more deprived end of
the socioeconomic spectrum who are most in need of co-ordinated care. On the other hand, effective
interventions may increase inequalities if they rely heavily on changing people’s self-care and lifestyle
behaviour and if individuals in deprived neighbourhoods are less likely to change their behaviour.188
Unfortunately, however, evidence about the impacts of interventions on socioeconomic health-care
outcomes is limited. Therefore, further research is needed including rigorous evaluation of interventions
designed to improve the co-ordination of care between primary care, secondary care and social care
providers. The indicators developed in this study can be used to facilitate evaluations of this kind, and to
help develop the evidence base for reducing inequalities in health-care outcomes through equity
monitoring and quality improvement work at local, national and international levels.
Our local equity indicators and dashboards also have potentially important implications for managers,
including health-care commissioners, the managers of hospital, primary and community health services,
and also the managers of social services and other local government services with impacts on health
outcomes. Managers do not yet know which areas of England are performing well or badly on tackling
inequalities in health-care access and outcomes, or which areas are showing sustained signs of
improvement or deterioration on equity. For example, managers in Liverpool currently do not know
whether they are doing better, worse or about the same as managers in Manchester at tackling
inequalities in health-care access and outcomes, or whether their equity performance relative to the
national average has been improving or deteriorating in recent years. Producing our local equity indicators
and dashboards on a routine basis could provide this information, and allow researchers and managers to
start finding out why some areas are performing better than others on equity, and why some areas are
improving and deteriorating faster than others. This information could also help managers to find out
which deprived neighbourhoods within their own local areas are suffering the worst health-care outcomes
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and why. This is important for hospital managers, as well as commissioners, primary care and public health
managers, as avoidable accident and emergency admissions are nearly two and a half times higher in the
most deprived fifth of neighbourhoods than the least deprived fifth. Hospital managers have a direct
interest and an important role to play in helping to reduce avoidable hospitalisation, through more
proactive identification and follow-up of patients at risk of repeated emergency admission, many of whom
will live in deprived neighbourhoods. Officials from NHS England and within CCGs have expressed an
interest in our equity indicators, as described in the letters of support at Appendix 7, and national
inequalities breakdowns are already starting to be included in the NHS Outcomes Framework. At the time
of writing, however, no announcement had been made about whether or not, or when, the NHS would
commence production of any local health-care equity indicators.
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Chapter 9 Conclusion and research recommendations
Main conclusions
We draw together our main conclusions below in this section, before turning to technical conclusions and
recommendations for further research in the next two sections. The overall research question of our study
was: ‘Can changes in the socioeconomic patterning of health-care utilisation and outcomes provide useful
indicators of change in NHS equity performance?’ Our overall conclusion is ‘yes’. We elaborate below,
with the following more specific conclusions:
l NHS actions can have measurable impacts on socioeconomic inequality in both health-care access and
health-care outcomes.
l Increasing the number of primary care physicians and paying them for the quality of care they provide
has been associated with small impacts on reducing inequality in health-care outcomes, although the
causal link between primary care inputs and health-care outcomes has not been established in
this study.
l Local NHS equity monitoring against a national NHS equity benchmark can produce useful findings
both to help managers improve quality and to enhance democratic accountability.
l Currently, the most useful indicators for local NHS equity monitoring are primary care supply, primary
care quality and preventable hospitalisation.
l National NHS monitoring of change over time in NHS equity can usefully be done using a much wider
range of indicators of health-care access and outcomes, including disease-specific indicators.
l Equity indicators are more useful to decision-makers if they are presented together on the same page,
alongside average performance indicators, and accompanied by graphs showing the underlying
inequality patterns.
l Variants on our equity indicators could be used for international comparisons of equity in health care
and for evaluating the impacts of interventions on equity in health care.
NHS actions can have measurable impacts on socioeconomic inequality in both
health-care access and health-care outcomes
Prior to this study, there was good evidence that the introduction of universal health care, and, in particular,
universal primary care, can help to reduce socioeconomic inequality in both health-care access and
outcomes.10,11 However, it was less clear whether or not further actions taken by a universal health system,
such as the NHS, can have a further measurable impact on either increasing or reducing socioeconomic
inequality in health-care access and outcomes.39,189–191 Our study shows that by strengthening its primary
care system in the 2000s, the NHS achieved substantial reductions in socioeconomic inequality in health-care
access (in terms of primary care physician supply and quality of care provided by these physicians as
measured by QOF) along with real, although modest, reductions in absolute inequality in health-care
outcomes (in terms of preventable hospitalisation and amenable mortality).
Increasing the number of primary care physicians and paying them for the quality of
care they provide has been associated with small impacts on reducing inequality
in health-care outcomes, although the causal link between primary care inputs and
health-care outcomes has not been established in this study
Along with the substantial reductions in socioeconomic inequality of access to primary care physicians
between 2004 and 2011, we also found small reductions in absolute inequality in preventable
hospitalisation and amenable mortality, and a slowdown in the increase in relative inequality. However,
substantial socioeconomic inequalities in health-care outcomes persist, despite the investments in health
care made in the 2000s. This partly reflects socioeconomic inequalities in morbidity and multimorbidity that
are beyond the control of the NHS. Although we risk-adjusted our health-care outcomes for age and sex,
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we were unable to also adjust for morbidity because of lack of comprehensive individual-level data on age
and morbidity covering all individuals in England. However, inequalities in health-care outcomes also reflect
socioeconomic differences in patient and provider behaviour, informal social support, and the use of
formal social care and public services. There is evidence that improved co-ordination of financing, planning
and delivery between different services, for instance, between primary, secondary and community care
providers, between specialties, and between health and non-health services, can help to reduce average
levels of preventable hospitalisation and amenable mortality.185,186 Although there is limited evidence about
health equity impacts, and the impacts may go in either direction, it is plausible that some forms of
improved care co-ordination, perhaps especially those that do not rely too heavily on patient behaviour
change, may deliver larger absolute reductions in more deprived neighbourhoods with higher rates of
preventable hospitalisation and mortality. Furthermore, some behaviour change interventions can have
small but important effects. The NHS can influence both provider and patient behaviour in various ways,
including behavioural public policies or ‘nudges’,192 such as effective ways of reminding people about
appointments and encouraging them to take up preventative care; workforce training for service providers
on how to deal with people who have different styles of communicating; and changes in the location and
timing of service provision.193 However, evidence about the inequality impacts of interventions is limited
and further research is needed.
Local NHS equity monitoring against a national NHS equity benchmark can produce
useful findings both to help managers improve quality and to enhance
democratic accountability
Local equity monitoring is capable of detecting areas that are performing significantly better or worse than
the national average at any geographical level containing populations greater than around 100,000
people, including CCGs, local authorities and accountable care organisations. In principle, local equity
monitoring can be done using all five of the following general health-care equity indicators: (1) primary
care supply, (2) primary care quality, (3) hospital waiting time, (4) preventable hospitalisation and (5) repeat
hospitalisation. All of these indicators, or variants based on the same underlying data sources, could be
produced annually, based on data collected during the financial year, and updated within 6 months of the
end of the financial year. The following general indicators are less useful for local NHS equity monitoring
purposes: (6) dying in hospital, (7) amenable mortality and (8) overall mortality. This is mainly because
these indicators are less able to robustly identify local areas performing significantly better and worse than
the national average, but also because they require use of ONS mortality data and so would suffer from
data lags of around 15 months.
Currently, the most useful indicators for local NHS equity monitoring are primary
care supply, primary care quality and preventable hospitalisation
Indicator production and communication is costly, both in terms of money and scarce analytical capacity,
and so the NHS will need to set priorities for indicator production. We recommend three of our indicators
as a high priority for local NHS monitoring against a national NHS benchmark: (1) primary care supply,
(2) primary care quality and (4) preventable hospitalisation. We recommend all three of these indicators
because (1) they all capture important, but distinct, general elements of health-care access and outcomes;
(2) NHS policy-makers and managers have a reasonable understanding of what actions they can take to
shift these indicators; and (3) they are all based on well-validated technical indicator definitions. Hospital
waiting time and repeat hospitalisation also meet these first two criteria, and our public consultation
exercise established that socioeconomic inequality in waiting time was of particular concern to members of
the public. However, these indicators are less well validated than the others and so we recommend further
work to validate and refine these two indicators before using them for routine monitoring purposes.
National NHS monitoring of change over time in NHS equity can usefully be done
using a much wider range of indicators of health-care access and outcomes,
including disease-specific indicators
National monitoring of change over time in health-care equity can be performed using all of the indicators
we have developed, including the eight general indicators described in the main report and the six
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disease-specific indicators for CHD and diabetes described in Appendices 1 and 2. Further general and
disease-specific indicators can also be constructed for national monitoring, including indicators in the NHS
Outcomes Framework. However, most of these indicators cannot be used for local equity monitoring
because small numbers of events at the local level mean that performance in almost all local areas is
statistically indistinguishable from the national average.
Indicators of equity are more useful to decision-makers if they are presented
together on the same page, alongside information about average NHS
performance, and accompanied by graphs showing the underlying
inequality patterns
During our extensive piloting work with NHS and public health officials at national and local levels,
and the equity experts on our advisory group, we learned three main lessons about effective ways of
communicating health equity indicators to decision-makers. First, that equity indicators are more useful to
decision-makers, and likely to have more impact, if they can be summarised in the form of a single
one-page ‘dashboard’. A dashboard approach allows comparisons between multiple indicators of
health-care access and outcome at different stages of the patient pathway. Furthermore, it also focuses
attention on a small number of key indicators and reduces the risk of equity information getting buried in
a ‘blizzard’ of indicators. This is important, as, in reality, equity objectives will always tend to have lower
priority for health-care managers than balancing the books and delivering high-quality care for the average
patient. We found that up to eight equity indicators can comfortably fit on a single page or screen, but
beyond that the text becomes too small for comfortable reading. Second, that equity indicators need to be
accompanied by information on average NHS performance, so that decision-makers can put equity
findings into context. For example, increasing inequality may be less worrying in a context of improving
average performance in which all social groups are becoming better off. Third, equity indicators need to
be accompanied by graphs that reveal the underlying inequality patterns and trends over time. Health
equity is a complex concept and headline equity statistics presented in isolation can be misleading.
So, before drawing conclusions and taking action to remedy apparent problems, decision-makers need to
understand what is going on behind the headline statistics. We found that graphs using five deprivation
quintile groups are generally sufficient to capture the main inequality time trends of interest, but that
10 deprivation decile groups are more useful for presenting the basic cross-sectional inequality gradient, as
the gradient in adverse health-care outcomes often starts to become steeper within the most deprived tail
of the social distribution.
Variants on our equity indicators could be used for international comparisons
of equity in health care and for evaluating the impacts of interventions
on equity in health care
Variants on all of our indicators could be produced in Scotland, Wales and Northern Ireland, which have
similar health information infrastructures to England including QOF data on primary care quality. Variants
on at least three of our general indicators of inequality in health-care outcomes, (1) primary care supply,
(4) preventable hospitalisation and (5) repeat hospitalisation, could also be produced in other countries
with comprehensive data on primary care supply and hospital activity linked to small-area-level or
individual-level measures of socioeconomic status. Crude versions of our indicators could also be produced
in countries with comprehensive national data on hospital activity linked to large-area deprivation
measures, although these are less accurate than the small-area-level measures of deprivation available in
England. Our indicators can also be used to facilitate evaluation of the equity impacts of interventions
through quasi-experimental studies of both national and local interventions. Little is known about the
equity impacts of interventions, and different studies use different equity metrics. Our indicators can
facilitate the incorporation of equity impacts into experimental and quasi-experimental studies, and may
even help to improve the comparability of equity impact findings between different studies by providing a
common set of metrics for equity evaluation studies.
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Technical conclusions about equity indicator production
and communication
In this section, we draw technical conclusions about appropriate analytical methods for producing and
communicating equity indicators. Some of our conclusions apply to equity indicator methods used in any
country, although some relate to the specific kinds of data available in England, for example conclusions
about how often it would be feasible to produce and report particular equity indicators given current data
release cycles in England.
Visualisation: as well as producing a headline equity statistic (e.g. the slope index
of inequality), we recommend visualising inequality levels and trends by producing
‘equity chart packs’ that include cross-sectional scatterplots showing the shape of the
social gradient, time trend line plots showing recent change in the social gradient,
matrix plots showing the breakdown of equity patterns by age and sex group,
and caterpillar plots showing how equity in your area compares with equity in
other areas and against the national benchmark
Equity is a complex concept that cannot be captured by any single summary statistic, such as a SII. It is
therefore essential to visualise the inequality patterns to give decision-makers a clear understanding of
what is going on underneath the headline findings. We have developed a suite of equity visualisation tools
that we believe provide all the necessary underpinning information in a concise and easy-to-read format.
Periodicity and indicator year: we recommend updating both national and local
equity indicators on an annual basis, based on the financial year
Because the socioeconomic patterning of health care does not change rapidly, there is limited value in
updating equity indicators more frequently than once a year, although in principle half-yearly or even
quarterly updating can be performed for national equity indicators based on hospital data, that is,
(3) hospital waiting time, (4) preventable hospitalisation and (5) repeat hospitalisation. The databases for
different indicators become available at different points in the year, are based on data collected at
different points in the year and suffer from different data lags. However, we recommend the financial year
as the most appropriate indicator year, as (1) NHS budgeting and planning mechanisms operate to the
financial year and (2) using the same indicator year facilitates comparisons between indicator findings.
The financial year is also the most appropriate period for indicators 1 and 2 (primary care supply and
quality) as the workforce census is taken in September each year, in the middle of the financial year, and
QOF data are collected at the end of March relating to the previous financial year. Indicators 3–5 can be
produced for any indicator year, as the required hospital record data becomes available to NHS analysts via
the Secondary Uses Service within a few months. If the indicators were to be produced by academic
analysts using HES data, rather than NHS analysts using Secondary Uses Service data, they would also find
the financial year convenient, as HES is released by financial year. However, indicators 6–8 require ONS
mortality data, which are typically released in early November for the previous calendar year. As the data
lag for these indicators is already at least 1 year, it may be sensible to base these indicators on the
calendar year rather than increasing the data lag to ≥ 2 years.
Data lags: it should be possible to release updated indicators for the previous
financial year in autumn or spring each year
The primary care workforce data required for indicator 1 are usually published in March and relate to the
previous September, so in principle this indicator could be produced and released by the summer.
However, indicators 3–5 based on hospital data for the previous financial year could not be released until
the autumn. This is because there would be a few months’ delay in the hospital data for the financial year
becoming available, and further delays in data access and data analysis. QOF data and ONS mortality data
are generally released at the end of October; therefore, allowing a few months’ delay for data access and
data analysis, the earliest that indicators 2, 6, 7 and 8 could be released is spring. This implies a data lag of
6 months from the end of the financial year for indicators 1, 3, 4 and 5; a data lag of 9–12 months from
the end of the financial year for indicator 2; and a data lag of 15 months from the end of the calendar
year for indicators 6, 7 and 8.
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Inequality measures: we recommend using the slope index of inequality as the
primary headline measure, supplemented by a battery of further measures
including at least one relative measure such as the relative index of inequality and
ideally both a relative shortfall measure and a relative attainment measure
Measuring inequality is essentially a matter of boiling down a many-valued distribution of observations
(in this case, more than 32,000 neighbourhoods) into a single number.194 This can be done in numerous
different ways, and there is no ‘one-size-fits-all’ summary measure of inequality as different measures
emphasise different aspects of a complex shape. As a primary equity measure we favour the SII because it
both (1) is fairly easy to understand and (2) summarises the whole social gradient rather than arbitrarily
focusing on two groups, such as the top and bottom fifth, or the bottom and middle fifth, or any other
essentially arbitrary choice of two groups. The slope index can be interpreted as the estimated gap
between most and least deprived neighbourhoods in England, allowing for the gradient in-between.
However, this is an absolute measure and so needs to be supplemented with at least one relative measure,
as absolute and relative inequality often move in different directions when the mean is changing.195 Ideally,
we also recommend presenting a further battery of inequality indices including (1) a relative attainment
index as well as a relative shortfall index, and (2) a range of extreme group measures including the
absolute and relative gap between the top and bottom fifths, between the bottom and middle fifths, and
between the top and middle fifths. It is worth checking relative attainment as well as relative shortfall, as
they can also move in different directions when the mean is changing, for instance inequality in mortality
(a shortfall concept) may be falling while inequality in survival (an attainment concept) is rising.179,196
However, for indicators based on adverse events, such as hospitalisation and mortality, it is only possible to
do this when indicators are based on the proportion of people experiencing one or more events, rather
than the rate of events including multiple events experienced by the same person. This is because a
proportion has an upper bound and so can be inverted between shortfall (the proportion experiencing the
adverse event) and attainment (the proportion not experiencing the adverse event). By contrast, an event
rate has no non-arbitrary upper bound and so it is only possible to compute a shortfall measure. Finally, it
is worth presenting extreme group measures because these are the simplest possible way of presenting
information on equity to members of the public and can be understood clearly and fully without any prior
training in statistics. The slope index cannot be fully understood without delving into the meaning of the
caveat ‘allowing for the gradient in-between’, which in turn requires an understanding of linear
regression modelling.
Recommendations for further research
Our recommendations for further research are:
1. to investigate potential explanations for variation in health-care equity performance between local NHS
areas, so that health-care managers can learn quality improvement lessons
2. to perform experimental and quasi-experimental evaluations of the impacts of complex interventions on
socioeconomic inequalities in health-care access and outcomes, including interventions to improve
system-wide co-ordination between different specialties, health-care settings and public services
3. to make international health-care equity comparisons using these indicators of health-care access
and outcomes
4. to develop broader measures of primary care access and quality that go beyond GP supply and the
aspects of quality captured by the QOF
5. to develop better measures of small-area-level need for primary care, by investigating how multiple
morbidity and disadvantage combine to generate additional health-care needs
6. to develop convincing methods for risk-adjusting small-area-level health-care outcomes for exogenous
morbidity factors beyond the control of health-care services
7. to develop methods for monitoring other social dimensions of health-care inequality
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8. to improve these indicator methods, for example by refining and adding indicators, decomposing
national inequality into between-area and within-area components, and exploring the use of statistical
process control methods, direct standardisation methods and non-linear functional forms
9. to develop sources of small-area-level data on the supply, utilisation, quality and outcomes of public
and private social care and other goods and services that may influence health-care outcomes.
To investigate potential explanations for variation in health-care equity
performance between local NHS areas, so that health-care managers can learn
quality improvement lessons
If and when detailed and up-to-date local monitoring of health-care equity commences, there will be a
valuable opportunity for quality improvement research involving in-depth investigation of the potential
explanations for variations in quality performance at local levels. The aim of this research would be to
understand why some areas do well and others badly in reducing social gradients in health-care access and
outcomes compared with the national average, and why some areas show signs of sustained improvement
while others show sustained deterioration. The findings of this quality improvement research could then be
used to help develop and implement best-practice guidance that will help health care and local authority
managers in local areas to deliver measurable reductions in health-care inequalities.
To perform experimental and quasi-experimental evaluations of the impacts of
complex interventions on socioeconomic inequalities in health-care access and
outcomes, including interventions to improve system-wide co-ordination between
different specialties, health-care settings and public services
Rigorous evaluation studies using experimental or quasi-experimental designs are needed to gather robust
evidence on the impacts of complex interventions on inequalities in health-care access and outcomes.197,198
This will need to include careful analysis of contextual factors and interactions, and careful analysis of
causal pathways, including investigation of the causal links between inequality in health-care access
and outcomes at different points on the patient pathway. This should include evaluation of complex
interventions designed to improve care for people with multiple conditions by improving co-ordination
between primary, secondary and social care settings, and between specialties, as these are likely to be of
particular importance in achieving further reductions in inequalities in health-care outcomes. The findings
of this research will help guide NHS policy-makers in developing and implementing national and regional
policies for tackling health-care inequalities.
To make international health-care equity comparisons using these indicators of
health-care access and outcomes
Further research is needed to develop international comparisons and benchmarks for both national and
local health-care equity improvement efforts. This can be done by producing some of our equity indicators
in other high-income countries with well-developed health data sets linked to small-area deprivation, such
as Scotland, Wales, Northern Ireland, Canada and the Nordic countries. International comparisons of this
kind will allow a step-change in public transparency about NHS performance on health-care equity by
providing a non-parochial assessment. They will also help the NHS to learn equity improvement lessons
from other countries, both to find win–win interventions that simultaneously improve equity and average
performance and also to identify potential trade-offs between equity objectives and other policy objectives.
To develop better measures of small-area-level need for primary care, by
investigating how multiple morbidity and disadvantage combine to generate
additional health-care needs
The Carr-Hill workload adjustment for primary care need fails to allow for multimorbidity and is now rather
outdated, as it is based on data from the early 2000s. Research is needed to develop more up-to-date
need adjustments, which take account of how multiple morbidity and disadvantage combine to generate
additional health-care needs. This research would help to inform the future development of geographical
resource allocation formulae as well as being useful for monitoring and evaluation purposes.
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To develop convincing methods for risk-adjusting small-area-level health-care
outcomes for exogenous morbidity factors beyond the control of
health-care services
Further research is needed to find ways of risk-adjusting health-care outcome indicators for ill health, as
well as for age and sex. For local equity monitoring, this will require individual-level data on age, sex and ill
health for everyone in the country. Perhaps the most promising suggestion is to use multimorbidity from
hospital records, as discussed at the end of Chapter 3. Another suggestion is to use all-cause mortality,
although for local equity monitoring this would require a 3- to 5-year moving average because of the small
number of deaths at the LSOA level. A final suggestion is to develop an indicator of multimorbidity using a
patient-level primary care data set, such as Clinical Practice Research Datalink, and then seek to roll this
out on a national basis as and when patient-level primary care data sets become available covering the
whole of England. However, this is a complex area, as the NHS, can to some extent, cause changes in
morbidity through preventative care. Ideally, as the aim is to adjust for ‘exogenous’ risks that are not under
the control of the health-care system, one would only want to adjust for changes in morbidity risks that
are not caused by health care.
To develop methods for monitoring other social dimensions of health-care
inequality
Policy-makers and the public may be concerned with other kinds of social inequality in health-care access
and outcomes, including inequalities by ethnicity, age, sex, geographical location and a host of other social
variables – including variables with both health and social aspects such as mental health and disability.
In principle, our basic small-area-level methods can readily be applied to ethnicity, which can be measured
at neighbourhood level, although there are complications in particular the fact that ethnicity is not an
ordered variable and so does not lend itself to the use of slope index methods.
To improve these indicator methods by refining and adding indicators, decomposing
national inequality into between-area and within-area components, and exploring
the use of statistical process control methods, direct standardisation methods
and non-linear functional forms
Further research is needed to decompose national health-care inequality into its component parts. In
principle, the national SII can be expressed as a weighted average of the between-area and within-area
slopes. Decomposing the index in this way could be a useful way of disentangling the role of decisions
about geographical resource allocation between different CCGs and local authorities (which influences the
between-area slope) versus within-area actions by particular CCGs and local authorities. Research is also
needed to find ways of analysing and communicating information on the substantial variation at small-area
and practice level that is not related to small-area deprivation, and comparing this to deprivation-related
inequality. This would be of particular value for indicators 1 and 2, as much of the non-deprivation-related
variation is likely to be systematic, and to persist over time, and so may reflect unfair inequality of policy
concern. Further research is also needed to explore ways of assessing the normal range of variation in local
inequality indices, using statistical process control theory. Research is also needed to explore ways of using
direct standardisation for age and sex in equity indicator production, and the pros and cons compared
with our indirect standardisation approach. One advantage of direct standardisation is reduced
computational burden and delay. However, a disadvantage is that this will lose granularity at local level by
requiring aggregation of data to larger population sizes, such as decile groups of small areas, to improve
stability. At the national level, the SII could then be estimated by using decile group-level regression and
simulating confidence intervals based on the estimated standard error around each decile group point,
along the lines of an approach that Public Health England are considering for their indicators of public
health inequality. Further modification of decile regression with simulated confidence intervals would be
required at local level; however, where fewer than 10 national decile groups may be represented in the
data. Research is needed to explore the implications of non-linear functional forms for computing slope
indices of inequality, including the value judgements underpinning such approaches as well as the model
fit and comparative sensitivity to change in health-care access and outcomes and different parts of the
socioeconomic spectrum. Finally, consideration should be given to an alternative locally relative version of
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the RGI. The approach taken in this report is a nationally relative RGI: the AGI divided by the national
mean. An alternative locally relative approach would be RGI = AGI/(α + 0.5 × AGI), where α is the intercept
in the local linear regression for computing the AGI. Unlike the nationally relative index, this index is scale
invariant at local level: if local rates in all social groups double, retaining the same proportional gaps,
this locally relative AGI index will not change. We are grateful to Robert Shaw, NHS England, for this
helpful suggestion.
To develop sources of small-area-level data on the supply, utilisation, quality
and outcomes of public and private social care and other goods and services
that may influence health-care outcomes
Health-care outcomes are influenced by public, private and informal social care, and by other social
determinants of health including the consumption of a wide range of market goods and public services
that impact upon individual resilience and ability to recover from episodes of illness. Improvements in the
social care data infrastructure will greatly facilitate research in this area, in helping to tease out the causal
pathways leading to health-care outcomes and to help disentangle the role of social-care and health-care
factors. As a substantial proportion of social care is privately funded and/or informally provided within
the household, it will be important to develop data sources that include privately funded and informally
provided care, and as a wide range of other market goods and public services also impact on health-care
outcomes it will be important to develop data sources on these as well.
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Appendix 1 Prototype coronary heart disease
indicators
This appendix reports on our prototype national equity indicators for CHD. We have analysed three indicators:
1. CHD1: primary care quality for CHD
2. CHD2: emergency hospitalisation for CHD
3. CHD3: mortality from CHD.
This appendix is divided into three sections: (1) indicator definitions, (2) graphical results, and (3) discussion.
Coronary heart disease indicator definitions
CHD1: primary care quality – blood pressure and cholesterol control in coronary
heart disease patients
Definition
This indicator measures primary care quality for people with CHD. We use a weighted average of the
following two indicators as defined in the QOF: (1) the proportion of people with CHD in whom the last
blood pressure reading (measured in the preceding 12 months) was 150/90 mmHg or less; and (2) the
proportion of people with CHD whose last measured cholesterol concentration (measured in the preceding
12 months) was 5 mmol/l or less. The numerator for (1) is the number of people with CHD who were
within the limit for blood pressure, and for (2) is the number of people with CHD who were within the
limit for cholesterol control. The denominator in both cases is the total number of people in each practice
who were registered as having CHD. An importance-weighted average based on estimated mortality
reduction impact (see below for details) of (1) and (2) was taken to measure performance on this indicator.
Technical details
General practitioner practices record the number of patients with CHD who are listed in their practice
registers. Blood pressure and cholesterol control in CHD patients are two of the quality indicators in QOF.
The denominator is the number of patients registered as having CHD, and who were not exception
reported by the practice, while the numerator is the number of CHD patients for whom (1) blood pressure
and (2) cholesterol control target was met. A weighted average of (1) and (2) was calculated, with weights
based on the Public Health Impact score for each indicator, as calculated by Ashworth et al.,85 based on
available evidence on mortality reduction.
We use reported achievement which excludes exception-reported patients from the population
denominator. We do not standardise this indicator, as factors such as the age and sex distribution in the
GP practice population are not legitimate justifications for variation in GP performance on this indicator.
CHD2: emergency hospitalisation for coronary heart disease
Definition
Emergency hospitalisation for CHD is defined as the number of people per 1000 population having one
or more emergency hospitalisations for CHD, adjusting for age and sex. This is an indicator of the
performance of primary care and the interface between primary and secondary care.
The numerator is the number of people with CHD-related emergency hospital admissions (both finished and
unfinished admission episodes, excluding transfers). This is derived from the HES APC, provided by the HSCIC.
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The denominator is the total number of people alive at mid-point in the current financial year. The ONS
mid-year England population estimates for the respective calendar years are used for this purpose.
Technical details
This indicator measures the rate of CHD-related emergency hospital admissions per 1000 people, adjusted
for age and sex. Hospital admissions for all ages, including young children and people aged > 75 years, for
all ICD-10 codes I20–I125 for ischaemic heart disease are included in this indicator. We focus on patients
with one of these codes in the primary diagnosis field. Only two of these codes are included in the NHS
Outcomes Framework list of ‘preventable’ emergency hospitalisations: I20 for ‘angina pectoris’ and I25 for
‘chronic ischaemic heart disease’. However, we also include codes I21, I22 and I23 which represent ‘acute
myocardial infarction’, ‘subsequent myocardial infarction’ and ‘certain current complications following
acute myocardial infarction’. We include these additional codes (1) for more complete coverage of CHD,
(2) for greater consistency with the companion indicator of mortality for CHD, and (3) because there is at
least some evidence that multidisciplinary health-care interventions can reduce emergency admissions for
these broader aspects of CHD. However, to avoid confusion with the NHS Outcomes Framework list we
label this as ‘emergency hospitalisation for CHD’ rather than ‘preventable hospitalisation’.
We calculate indirectly standardised emergency hospital admission rate for CHD for each small area to allow
for differing age and sex structure by deprivation level. To do so, we start with individual-level HES data on
CHD emergency admissions and aggregate up to small-area level. We then compute the expected
hospitalisation counts for each small area by applying national age–sex hospitalisation rates to small-area-level
numbers of people in each age–sex group. We then compute the adjusted rate for each small area as the
product of the ratio of observed over expected count for the small area and the national rate. We then
compute the adjusted count for each small area as adjusted rate times the small-area population. Finally, we
aggregate up this adjusted count to quantile group level to present adjusted count per 1000 people in each
quantile group.
CHD3: amenable mortality – mortality from coronary heart disease, age and
sex adjusted
Definition
Amenable mortality from CHD is defined as the number of deaths from CHD per 1000 population,
allowing for age and sex. The numerator is the number of people who died in the current financial year
because of CHD. The denominator is the total number of people aged < 75 years alive at the mid-point in
the current financial year, from ONS mid-year population estimates.
Technical details
Amenable mortality from CHD was defined according to all the ICD-10 codes I20–I25, which are listed in
the ONS list of causes of death considered amenable to health care. CHD is one of the conditions that has
a clear link between the number of deaths and health-care interventions. In line with the ONS specification
of avoidable mortality from CHD, an age limit of 0–74 years is applied to both the numerator and
denominator. This is because identification of the underlying cause of death after age 75 years becomes
increasingly unreliable.
We calculate indirectly standardised amenable mortality rate from CHD for each small area to allow for
differing age and sex structure by deprivation level, as described in Chapter 4. In brief, we start with
individual-level ONS mortality data and aggregate up to small-area level. We then compute the expected
number of deaths in each small area by applying national age–sex mortality rates to small-area-level
numbers of people in each age–sex group. We then compute the adjusted rate for each small area as the
product of the national rate and the ratio of observed over expected. For visualisation purposes, we then
aggregate to quantile group level.
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FIGURE 72 National social gradient in mortality from CHD in 2011/12. Notes: (1) dots represent decile groups;
(2) the slope of the line is the SII; and (3) the shaded area shows the inequity gap.
Discussion of coronary heart disease indicator findings
The basic pattern of our CHD findings is an improvement in average quality and a reduction in absolute
inequality between 2001 and 2011. This pattern is entirely in line with our general findings for primary
care quality, preventable hospitalisation and amenable mortality, although the improvements and absolute
inequality reductions are even larger. However, as with the general indicators, these reductions in absolute
inequality do not translate into improvements in relative inequality in the case of hospitalisation and
mortality because the mean level of CHD hospitalisation and mortality is falling fast.
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Appendix 2 Prototype diabetes indicators
This appendix reports on our prototype national equity indicators for diabetes mellitus. We have analysedthree indicators:
1. diabetes1: primary care quality for diabetes
2. diabetes2: emergency hospitalisation for diabetes
3. diabetes: mortality from diabetes.
This appendix is divided into three sections: (1) indicator definitions, (2) graphical results, and (3) discussion.
Diabetes indicator definitions
Diabetes1: primary care quality – glycaemic control in diabetic patients
Definition
This indicator measures the proportion of people with diabetes who have achieved tight glycaemic
control according to the most recently recorded set of measurements within the last 12 months. This is
measured by glycated haemoglobin (HbA1c) targets for average plasma glucose (sugar) concentration over
a sustained period (about 3 months). We use glycaemic control as a measure of quality of diabetes care in
the primary care setting. The numerator is the number of people with diabetes who were within the limit
for glycaemic control. The denominator is the total number of people in each practice who were registered
as having diabetes.
Technical details
General practitioner practices record the number of patients with diabetes who are listed in their practice
registers. Achieving glycaemic control in diabetic patients, as measured by HbA1c level in blood, is one of
the indicators in the QOF (UK Prospective Diabetes Study 1998).199 The denominator of the indicator is
the number of patients registered as having diabetes and who were not ‘exception reported’ by the
practice, and the numerator is the number of diabetes patients for whom glycaemic control target was
met (as set in the QOF for a particular year, details below). Therefore, the reported achievement is the
proportion of diabetic patients for whom the practice met the indicator target for glycaemic control.
The threshold level for glycaemic control has changed slightly on various occasions since the inception of
QOF in 2004/5. Therefore, we use the relevant threshold for each year (Table 4).
We do not standardise this indicator, as factors such as the age and sex distribution in the GP practice
population are not legitimate justifications for variation in GP performance on this indicator.
TABLE 4 The QOF target for HbA1c level
Indicator name in QOF Years HbA1c threshold (%)
DM6 2004/5; 2005/6 ≤ 7.4
DM20 2006/7; 2007/8; 2008/9 (replaced DM6) ≤ 7.5
DM23 2009/10; 2010/11 (replaced DM20) ≤ 7
DM26 2011/12 onward (replaced DM23) ≤ 7.5
DM, diabetes mellitus.
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The basic geographical unit of analysis was the 2001 LSOA. Primary care quality data for glycaemic control
were attributed from practice level to LSOA level using the NHS ADS of GP-registered populations for the
8 years 2004/05 through 2011/12.
Diabetes2: emergency hospitalisation for diabetes
Definition
Emergency hospitalisation for diabetes is defined as the number of people per 1000 population having one
or more emergency hospitalisations for diabetes complications, adjusting for age and sex. Diabetes is a
condition that should not normally result in an emergency admission if appropriately managed.
The numerator is the number of people with diabetes-related emergency hospital admissions during the
indicator year (both finished and unfinished admission episodes, excluding transfers). This is derived from
the HES APC, provided by the HSCIC.
The denominator is the total number of people alive at the mid-point of the current financial year. The
ONS mid-year England population estimates for the respective calendar years are used for this purpose.
Technical details
This indicator measures the rate of diabetes-related emergency hospital admissions per 1000 people.
This is often used as an indicator of the performance of primary care and the interface between primary
and secondary care. To identify diabetes-related emergency admissions, we focus on the primary diagnosis
field using diabetes-related ICD-10 codes E10–E14 representing ‘type 1 diabetes mellitus’, ’type 2 diabetes
mellitus’, ‘E13: other specified diabetes mellitus’, and ‘E14: unspecified diabetes mellitus. This is a broader
list of codes than used by the ONS to identify ‘preventable hospitalisation’ for diabetes. We use this
broader list for simplicity and for greater comparability with our indicator of diabetes-related mortality.
Like the ONS, however, we use emergency hospital admissions for all ages, including young children and
people over 75 years.
The more restrictive ONS list of preventable hospitalisations for chronic ambulatory care-sensitive
conditions, as used in the NHS Outcomes Framework, includes admissions for one of the
following reasons:
i. all complications due to poor short-term glycaemic control
ii. acute hyperglycaemia (ketoacidosis and coma)
iii. non-specific hyperglycaemia
iv. hypoglycaemia.
The ICD-10 codes for this more restrictive list of diabetes-related admissions are presented in Table 5. This
restrictive list is used in other literature, although sometimes with additions; for example, Dusheiko et al.78
use one additional code of E162: hypoglycaemia, unspecified.
We calculate indirectly standardised emergency hospital admission rate for diabetes for each small area to
allow for differing age and sex structure by deprivation level. To do so, we start with individual-level HES
data on diabetes-related emergency admissions and aggregate up to small-area level. We then compute
the expected hospitalisation counts for each small area by applying national age–sex hospitalisation rates
to small-area-level numbers of people in each age–sex group. We then compute the adjusted rate for each
small area as the product of the ratio of observed over expected count for the small area and the national
rate. We then compute the adjusted count for each small area as adjusted rate times the small-area
population. Finally, we aggregate up this adjusted count to quantile group level to present the adjusted
count per 1000 people in each quantile group.
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Diabetes3: amenable mortality from diabetes, age and sex adjusted
Definition
Amenable mortality from diabetes is defined as the number of deaths per 1000 people from diabetes,
allowing for age and sex. The numerator is the number of people aged 0–74 years who died in the current
financial year because of diabetes. The denominator is the number of people aged 0–74 years alive at
mid-point in the current financial year.
Technical details
Amenable mortality from diabetes was defined according to the ICD-10 codes listed in the ONS list of
causes of death considered amenable to health care; the ICD-10 codes are E10-E14 representing ‘type 1
diabetes mellitus’, ’type 2 diabetes mellitus’, ‘E13: other specified diabetes mellitus’, and ‘E14: unspecified
diabetes mellitus.
Diabetes is on the ONS list of ‘mortality amenable to health-care’ conditions that are responsible for at
least 100 deaths in a year and that have a clear link between the number of deaths and health-care
interventions. We depart slightly from the ONS list, by applying a higher age limit of 74 years to numerator
and denominator, rather than the ONS age limit of 49 years. The ONS apply an age limit of 49 years
largely because identification of the underlying cause of death is particularly problematic for diabetes, and
so identification can become unreliable after the age of 50 years. This cut-off point of 49 years is also used
in other literature, for example Nolte and McKee.58 However, we use a higher age limit for greater
comparability with the age profiles used in our other diabetes indicators.
We calculate indirectly standardised amenable mortality rate from diabetes for each small area to allow for
differing age and sex structure by deprivation level. To do so, we start with individual-level ONS mortality
data and aggregate up to small-area level. We then compute the expected number of deaths in each small
area by applying national age–sex mortality rates to small-area-level numbers of people in each age–sex
group. We then compute the adjusted rate for each small area as the product of the ratio of observed over
expected count for the small area and the national rate. We then compute the adjusted count for each
small area as adjusted rate times the small-area population. Finally, we aggregate up this adjusted count to
quantile group level to present the adjusted count per 1000 people in each quantile group.
TABLE 5 The ONS classification of emergency diabetes admissions
Type of complication ICD-10
All diabetes complications E100, E101, E110, E111, E120, E121, E130, E131, E140, E141, E162, E107, E108,
E109, E117, E118, E119, E127, E128, E129, E137, E138, E139, E147, E148, E149
Code type Definition
ICD-10 codes E10: insulin-dependent diabetes mellitus
E11: non-insulin-dependent diabetes mellitus
E13: other specified diabetes mellitus
E14: unspecified diabetes mellitus
ICD-10 extension 0: with coma
1: with ketoacidosis
7: with multiple complications
8: with unspecified complications
9: without complications
DOI: 10.3310/hsdr04260 HEALTH SERVICES AND DELIVERY RESEARCH 2016 VOL. 4 NO. 26
© Queen’s Printer and Controller of HMSO 2016. This work was produced by Cookson et al. under the terms of a commissioning contract issued by the Secretary of State for
Health. This issue may be freely reproduced for the purposes of private research and study and extracts (or indeed, the full report) may be included in professional journals
provided that suitable acknowledgement is made and the reproduction is not associated with any form of advertising. Applications for commercial reproduction should be
addressed to: NIHR Journals Library, National Institute for Health Research, Evaluation, Trials and Studies Coordinating Centre, Alpha House, University of Southampton Science
Park, Southampton SO16 7NS, UK.
177
G
ra
p
h
ic
a
l
re
su
lt
s
fo
r
d
ia
b
e
te
s
in
d
ic
a
to
rs
Diabetes primary care quality
20
04
/5
20
05
/6
20
06
/7
20
07
/8
45505560
(a
)
20
08
/9
20
09
/1
0
20
10
/1
1
20
11
/1
2
Q
1 
(m
o
st
 d
ep
ri
ve
d
)
Q
2
Q
3
Q
4
Q
5 
(l
ea
st
 d
ep
ri
ve
d
)
IM
D
 g
ro
u
p
Y
ea
r
FI
G
U
R
E
73
Eq
u
it
y
ti
m
e
tr
en
d
in
d
ia
b
et
es
p
ri
m
ar
y
ca
re
q
u
al
it
y.
N
o
te
s:
(1
)
th
e
so
lid
b
la
ck
lin
e
sh
o
w
s
th
e
m
o
st
d
ep
ri
ve
d
q
u
in
ti
le
an
d
th
e
so
lid
b
lu
e
lin
e
sh
o
w
s
th
e
le
as
t
d
ep
ri
ve
d
q
u
in
ti
le
;
(2
)
n
eg
at
iv
e
SI
Ii
n
d
ic
at
es
p
ro
-p
o
o
r
d
is
tr
ib
u
ti
o
n
,
w
h
ile
a
p
o
si
ti
ve
SI
Ii
n
d
ic
at
es
a
p
ro
-r
ic
h
d
is
tr
ib
u
ti
o
n
in
ab
so
lu
te
te
rm
s;
an
d
(3
)
n
eg
at
iv
e
R
II
in
d
ic
at
es
p
ro
-p
o
o
r
d
is
tr
ib
u
ti
o
n
,
w
h
ile
a
p
o
si
ti
ve
R
II
in
d
ic
at
es
a
p
ro
-r
ic
h
d
is
tr
ib
u
ti
o
n
in
re
la
ti
ve
te
rm
s.
(c
o
n
ti
n
u
ed
)
APPENDIX 2
NIHR Journals Library www.journalslibrary.nihr.ac.uk
178
234
20
04
/5
20
05
/6
20
06
/7
20
07
/8
Y
ea
r
20
08
/9
20
09
/1
0
20
10
/1
1
20
11
/1
2
(b
)
SII
4 3567
20
04
/5
20
05
/6
20
06
/7
20
07
/8
Y
ea
r
20
08
/9
20
09
/1
0
20
10
/1
1
20
11
/1
2
(c
) RII (%)
FI
G
U
R
E
73
Eq
u
it
y
ti
m
e
tr
en
d
in
d
ia
b
et
es
p
ri
m
ar
y
ca
re
q
u
al
it
y.
N
o
te
s:
(1
)
th
e
so
lid
b
la
ck
lin
e
sh
o
w
s
th
e
m
o
st
d
ep
ri
ve
d
q
u
in
ti
le
an
d
th
e
so
lid
b
lu
e
lin
e
sh
o
w
s
th
e
le
as
t
d
ep
ri
ve
d
q
u
in
ti
le
;
(2
)
n
eg
at
iv
e
SI
Ii
n
d
ic
at
es
p
ro
-p
o
o
r
d
is
tr
ib
u
ti
o
n
,
w
h
ile
a
p
o
si
ti
ve
SI
Ii
n
d
ic
at
es
a
p
ro
-r
ic
h
d
is
tr
ib
u
ti
o
n
in
ab
so
lu
te
te
rm
s;
an
d
(3
)
n
eg
at
iv
e
R
II
in
d
ic
at
es
p
ro
-p
o
o
r
d
is
tr
ib
u
ti
o
n
,
w
h
ile
a
p
o
si
ti
ve
R
II
in
d
ic
at
es
a
p
ro
-r
ic
h
d
is
tr
ib
u
ti
o
n
in
re
la
ti
ve
te
rm
s.
DOI: 10.3310/hsdr04260 HEALTH SERVICES AND DELIVERY RESEARCH 2016 VOL. 4 NO. 26
© Queen’s Printer and Controller of HMSO 2016. This work was produced by Cookson et al. under the terms of a commissioning contract issued by the Secretary of State for
Health. This issue may be freely reproduced for the purposes of private research and study and extracts (or indeed, the full report) may be included in professional journals
provided that suitable acknowledgement is made and the reproduction is not associated with any form of advertising. Applications for commercial reproduction should be
addressed to: NIHR Journals Library, National Institute for Health Research, Evaluation, Trials and Studies Coordinating Centre, Alpha House, University of Southampton Science
Park, Southampton SO16 7NS, UK.
179
61 62 63
Diabetes primary care quality
64 L
ea
st
 d
ep
ri
ve
d
M
o
st
 d
ep
ri
ve
d
Sm
al
l-
ar
ea
 d
ep
ri
va
ti
o
n
 r
an
k
FI
G
U
R
E
74
N
at
io
n
al
so
ci
al
g
ra
d
ie
n
t
in
d
ia
b
et
es
p
ri
m
ar
y
ca
re
q
u
al
it
y
in
20
11
/1
2.
N
o
te
s:
(1
)
d
o
ts
re
p
re
se
n
t
d
ec
ile
g
ro
u
p
s;
(2
)
th
e
sl
o
p
e
o
f
th
e
lin
e
is
th
e
SI
I;
an
d
(3
)
th
e
sh
ad
ed
ar
ea
sh
o
w
s
th
e
in
eq
u
it
y
g
ap
.
APPENDIX 2
NIHR Journals Library www.journalslibrary.nihr.ac.uk
180
40608010
0
Emergency hospital admissions for diabetes (per 100,000)
20
03
/4
20
04
/5
20
05
/6
20
06
/7
20
07
/8
(a
)
20
08
/9
20
09
/1
0
20
10
/1
1
20
11
/1
2
Q
1 
(m
o
st
 d
ep
ri
ve
d
)
Q
2
Q
3
Q
4
Q
5 
(l
ea
st
 d
ep
ri
ve
d
)
IM
D
 g
ro
u
p
Y
ea
r
FI
G
U
R
E
75
U
n
ad
ju
st
ed
eq
u
it
y
ti
m
e
tr
en
d
in
em
er
g
en
cy
h
o
sp
it
al
is
at
io
n
fo
r
d
ia
b
et
es
.
N
o
te
s:
(1
)
th
e
so
lid
b
la
ck
lin
e
sh
o
w
s
th
e
m
o
st
d
ep
ri
ve
d
q
u
in
ti
le
an
d
th
e
so
lid
b
lu
e
lin
e
sh
o
w
s
th
e
le
as
t
d
ep
ri
ve
d
q
u
in
ti
le
;(
2)
n
eg
at
iv
e
SI
Ii
n
d
ic
at
es
p
ro
-p
o
o
r
d
is
tr
ib
u
ti
o
n
,
w
h
ile
a
p
o
si
ti
ve
SI
Ii
n
d
ic
at
es
a
p
ro
-r
ic
h
d
is
tr
ib
u
ti
o
n
in
ab
so
lu
te
te
rm
s;
an
d
(3
)
n
eg
at
iv
e
R
II
in
d
ic
at
es
p
ro
-p
o
o
r
d
is
tr
ib
u
ti
o
n
,
w
h
ile
a
p
o
si
ti
ve
R
II
in
d
ic
at
es
a
p
ro
-r
ic
h
d
is
tr
ib
u
ti
o
n
in
re
la
ti
ve
te
rm
s.
(c
o
n
ti
n
u
ed
)
DOI: 10.3310/hsdr04260 HEALTH SERVICES AND DELIVERY RESEARCH 2016 VOL. 4 NO. 26
© Queen’s Printer and Controller of HMSO 2016. This work was produced by Cookson et al. under the terms of a commissioning contract issued by the Secretary of State for
Health. This issue may be freely reproduced for the purposes of private research and study and extracts (or indeed, the full report) may be included in professional journals
provided that suitable acknowledgement is made and the reproduction is not associated with any form of advertising. Applications for commercial reproduction should be
addressed to: NIHR Journals Library, National Institute for Health Research, Evaluation, Trials and Studies Coordinating Centre, Alpha House, University of Southampton Science
Park, Southampton SO16 7NS, UK.
181
65 6075 7080
20
03
/4
20
04
/5
20
05
/6
20
06
/7
20
07
/8
Y
ea
r
20
08
/9
20
09
/1
0
20
10
/1
1
20
11
/1
2
(b
)
SII
10
0
10
5
11
0
20
03
/4
20
04
/5
20
05
/6
20
06
/7
20
07
/8
Y
ea
r
20
08
/9
20
09
/1
0
20
10
/1
1
20
11
/1
2
(c
) RII (%)
FI
G
U
R
E
75
U
n
ad
ju
st
ed
eq
u
it
y
ti
m
e
tr
en
d
in
em
er
g
en
cy
h
o
sp
it
al
is
at
io
n
fo
r
d
ia
b
et
es
.
N
o
te
s:
(1
)
th
e
so
lid
b
la
ck
lin
e
sh
o
w
s
th
e
m
o
st
d
ep
ri
ve
d
q
u
in
ti
le
an
d
th
e
so
lid
b
lu
e
lin
e
sh
o
w
s
th
e
le
as
t
d
ep
ri
ve
d
q
u
in
ti
le
;(
2)
n
eg
at
iv
e
SI
Ii
n
d
ic
at
es
p
ro
-p
o
o
r
d
is
tr
ib
u
ti
o
n
,
w
h
ile
a
p
o
si
ti
ve
SI
Ii
n
d
ic
at
es
a
p
ro
-r
ic
h
d
is
tr
ib
u
ti
o
n
in
ab
so
lu
te
te
rm
s;
an
d
(3
)
n
eg
at
iv
e
R
II
in
d
ic
at
es
p
ro
-p
o
o
r
d
is
tr
ib
u
ti
o
n
,
w
h
ile
a
p
o
si
ti
ve
R
II
in
d
ic
at
es
a
p
ro
-r
ic
h
d
is
tr
ib
u
ti
o
n
in
re
la
ti
ve
te
rm
s.
APPENDIX 2
NIHR Journals Library www.journalslibrary.nihr.ac.uk
182
40608010
0
12
0
Emergency hospital admissions for diabetes (per 100,000)
20
03
/4
20
04
/5
20
05
/6
20
06
/7
20
07
/8
(a
)
20
08
/9
20
09
/1
0
20
10
/1
1
20
11
/1
2
Q
1 
(m
o
st
 d
ep
ri
ve
d
)
Q
2
Q
3
Q
4
Q
5 
(l
ea
st
 d
ep
ri
ve
d
)
IM
D
 g
ro
u
p
Y
ea
r
FI
G
U
R
E
76
A
d
ju
st
ed
eq
u
it
y
ti
m
e
tr
en
d
in
em
er
g
en
cy
h
o
sp
it
al
is
at
io
n
fo
r
d
ia
b
et
es
.N
o
te
s:
(1
)
th
e
so
lid
b
la
ck
lin
e
sh
o
w
s
th
e
m
o
st
d
ep
ri
ve
d
q
u
in
ti
le
an
d
th
e
so
lid
b
lu
e
lin
e
sh
o
w
s
th
e
le
as
t
d
ep
ri
ve
d
q
u
in
ti
le
;
(2
)
n
eg
at
iv
e
SI
Ii
n
d
ic
at
es
p
ro
-p
o
o
r
d
is
tr
ib
u
ti
o
n
,
w
h
ile
a
p
o
si
ti
ve
SI
Ii
n
d
ic
at
es
a
p
ro
-r
ic
h
d
is
tr
ib
u
ti
o
n
in
ab
so
lu
te
te
rm
s;
an
d
(3
)
n
eg
at
iv
e
R
II
in
d
ic
at
es
p
ro
-p
o
o
r
d
is
tr
ib
u
ti
o
n
,
w
h
ile
a
p
o
si
ti
ve
R
II
in
d
ic
at
es
a
p
ro
-r
ic
h
d
is
tr
ib
u
ti
o
n
in
re
la
ti
ve
te
rm
s.
(c
o
n
ti
n
u
ed
)
DOI: 10.3310/hsdr04260 HEALTH SERVICES AND DELIVERY RESEARCH 2016 VOL. 4 NO. 26
© Queen’s Printer and Controller of HMSO 2016. This work was produced by Cookson et al. under the terms of a commissioning contract issued by the Secretary of State for
Health. This issue may be freely reproduced for the purposes of private research and study and extracts (or indeed, the full report) may be included in professional journals
provided that suitable acknowledgement is made and the reproduction is not associated with any form of advertising. Applications for commercial reproduction should be
addressed to: NIHR Journals Library, National Institute for Health Research, Evaluation, Trials and Studies Coordinating Centre, Alpha House, University of Southampton Science
Park, Southampton SO16 7NS, UK.
183
60708090
20
03
/4
20
04
/5
20
05
/6
20
06
/7
20
07
/8
Y
ea
r
20
08
/9
20
09
/1
0
20
10
/1
1
20
11
/1
2
(b
)
SII
10
5
11
0
11
5
12
0
20
03
/4
20
04
/5
20
05
/6
20
06
/7
20
07
/8
Y
ea
r
20
08
/9
20
09
/1
0
20
10
/1
1
20
11
/1
2
(c
) RII (%)
FI
G
U
R
E
76
A
d
ju
st
ed
eq
u
it
y
ti
m
e
tr
en
d
in
em
er
g
en
cy
h
o
sp
it
al
is
at
io
n
fo
r
d
ia
b
et
es
.N
o
te
s:
(1
)
th
e
so
lid
b
la
ck
lin
e
sh
o
w
s
th
e
m
o
st
d
ep
ri
ve
d
q
u
in
ti
le
an
d
th
e
so
lid
b
lu
e
lin
e
sh
o
w
s
th
e
le
as
t
d
ep
ri
ve
d
q
u
in
ti
le
;
(2
)
n
eg
at
iv
e
SI
Ii
n
d
ic
at
es
p
ro
-p
o
o
r
d
is
tr
ib
u
ti
o
n
,
w
h
ile
a
p
o
si
ti
ve
SI
Ii
n
d
ic
at
es
a
p
ro
-r
ic
h
d
is
tr
ib
u
ti
o
n
in
ab
so
lu
te
te
rm
s;
an
d
(3
)
n
eg
at
iv
e
R
II
in
d
ic
at
es
p
ro
-p
o
o
r
d
is
tr
ib
u
ti
o
n
,
w
h
ile
a
p
o
si
ti
ve
R
II
in
d
ic
at
es
a
p
ro
-r
ic
h
d
is
tr
ib
u
ti
o
n
in
re
la
ti
ve
te
rm
s.
APPENDIX 2
NIHR Journals Library www.journalslibrary.nihr.ac.uk
184
10
0
12
5 75 50
Emergency hospital admissions for diabetes (per 100,000)
25 L
ea
st
 d
ep
ri
ve
d
M
o
st
 d
ep
ri
ve
d
Sm
al
l-
ar
ea
 d
ep
ri
va
ti
o
n
 r
an
k
FI
G
U
R
E
77
N
at
io
n
al
so
ci
al
g
ra
d
ie
n
t
in
em
er
g
en
cy
h
o
sp
it
al
is
at
io
n
fo
r
d
ia
b
et
es
in
20
11
/1
2.
N
o
te
s:
(1
)
d
o
ts
re
p
re
se
n
t
d
ec
ile
g
ro
u
p
s;
(2
)
th
e
sl
o
p
e
o
f
th
e
lin
e
is
th
e
SI
I;
an
d
(3
)
th
e
sh
ad
ed
ar
ea
sh
o
w
s
th
e
in
eq
u
it
y
g
ap
.
DOI: 10.3310/hsdr04260 HEALTH SERVICES AND DELIVERY RESEARCH 2016 VOL. 4 NO. 26
© Queen’s Printer and Controller of HMSO 2016. This work was produced by Cookson et al. under the terms of a commissioning contract issued by the Secretary of State for
Health. This issue may be freely reproduced for the purposes of private research and study and extracts (or indeed, the full report) may be included in professional journals
provided that suitable acknowledgement is made and the reproduction is not associated with any form of advertising. Applications for commercial reproduction should be
addressed to: NIHR Journals Library, National Institute for Health Research, Evaluation, Trials and Studies Coordinating Centre, Alpha House, University of Southampton Science
Park, Southampton SO16 7NS, UK.
185
123456
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FIGURE 80 National social gradient in mortality from diabetes in 2011/12. Notes: (1) dots represent decile groups;
(2) the slope of the line is the SII; and (3) the shaded area shows the inequity gap.
Discussion of diabetes indicator findings
It is not possible to draw clear time series conclusions from the clinical process quality indicator for diabetes,
because of the repeated changes of indicator definition which manifest themselves as repeated breaks in
the time series. If anything, however, both average quality and socioeconomic inequality appear not to have
changed much over the period. This contrasts with the situation for CHD and general indicators of clinical
process quality, which show a clear pattern of improving quality and reducing inequality.
There is a clear pattern of increasing average emergency hospitalisation for diabetes from 2001 to 2011
along with an increase in absolute inequality. This is the direct opposite of the pattern for preventable
hospitalisation in general, and for emergency hospitalisation for CHD, both of which show a pattern of falling
average emergency hospitalisation and falling absolute inequality. This increase in hospitalisation may be partly
because of increasing prevalence of diabetes, as we adjust for age and sex but not for disease prevalence.
Reported prevalence increased during the period, although this may be partly because of changes in diagnosis
and reporting behaviour leading to earlier and more complete reporting of cases as opposed to a rise in
the true underlying number of cases at risk of emergency hospitalisation for diabetes. In addition, clinical
guidelines introduced during the 2000s recommended interventions to achieve lower target levels of HbA1c,
related to lower blood sugars. These interventions are associated with increased use of insulin and higher
doses of oral hypoglycaemics, which increases the risk of hypoglycaemia which may increase the risk of
hypoglycaemic attack and hence an increase in emergency hospitalisation.
Finally, mortality from diabetes has fallen over the period, as has both absolute and relative inequality in
mortality. This contrasts sharply with the pattern for emergency hospitalisation for diabetes, and raises an
interesting puzzle for future research: why did mortality from diabetes fall at a time of increasing prevalence of
diabetes? The reason may be that the mortality impact of diabetes depends on the presence of comorbid
conditions, as well as the quality of diabetes management. Cardiovascular disease is the main cause of death
in people with diabetes, accounting for between 52% and 80% of all deaths.200 Declining morbidity from
diabetes may therefore reflect declining CHD prevalence and mortality caused by changes in lifestyle behaviour
and improved medical technology for the treatment of CHD. In essence, our hypothesis is that success in
tackling CHD is reducing the mortality impact of diabetes while increasing its prevalence, because people who
would otherwise have died prematurely from CHD are now living long enough to suffer from diabetes. This is
purely a speculation, however, and would need testing in further research.
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Appendix 4 Indicator definitions
Primary care supply
Definition
Primary care supply is defined as the number of patients per FTE GP, excluding registrars and retainers,
adjusted for age, sex and neighbourhood ill health using the Carr-Hill workload adjustment. The
numerator is the ONS estimate of the total resident population at the mid-point of the current calendar
year, which includes the homeless and people living in institutions such as care homes, prisons and
barracks. The denominator is the number of FTE GPs excluding registrars and retainers attributed to each
small area in the current indicator year.
Technical details
Our data on primary care supply at GP-practice level were obtained from the annual NHS GMS workforce
census, taken 30 September each year, midway through the financial year. In keeping with standard
measures of the GP workforce, we exclude GP registrars and GP retainers from our measure.
We used these data to construct whole-population national data sets at small-area (LSOA) level by using
the NHS ADS of GP-registered populations to attribute FTE GPs from GP practices to LSOAs. The
attribution data set details the LSOAs in which the patients registered with the practice live. We use this
information to determine the proportion of the FTE GP workforce attached to the practice to attribute to
each of the LSOAs that the patients registered with the practice live in. Applying this attribution calculation
to each GP practice and then aggregating the GP supply attributed from the different practices at LSOA
level gives us our measure of primary care supply at LSOA level. We linked practice-level data on primary
care supply for the 10 years 2004/05 through 2011/12 with corresponding LSOA-level data on population
and deprivation. We used data from all 9092 general practices in the English NHS that were open for at
least 1 year of the study period.
We then need-weighted the population for each small area for age, sex and IMD 2010 health and
disability domain using the Carr-Hill formula workload adjustment (updated 2007 version, Table 6).
This adjustment upscales populations that are expected to require more primary care and downscales
populations expected to require less.54,201 The Carr-Hill formula is used for distributing funding to GP
practices. The version of the formula we use was recommended in 2007 by the Formula Review Group,
established by NHS Employers and the BMA, and although never implemented in practice it remains the
most authoritative and up-to-date analysis of the determinants of primary care workload in England.
We do not adjust for temporary resident population, the fourth and final workload adjustment factor in
the Carr-Hill formula, as the HSCIC were unable to provide us with the patient-level data necessary to
make this adjustment.
An alternative would have been to use GP practice registered populations as the population numerator,
rather than ONS estimates of resident population. However, we did not do this for the sake of consistency
with the other indicators. We have chosen to use ONS mid-year population estimates for all our indicators,
because of the concern about GP practice list inflation. This occurs, for example, when people leave an
area without telling their local GP, and means that GP registers tend to overestimate the total population.
We believe that the Carr-Hill formula underestimates additional need for primary care supply in deprived
areas. This is because it only allows for morbidity and not also for how multiple morbidity and
disadvantage combine to generate additional health-care needs.
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Primary care quality
Definition
Primary care quality is a score between 0 and 100, and defined as a weighted average clinical process
quality score in terms of population achievement for 16 indicators in the national QOF. Each indicator
measures the percentage of the relevant patient population for whom the quality target is achieved.
The weights used to combine these indicators into a primary care quality score are proportional to
importance of the individual indicators in terms of the estimated mortality reduction impact associated
with improvement on the indicator.
Technical details
The list of indicators is reported in Table 7. This list includes some ‘intermediate outcomes’, such as
measures of blood pressure and glucose control, as well as ‘pure’ clinical process quality indicators such as
the proportion of patients with CHD receiving beta blockers.
We measure ‘population achievement’ on each clinical indicator. The denominator is the number of
patients diagnosed with the relevant condition, and the numerator is the number of patients for whom
the indicator was met. This is typically lower than ‘reported achievement’, which excludes from the
denominator all patients declared as ‘exceptions’ by the practice. Population achievement is a more
exacting target than reported achievement, and arguably provides a more consistent standard across
different practices as some practices may engage in ‘gaming’ of their exception reporting statistics in order
to report higher achievement and thereby receive greater income.202,203 However, in sensitivity analysis we
also examined ‘reported achievement’.
TABLE 6 Component weights for the calculation of patient-level overall workload weights
Age–sex weight Registration status weight
IMD health and disability
domain score weightBand Weight Band Weight
Male, 0–4 years 2.354 Registered with practice for
≥ 12 months
1.000 The weight is calculated as:
1.054 to the power of the IMD
Health Domain score associated
with the patient’s postcodeMale, 5–14 years 1.000 Registered with practice in
last 12 months
1.689
Male, 15–44 years 0.913
Male, 45–64 years 1.373
Male, 65–74 years 2.531
Male, 75–84 years 3.254
Male, ≥ 85 years 3.193
Female, 0–4 years 2.241
Female, 5–14 years 1.030
Female, 15–44 years 1.885
Female, 45–64 years 2.115
Female, 65–74 years 2.820
Female, 75–84 years 3.301
Female, ≥ 85 years 3.090
Source: Formula Review Group. Review of the General Medical Services Global Sum Formula. London: NHS Employers and
BMA, 2007.54
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We started with a group of 20 QOF indicators, identified by Ashworth et al.,85 based on available evidence
on mortality reduction. We then selected 16 out of the 20 indicators for which data were available
throughout our period of analysis in a consistent format. Each indicator was then weighted based on
importance in terms of the estimated number of lives saved per 100,000 patients. These weights were
derived from Ashworth et al.,85 who identified the highest level of evidence for risk reduction in all-cause
mortality and converted risk reduction estimates into estimated mortality reduction rates per 100,000
population per annum (see Table 7 for details).
Numerators and denominators for the QOF indicators were attributed from GP practice to LSOA level in an
identical manner to that used to attribute primary care supply as described above. The QOF indicators were
then calculated at LSOA level and these were then combined using the weighting process described to
give average performance in terms of primary care quality score at LSOA level.
We do not need to risk adjust this indicator, as it is a nationally comparable quality measure that already
allows for case mix by focusing only on the patient population diagnosed with the relevant condition.
We do not additionally adjust for age and sex, on the basis of the value judgement that age and sex are
not legitimate justifications for poor quality care.
TABLE 7 List of conditions in the QOF
QOF
indicator Summary description of indicator
Crude prevalence per
100,000 registered
patients, mean (SD)
Annual mortality
reduction, per 100,000
registered patients
DM18 Diabetes: influenza vaccination 4420 (1881) 63.7
CHD12 CHD: influenza vaccination 3448 (1487) 61.6
BP5a Hypertension: BP ≤ 150/90 mmHg 13 548 (5117) 48.2
CHD10a CHD: beta-blocker treatment 3448 (1487) 45.9
STROKE10 Stroke/TIA: influenza vaccination 1649 (967) 28.1
DM23a Diabetes: HbA1c ≤ 7.0% 4420 (1881) 26.5
COPD8 COPD: influenza vaccination 1626 (958) 24.9
CHD9a CHD: aspirin or other antithrombotic therapy 3448 (1487) 24.8
CHD8a CHD: cholesterol ≤ 5.0 mmol/l 3448 (1487) 15.8
STROKE12a Stroke (non-haemorrhagic): aspirin or other
antithrombotic therapy
1080 (649) 15.8
DM12 Diabetes: BP ≤ 145/85 mmHg 4420 (1881) 13.5
CHD6a CHD: BP ≤ 150/90 mmHg 3448 (1487) 11.3
SMOKING4 CHD, stroke/TIA, hypertension, DM, CKD, COPD,
asthma, psychosis: smoking cessation advice
3903 (2525) 10.9
DM25 Diabetes: HbA1c ≤ 9.0% 4420 (1881) 7.4
DM15a Diabetes with proteinuria or microalbuminuria:
ACEI or ARB therapy
505 (513) 3.4
CHD11a CHD (myocardial infarction): ACEI or ARB therapy 572 (291) 1.5
ACEI, angiotensin-converting enzyme inhibitor; ARB, angiotensin receptor blocker; BP, blood pressure; CKD, chronic kidney
disease; DM, diabetes mellitus; SD, standard deviation; TIA, transient ischaemic attack.
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Hospital waiting time
Definition
Hospital waiting time is defined as the mean number of days waited from outpatient decision-to-treat to
inpatient admission-for-treatment. This can be termed the ‘inpatient waiting time’, to distinguish it from
the ‘outpatient waiting time’ (from GP referral to specialist visit) and the ‘referral-to-treatment’ waiting
time (from GP referral to inpatient admission). We allow for differences in waiting times by specialty, by
adjusting for the main specialty of the treating consultant. We do not additionally allow for age and sex,
on the basis of the value judgement that in most cases age and sex are not a legitimate justification for
making people wait longer for needed treatment. Unlike most indicators, this is a mean rather than a ratio
and so there is no numerator or denominator.
Technical details
This indicator measures the number of days waited from outpatient referral to inpatient admission per
person hospitalised during the indicator year. We exclude ‘planned’ admissions for which waiting is
medically appropriate rather than being a result of research constraints, for example because of the regular
chemotherapy cycle or the planned removal of an internal fixation after 3 months (see the description
on this HSCIC website http://systems.hscic.gov.uk/data/nhsdmds/faqs/waiting/plannedad; accessed
12 July 2015). There is no evidence of substantial ‘gaming’ of the coding of ‘planned’ versus ‘unplanned’
admissions that could lead to bias.100 Other than ‘planned’ admissions, all patients who had an elective
hospital admission during the indicator year were included, including young children and people over
75 years, either in NHS hospitals or in private hospitals with NHS funding.
We measure hospital waiting time in terms of days from outpatient decision-to-treat to inpatient
admission-for-treatment. This is often termed the inpatient waiting time in the literature. Another
commonly used indicator is the outpatient waiting time, defined as the period between referral from a GP
to the outpatient appointment with a specialist. A third and more comprehensive indicator used in the
NHS since the late 2000s is the referral-to-treatment waiting time, which measures the time from referral
from a GP to inpatient admission-for-treatment, including adjustment to allow for ‘clock stop’ periods of
waiting attributable to patient choices (e.g. not attending an appointment) rather than NHS supply. This
can be further divided into admitted and non-admitted waiting times, by distinguishing patients who are
admitted for inpatient treatment from patients whose course of treatment ends at the outpatient stage
without requiring inpatient admission.
However, we focus on inpatient waiting time because it is considerably quicker and easier to compute,
and less subject to bias as a result of coding and linkage error. Computing referral-to-treatment times
requires linking outpatient and inpatient HES at individual level across multiple years. However, this is
time-consuming in terms of both coding time and computational time, has never previously been done
across all possible procedures and specialties, and would be subject to an unknown degree of coding bias
and selection bias due to linkage failures. It would also be impossible using HES data to fully implement
the complex ‘clock stop’ rules required to replicate official NHS statistics on referral-to-treatment times; and
so the resulting indicator would still not precisely match official NHS statistics. Use of inpatient waiting
time is also more internationally comparable, and is consistent with the definition of waiting time used in
most OECD countries to measure health-system performance.
We calculate hospital waiting time for all elective (non-emergency) hospital admissions for each patient
within each small area. We drop all waiting times greater than 12 months and then calculate the small-
area mean. The waiting times indicator is then indirectly standardised at LSOA level for specialty using the
specialty code of the consultant under whose care the patient was. It is important to adjust for specialty
because waiting time varies based by specialty. We do not additionally allow for age and sex, on the basis
of the value judgement that (at least in most cases) age and sex are not a legitimate justification for
making people wait longer for needed treatment. Our indirect standardisation procedure is described in
Chapter 4. In brief, we compute the expected mean waiting time for a small area by multiplying the
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number of patients in the small area treated in each specialty by the national mean waiting time for that
specialty, and then dividing by the total number of patients treated in the small area. The standardised
waiting time ratio is then the ratio of observed divided by expected mean waiting time. The adjusted
waiting time is the standardised waiting time ratio multiplied by the national mean waiting time. Finally,
we aggregate up this adjusted waiting time to quantile group level to present adjusted mean waiting time
per CIPS for patients who had an elective hospital admission in each quantile group.
Preventable hospitalisation
Definition
Preventable hospitalisation is defined as the number of people per 1000 population having one or more
emergency hospitalisations for a chronic ambulatory care-sensitive condition, adjusting for age and sex.
This indicator could also be described as ‘emergency hospitalisation sensitive to primary care’.
The numerator is the number of people with emergency hospital admissions (both finished and unfinished
admission episodes, excluding transfers) for specific long-term conditions which should not normally
require hospitalisation. This is derived from the HES APC, provided by the HSCIC.
The denominator is the total number of people alive at mid-point in the current financial year. The ONS
mid-year England population estimates for the respective calendar years are used for this purpose.
Technical details
This indicator measures the number of people having an emergency hospital admission per 1000 of
population for specific long-term conditions considered amenable to health care. This is often used as an
indicator of the performance of primary care and the interface between primary and secondary care.
We use the list of conditions defined in the NHS outcomes framework indicator 2.3i (Table 8). Hospital
admissions for all ages, including young children and people over 75 years, are included in this indicator.
TABLE 8 The ICD-10 codes for chronic ambulatory care-sensitive conditions.204 This is based on the list produced by
the ONS and adopted by the NHS Outcomes Framework
ICD code Descriptor
Infections
B18.1 Chronic viral hepatitis B, without delta-agent
B18.0 Chronic viral hepatitis B, with delta-agent
Nutritional, endocrine and metabolic
E10 Insulin-dependent diabetes mellitus
E11 Non-insulin-dependent diabetes mellitus
E12 Malnutrition-related diabetes mellitus
E13 Other specified diabetes mellitus
E14 Unspecified diabetes mellitus
Diseases of the blood
D50.1 Sideropenic dysphagia
D50.8 Other iron-deficiency anaemias
D50.9 Iron-deficiency anaemia, unspecified
D51 Vitamin B12-deficiency anaemia
D52 Folate-deficiency anaemia
continued
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We calculate indirectly standardised emergency hospital admission rate for each small area to allow for
differing age and sex structure by deprivation level. To do so, we start with individual-level HES data on
emergency admissions and aggregate up to small-area level. We then compute the expected hospitalisation
counts for each small area by applying national age–sex hospitalisation rates to small-area-level numbers
of people in each age–sex group. We then compute the adjusted rate for each small area as the product of
the ratio of observed over expected count for the small area and the national rate. We then compute the
adjusted count for each small area as adjusted rate times the small-area population. Finally, we aggregate
up this adjusted count to quantile group level to present adjusted count per 1000 people in each quantile
group. The calculations are set out in Chapter 4.
We note that our definition of preventable hospitalisations focuses on individuals in the numerator
(individuals who have had one or more hospitalisations), whereas the NHS Outcomes Framework definition
focuses on events, as does the OECD definition of preventable hospitalisations. We have chosen to do this
TABLE 8 The ICD-10 codes for chronic ambulatory care-sensitive conditions.204 This is based on the list produced by
the ONS and adopted by the NHS Outcomes Framework (continued )
ICD code Descriptor
Mental and behavioural disorders
F00 Dementia in Alzheimer’s disease
F01 Vascular dementia
F02 Dementia in other diseases classified elsewhere
F03 Unspecified dementia
Neurological disorders
G40 Epilepsy
G41 Status epilepticus
Cardiovascular diseases
I10X Essential (primary) hypertension
I11.0 Hypertensive heart disease with (congestive) heart failure
I11.9 Hypertensive heart disease without (congestive) heart failure
I13.0 Hypertensive heart and renal disease with (congestive) heart failure
I20 Angina pectoris
I25 Chronic ischaemic heart disease
I50 Heart failure
I48X Atrial fibrillation and flutter
J81X Pulmonary oedema
Respiratory diseases
J20 Acute bronchitis
J41 Simple and mucopurulent chronic bronchitis
J42X Unspecified chronic bronchitis
J43 Emphysema
J44 Other chronic obstructive pulmonary disease
J45 Asthma
J46X Status asthmaticus
J47X Bronchiectasis
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differently because (1) we have a separate measure of repeat hospitalisation and, therefore, keep the focus
of this measure on the incidence of hospitalisation (the proportion of people hospitalised) rather than the
intensity (the number of times each individual is hospitalised); and (2) we think that a proportion of the
population or a probability (X people per 1000) is slightly easier for the public to understand than an
event rate.
We also note that our definition of preventable hospitalisation uses all ages in both numerator and
denominator, like the NHS Outcomes Framework definition. However, the OECD definition only includes
age ≥ 15 years, that is we include children but the OECD does not.
Repeat hospitalisation
Definition
Repeat hospitalisation is defined as the proportion of people with any elective or emergency inpatient
hospital admission in a given year who have one or more subsequent any-cause emergency readmission in
the same year, adjusting for age and sex. This is an indicator of the quality of post hospital care, including
the quality of co-ordination between primary, secondary, community care and informal social support. This
is a non-standard indicator developed specifically for the purposes of this project, rather than a standard
and previously validated indicator commonly used for monitoring average health-care quality.
The numerator is the number of people with one or more repeat hospitalisations from any cause in the
indicator year. The denominator is the total number of people with an inpatient admission from any cause
in the same year. Both numerator and denominator are derived from the HES APC, provided by the HSCIC.
Technical details
This indicator measures the proportion of people with an inpatient hospitalisation during the indicator year
who had a second or subsequent emergency rehospitalisation within the same indicator year. The
denominator included all patients who had a hospital admission during the indicator year, including young
children and people aged > 75 years, either in NHS hospitals or in private hospitals with NHS funding.
People with one or more repeat emergency hospitalisation from any-cause were included in the
numerator, as long as it occurred in the same indicator year as the first hospitalisation.
We calculate indirectly standardised all-cause repeat hospitalisation proportion for each small area to allow
for differing age and sex structure by deprivation level. To do so, we start with individual-level HES data on
repeat hospital admissions and aggregate up to small-area level. We then compute the expected repeat
hospitalisation count for each small area by applying national age and sex-specific repeat hospitalisation
rate to small-area-level number of people in each age and sex category. We then compute the adjusted
repeat hospitalisation rate for each small area as the product of the ratio of observed over expected repeat
hospitalisation count for the small area and the national rate. We then compute the adjusted repeat
hospitalisation count for each small area as adjusted rate times the small-area population. Finally, we
aggregate up this adjusted count to quantile group level to present adjusted proportion of repeat
hospitalisation in each quantile group. The calculations are presented in Chapter 4.
We note that we defined repeat hospitalisation within the year rather than computing 30-day or 90-day
repeat hospitalisation for the following reasons: (1) we are interested in whole-system co-ordinated care,
beyond the primary cause of hospital admission and the immediate post-hospital period; and (2) all-cause
repeat hospitalisation within the indicator year provides a larger number of events for the purpose of
detecting statistically significant differences between CCG-level and national-level absolute
inequality gradients.
In addition, we used repeat hospitalisation within the indicator year rather than 12-month readmission
because the latter requires following patients across years which is substantially more time-consuming in
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terms of coding and computational burden. In addition, 12-month readmission would result in a less
up-to-date indicator by either imposing a 1-year data lag or a focus on patients admitted the year before
the indicator year. The drawback of our approach is that it may produce biased estimates of the national
social gradient in 12-month readmission, although this is unlikely substantially to hamper comparisons
between CCGs and over time. The advantage is that this is a simpler, less computationally expensive and
timelier approach.
Dying in hospital
Definition
Dying in hospital is defined as the proportion of deaths from all causes that occurred in hospital in a given
year. The numerator for this indicator is the number of deaths from any cause that occurred in hospital in
a given year, measured using HES data. The denominator is the total number of deaths from any cause
in a given year, irrespective of the place of death, measured using ONS mortality data.
Technical details
This indicator measures the proportion of people dying in hospital. This is an indicator of the quality of
end-of-life care planning and the availability of palliative care and community nursing care at home.
We include deaths from all causes and all ages in both the numerator and the denominator, with the
numerator including only the deaths that occurred in NHS hospitals or in private hospitals with
NHS funding.
There are no adjusted results to present for this indicator, on the basis of the value judgement that age,
sex and other patient characteristics are not legitimate reasons for differential rates of deaths in hospital.
Amenable mortality
Definition
Amenable mortality is defined as the number of deaths per 1000 people from causes considered amenable
to health care, allowing for age and sex. The numerator is the number of people who died in the current
financial year as a result of a cause of death considered amenable to health care. The denominator is the
total number of people alive at mid-point in the current financial year.
Technical details
Amenable mortality was defined according to the conditions listed in the ONS Outcomes Framework
(Table 9). This includes conditions that are responsible for at least 100 deaths in a year and that have a
clear link between the number of deaths and health-care interventions. The classification takes account of
appropriate age limits and each death is counted only once.
We use ONS mortality data for this indicator which is based on the 2001 version of ICD-10 codes.51 From
January 2010, the ONS adopted a new version of ICD-10 codes.205 As we use the data provided by the
ONS, our data are based on the 2001 version of ICD-10 until 2010/11 and then on the 2010 version of
ICD-10 for 2011/12. As this change in coding from 2011/12 may have a small effect on classification of
amenable mortality in those aged > 65 years, we did not see any substantial impact of this coding change
on the inequality trend in our overall amenable mortality trend from 2010/11 to 2011/12.
We calculate indirectly standardised amenable mortality rate for each small area to allow for differing age
and sex structure by deprivation level. To do so, we start with individual-level ONS mortality data and
aggregate up to small-area level. We then compute the expected number of deaths in each small area by
applying national age–sex mortality rates to small-area-level numbers of people in each age–sex group.
We then compute the adjusted rate for each small area as the product of the ratio of observed over
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TABLE 9 The ONS list of causes of death considered amenable to health care.137 Note that the ONS produce
separate lists for ‘amenable’ and ‘preventable’ deaths, where the latter are considered preventable by wider public
health activities outside the health-care system. In line with the NHS Outcomes Framework, we use the former list
(i.e. ‘amenable’)
Condition group and cause ICD-10 codes Age (years)
Infections
Tuberculosis A15–A19, B90 0–74
Selected invasive bacterial and protozoal infections A38–A41, A46, A48.1, B50–B54, G00,
G03, J02, L03
0–74
Hepatitis C B17.1, B18.2 0–74
HIV/AIDS B20–B24 All
Neoplasms
Malignant neoplasm of colon and rectum C18–C21 0–74
Malignant melanoma of skin C43 0–74
Mesothelioma C45 0–74
Malignant neoplasm of breast C50 0–74
Malignant neoplasm of cervix uteri C53 0–74
Malignant neoplasm of bladder C67 0–74
Malignant neoplasm of thyroid gland C73 0–74
Hodgkin’s disease C81 0–74
Leukaemia C91, C92.0 0–44
Benign neoplasms D10–D36 0–74
Nutritional, endocrine and metabolic
Disorders of thyroid gland E00–E07 0–74
Diabetes mellitus E10–E14 0–49
Neurological disorders
Epilepsy and status epilepticus G40–G41 0–74
Cardiovascular diseases
Rheumatic and other valvular heart disease I01–I09 0–74
Hypertensive diseases I10–I15 0–74
Ischaemic heart disease I20–I25 0–74
Cerebrovascular diseases I60–I69 0–74
Respiratory diseases
Influenza (including swine flu) J09–J11 0–74
Pneumonia J12–J18 0–74
Asthma J45–J46 0–74
Digestive disorders
Gastric and duodenal ulcer K25–K28 0–74
Acute abdomen, appendicitis, intestinal
obstruction, cholecystitis/lithiasis,
pancreatitis, hernia
K35–K38, K40–K46, K80–K83, K85,
K86.1–K86.9, K91.5
0–74
continued
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expected count for the small area and the national rate. We then compute the adjusted count for each
small area as adjusted rate times the small-area population. Finally, we aggregate up this adjusted count to
quantile group level to present adjusted count per 1000 people in each quantile group. The calculations
are presented in Appendix 1.
We used the list of causes of death considered amenable to health care from the NHS Outcomes
Framework (indicator 1.1), which in turn is based on a list produced by the ONS. The NHS Outcomes
Framework turns the resulting mortality counts into an estimate of ‘potential years of life lost’ from
premature deaths aged < 75 years. The OECD also applies a cut-off point, by only including ages
0–74 years in both the numerator and population denominator. However, we have used a simple all-age
mortality rate including deaths in those aged ≥ 75 years, as (1) our approach is more comprehensive
(people > 75 years experience by far the highest rate of amenable mortality) and (2) based on advice from
two lay members of our advisory group and a media expert, we believe that mortality rates are easier for
the public to understand than ‘potential years of life lost’.
However, we recommend that in future work a cut-off point of age 74 years is applied to our indicator for
both the mortality numerator and population denominator. This is because using an all-age population
denominator artificially deflates the rates for some of the mortality causes, and may lead to artificial
variation between areas with different proportions of elderly people over the age of 75 years.
Overall mortality
Definition
Overall all-age all-cause mortality is defined as the number of deaths for all ages and all causes in a given
year as a proportion of the total number of people alive at the start of the year. The numerator for this
indicator is the number of deaths from any cause that occurred in a given year. The denominator is the
total number of people alive at the start of a given year.
TABLE 9 The ONS list of causes of death considered amenable to health care.137 Note that the ONS produce
separate lists for ‘amenable’ and ‘preventable’ deaths, where the latter are considered preventable by wider public
health activities outside the health-care system. In line with the NHS Outcomes Framework, we use the former list
(i.e. ‘amenable’) (continued )
Condition group and cause ICD-10 codes Age (years)
Genitourinary disorders
Nephritis and nephrosis N00–N07, N17–N19, N25–N27 0–74
Obstructive uropathy and prostatic hyperplasia N13, N20–N21, N35, N40, N99.1 0–74
Maternal and infant
Complications of perinatal period P00–P96, A33 All
Congenital malformations, deformations and
chromosomal anomalies
Q00–Q99 0–74
Injuries
Misadventures to patients during surgical and
medical care
Y60–Y69, Y83–Y84 All
AIDS, acquired immune deficiency syndrome; HIV, human immunodeficiency virus.
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Technical details
This indicator is expressed as the number of deaths from all causes at all ages per 1000 people alive.
We use all-age all-cause mortality as a contextual indicator of inequality in health, to help interpret levels
and trends in our seven health-care equity indicators. As the age and sex structure of each area can
affect the mortality rate, we adjust the mortality rate by taking account of the age and sex structure of
the population.
We calculate indirectly standardised all-cause all-age mortality for each small area to allow for differing age
and sex structure by deprivation level. To do so, we start with individual-level ONS mortality data for all
ages and aggregate up to small-area level. We then compute the expected number of deaths for each
small area by applying national age and sex-specific mortality rate to small-area-level number of people in
each age and sex category. We then compute the adjusted mortality rate for each small area as the
product of the ratio of observed over expected mortality count for the small area and the national rate.
We then compute the adjusted mortality count for each small area as adjusted rate times the small-area
population. Finally, we aggregate up this adjusted count to quantile group level to present adjusted
proportion of all-cause mortality per 1000 people in each quantile group. The calculations are presented in
Chapter 4.
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Appendix 5 Trimming analysis
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FIGURE 81 Kernel density plots by indicator, showing six standard deviation trim points in 2011/12. (a) Indicator 1:
primary care supply; (b) indicator 2: primary care quality; (c) indicator 3: hospital waiting time; (d) indicator 4:
preventable hospitalisation; (e) indicator 5: repeat hospitalisation; (f) indicator 6: dying in hospital; (g) indicator 7:
amenable mortality; and (h) indicator 8: mortality.
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FIGURE 82 Bar charts by indicator, showing percentage trimmed by deprivation vingtile in 2011/12 using six
standard deviation trim points.
APPENDIX 5
NIHR Journals Library www.journalslibrary.nihr.ac.uk
206
(a)
0.18
0.12
0.16
0.14
0.10
N
u
m
b
er
 o
f 
d
at
a 
tr
im
m
ed
 (
%
)
2001/2 2002/3 2003/4 2004/5 2005/6 2006/7
Year
2007/8 2008/9 2009/10 2010/11 2011/12
(b)
0.9
1.0
0.7
0.8
N
u
m
b
er
 o
f 
d
at
a 
tr
im
m
ed
 (
%
)
2001/2 2002/3 2003/4 2004/5 2005/6 2006/7
Year
2007/8 2008/9 2009/10 2010/11 2011/12
FIGURE 83 Percentage of LSOAs trimmed by year for each indicator, using six standard deviation trim points. (continued)
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FIGURE 83 Percentage of LSOAs trimmed by year for each indicator, using six standard deviation trim points. (continued)
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FIGURE 83 Percentage of LSOAs trimmed by year for each indicator, using six standard deviation trim points. (continued)
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FIGURE 84 Kernel density plots by indicator, showing three standard deviation trim points in 2011/12.
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FIGURE 85 Bar charts by indicator, showing percentage trimmed by deprivation vingtile in 2011/12 using three
standard deviation trim points.
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FIGURE 86 Percentage of LSOAs trimmed by year for each indicator, using three standard deviation
trim points. (continued )
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FIGURE 86 Percentage of LSOAs trimmed by year for each indicator, using three standard deviation
trim points. (continued )
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FIGURE 86 Percentage of LSOAs trimmed by year for each indicator, using three standard deviation
trim points. (continued )
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FIGURE 86 Percentage of LSOAs trimmed by year for each indicator, using three standard deviation trim points.
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Appendix 6 Public consultation materials
Recruitment materials for the citizens’ panel exercise
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Consent form for the citizens’ panel event
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Rating question about the most unfair inequalities in health and healthcare 
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Rating question about the most unfair inequalities in health
and health care
Screenshot from the online questionnaire
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Appendix 7 Letters of support
E-mail from Health Inequalities Lead, NHS England Equality and
Health Inequalities Unit
 
Health Equity Compass 
1 message 
 
9 November 2015 at 15:57
Dear Richard, 
Thank you for engaging with the equality and health inequalities unit.  It has been a 
pleasure to be able to see how the research work on the health equity dashboard/compass 
has developed over the last year. 
It is important that NHS investment in research can then add further value through 
operationalisation. We will, subject to resources, seek to develop key aspects of the work 
in our approach to measuring progress on health equity.   The Equality and Health 
Inequalities Programme Board supported the attached paper which references this 
approach.  
 Kind regards, 
  
Lead -  Health Inequalities 
Equality and Health Inequalities Unit 
Commissioning Strategy 
NHS England  
4E44| Quarry House| Quarry Hill| Leeds| LS2 7UE 
 
www.england.nhs 
 “High quality care for all, now and for future generations.” 
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E-mail from chairperson of Hull Clinical Commissioning Group
 
NHS equity indicators 
1 message 
 
13 November 2015 at 08:18
  
The Hull CCG would formally like to express its support for the work that Richard 
Cookson and his colleagues have been undertaking at the University of York on NHS 
Equity Indicators. 
  
As we move towards delegated commissioning for Primary Care Services in Hull and 
also develop new models of care in the City the detail, breadth and significance of this 
intelligence about what is happening on the ground is of vital importance for us as we 
look at assessing the needs of the population of our city. 
  
We had a presentation of the work at our co-commissioning board in June and as a group 
of clinicians and non-clinicians we found the information of great interest and we look 
forward to its further development and possible dissemination. 
  
Other health economies I am sure will find it as useful as we do and we feel that these are 
exactly the sort of statistics that should be produced as they are directly applicable to the 
commissioning decisions we have to make. 
  
  
 
Chair 
Hull CCG 
Wilberforce Court  
Alfred Gelder Street 
Hull  
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Letter from Chief Clinical Officer, Value of York Clinical
Commissioning Group
Letter from  
Chief Clinical Officer, Value of York CCG
 
 
 
Ref  MH/HN-ms 
 
 
 
Professor Richard Cookson 
Centre for Health Economics 
University of York
York  
YO10 5DD 
West Offices 
Station Rise 
York,  
YO1 6GA 
Tel: 
RNID typetalk: 
Email: 
 Website: 
11 November 2015 
Dear Professor Cookson 
 
RE: Prototype Health Equity Indicators 
 
I am writing in support of the prototype NHS equity indicators that you demonstrated earlier 
this year to a group of colleagues across the health system in York. We found the rationale 
for the selected indicators convincing, and in covering the end-to-end patient journey gave a 
wide range of points of comparison.  
 
It was clear from the presentation and data that these indicators, available on a national basis 
and updated annually, would provide a firm foundation for health equity monitoring and for 
improvement purposes, as well as for planning and delivering local health services. We 
would be interested in working with these indicators in conjunction with local authority and 
public health colleagues to understand where effective interventions can be made on the basis 
of this data, and hope that full consideration is given to rolling out this approach at national 
level. 
 
Yours sincerely 
 
Chief Clinical Officer 
 
 
 
 
  
NHS Vale of York Clinical Commissioning Group 
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